Photo Gallery
Factory & Principals
Home Page

Confidential Research

Separate Search Page
or search below


Ayurvedic Activated MSM

CalmCream Company
Bulk & Retail Packages
MSM
CalmCream Slide Show Table Of Contents
DMG TMG Homeopathy

Transfer Factor

Research & Technical


Top


Results for your query on April 30, 1999:
Search all fields for: transfer factor
Published in 1988
Only select references with abstracts available
Show references published in English only
Documents: 1 to 200 of 255
1 Rozzo SJ, et al; Murine transfer factor. IV. Studies with genetically regulated immune responses. (Cell Immunol, 1988 Aug, Abstract available) [MEDLINE]
2 Kirkpatrick CH; Transfer factor. (J Allergy Clin Immunol, 1988 May, Abstract available) [MEDLINE]
3 Wilson GB, et al; De novo initiation of specific cell-mediated immune responsiveness in chickens by transfer factor (specific immunity inducer) obtained from bovine colostrum and milk. (Acta Virol, 1988 Jan, Abstract available) [MEDLINE]
4 Karhumäki E, et al; Chromatographic and enzymatic effects on transfer factor-like activity from human leukocytes and porcine spleen dialysate. (Int J Biochem, 1988, Abstract available) [MEDLINE]
5 Hancock BW, et al; Transfer factor in Hodgkin's disease: a randomized clinical and immunological study. (Eur J Cancer Clin Oncol, 1988 May, Abstract available) [MEDLINE]
6 Zachar V, et al; Varicella-zoster virus IgG antibodies during primoinfection in competent and transfer factor modulated immunocompromised host: comparison of three indirect assays. (Acta Virol, 1988 May, Abstract available) [MEDLINE]
7 Miller LL, et al; A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanoma. (Cancer, 1988 Apr, Abstract available) [MEDLINE]
8 Banks JB, et al; Evidence for protein-catalyzed transfer of platelet activating factor by macrophage cytosol. (Biochim Biophys Acta, 1988 Jul, Abstract available) [MEDLINE]
9 Babkina GT, et al; Affinity labeling at the A-site of Escherichia coli ribosomes by a non-hydrolyzable gamma-amide analog of GTP. (Biochimie, 1988 May, Abstract available) [MEDLINE]
10 Seifried SE, et al; Fluorescent modification of the cysteine 202 residue of Escherichia coli transcription termination factor rho. (J Biol Chem, 1988 Sep, Abstract available) [MEDLINE]
11 Lukács K, et al; Adult chronic granulomatosis disease-like neutrophil granulocyte disorder corrected by dialysable leukocyte extract. (Allergol Immunopathol (Madr), 1988 Mar, Abstract available) [MEDLINE]
12 Maldonado PE, et al; Growth factors modulate junctional cell-to-cell communication. (J Membr Biol, 1988 Dec, Abstract available) [MEDLINE]
13 Vijgenboom E, et al; The elongation factor EF-Tu from E. coli binds to the upstream activator region of the tRNA-tufB operon. (Nucleic Acids Res, 1988 Nov, Abstract available) [MEDLINE]
14 Collins MK, et al; Transfer of functional EGF receptors to an IL3-dependent cell line. (J Cell Physiol, 1988 Nov, Abstract available) [MEDLINE]
15 Chinali G, et al; Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems. (Biochim Biophys Acta, 1988 Nov, Abstract available) [MEDLINE]
16 Jakubowski H; Negative correlation between the abundance of Escherichia coli aminoacyl-tRNA families and their affinities for elongation factor Tu-GTP. (J Theor Biol, 1988 Aug, Abstract available) [MEDLINE]
17 Van Delft JH, et al; Control of the tRNA-tufB operon in Escherichia coli. 3. Feedback inhibition of tufB expression by an EF-Tu with a deletion in the guanine-nucleotide-binding domain. (Eur J Biochem, 1988 Aug, Abstract available) [MEDLINE]
18 Abrahams JP, et al; Zone-interference gel electrophoresis: a new method for studying weak protein-nucleic acid complexes under native equilibrium conditions. (Nucleic Acids Res, 1988 Nov, Abstract available) [MEDLINE]
19 Clark DJ, et al; A yeast sigma composite element, TY3, has properties of a retrotransposon. (J Biol Chem, 1988 Jan, Abstract available) [MEDLINE]
20 Van Delft JH, et al; Control of the tRNA-tufB operon in Escherichia coli. 2. Mechanisms of the feedback inhibition of tufB expression studied in vivo and in vitro. (Eur J Biochem, 1988 Aug, Abstract available) [MEDLINE]
21 Van Delft JH, et al; Control of the tRNA-tufB operon in Escherichia coli. 1. rRNA gene dosage effects and growth-rate-dependent regulation. (Eur J Biochem, 1988 Aug, Abstract available) [MEDLINE]
22 Sandmeyer SB, et al; Sigma elements are position-specific for many different yeast tRNA genes. (Nucleic Acids Res, 1988 Feb, Abstract available) [MEDLINE]
23 Rosenberg SA; The development of new immunotherapies for the treatment of cancer using interleukin-2. A review. (Ann Surg, 1988 Aug, Abstract available) [MEDLINE]
24 Moazed D, et al; Interaction of elongation factors EF-G and EF-Tu with a conserved loop in 23S RNA. (Nature, 1988 Jul, Abstract available) [MEDLINE]
25 Church WR, et al; A conserved epitope on several human vitamin K-dependent proteins. Location of the antigenic site and influence of metal ions on antibody binding. (J Biol Chem, 1988 May, Abstract available) [MEDLINE]
26 Kosano H, et al; Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid. (Cancer Res, 1988 Nov, Abstract available) [MEDLINE]
27 Allan B, et al; Heat shock response of Pseudomonas aeruginosa. (J Bacteriol, 1988 Aug, Abstract available) [MEDLINE]
28 Bar RS, et al; IGF receptors in myocardial capillary endothelium: potential regulation of IGF-I transport to cardiac muscle. (Biochem Biophys Res Commun, 1988 Apr, Abstract available) [MEDLINE]
29 Brannon PM, et al; Effects of epidermal growth factor, insulin and insulin-like growth factor I on rat pancreatic acinar cells cultured in serum-free medium. (Pancreas, 1988, Abstract available) [MEDLINE]
30 Collier M, et al; Biochemical and pharmacological characterization of human embryo-derived platelet activating factor. (Hum Reprod, 1988 Nov, Abstract available) [MEDLINE]
31 von Rüden T, et al; Expression of functional human EGF receptor on murine bone marrow cells. (EMBO J, 1988 Sep, Abstract available) [MEDLINE]
32 Church WR, et al; An inhibitory monoclonal antibody to factor X that blocks prothrombin activation but not prothrombinase enzyme assembly. (Blood, 1988 Dec, Abstract available) [MEDLINE]
33 Robertson B, et al; Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. (J Immunol, 1988 Jun, Abstract available) [MEDLINE]
34 Colburn NH, et al; Comparison of mouse pro-1 and pro-2 transfectants for responses to tumor promoters and antipromoters. (Cancer Res, 1988 Nov, Abstract available) [MEDLINE]
35 Pai JK, et al; Activation of phospholipase D by chemotactic peptide in HL-60 granulocytes. (Biochem Biophys Res Commun, 1988 Jan, Abstract available) [MEDLINE]
36 Cosby RL, et al; Elevated plasma atrial natriuretic factor and vasopressin in high-altitude pulmonary edema. (Ann Intern Med, 1988 Nov, Abstract available) [MEDLINE]
37 Silva CL, et al; Tumor necrosis factor (cachectin) mediates induction of cachexia by cord factor from mycobacteria. (Infect Immun, 1988 Dec, Abstract available) [MEDLINE]
38 Barry EL, et al; Factor XIII cross-linking of fibronectin at cellular matrix assembly sites. (J Biol Chem, 1988 Jul, Abstract available) [MEDLINE]
39 Hamel E, et al; Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation. (Cancer Res, 1988 May, Abstract available) [MEDLINE]
40 Emoto N, et al; The effect of tumor necrosis factor/cachectin on follicle-stimulating hormone-induced aromatase activity in cultured rat granulosa cells. (Biochem Biophys Res Commun, 1988 Jun, Abstract available) [MEDLINE]
41 Hermansson M, et al; Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. (Proc Natl Acad Sci U S A, 1988 Oct, Abstract available) [MEDLINE]
42 Downs SM, et al; Induction of maturation in cumulus cell-enclosed mouse oocytes by follicle-stimulating hormone and epidermal growth factor: evidence for a positive stimulus of somatic cell origin. (J Exp Zool, 1988 Jan, Abstract available) [MEDLINE]
43 Jones FS, et al; A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. (Proc Natl Acad Sci U S A, 1988 Apr, Abstract available) [MEDLINE]
44 Wu JH, et al; The product of the F plasmid transfer operon gene, traF, is a periplasmic protein. (J Bacteriol, 1988 Aug, Abstract available) [MEDLINE]
45 Fukuma K, et al; Immunologic and clinical studies on murine experimental autoimmune gastritis induced by neonatal thymectomy. (Gastroenterology, 1988 Feb, Abstract available) [MEDLINE]
46 Filetici E, et al; R-plasmids in Salmonella isolates from sporadic cases of gastroenteritis. (Eur J Epidemiol, 1988 Sep, Abstract available) [MEDLINE]
47 Carr BR, et al; The effects of alpha-human atrial natriuretic polypeptide on steroidogenesis by fetal zone cells of the human fetal adrenal gland. (Am J Obstet Gynecol, 1988 Dec, Abstract available) [MEDLINE]
48 Miyawaki S, et al; Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice. (Lab Anim Sci, 1988 Jun, Abstract available) [MEDLINE]
49 Knight KR, et al; Effect of the vasodilator peptides calcitonin gene-related peptide and atriopeptin on rabbit microvascular blood flow. Preliminary communication. (Br J Plast Surg, 1988 Mar, Abstract available) [MEDLINE]
50 Ruschen S, et al; An ELISA for IgA, IgG and IgM-RF measurement. I. Parameters of the assay. (Scand J Rheumatol Suppl, 1988, Abstract available) [MEDLINE]
51 Traxler BA, et al; Evidence that DNA helicase I and oriT site-specific nicking are both functions of the F TraI protein. (J Mol Biol, 1988 Nov, Abstract available) [MEDLINE]
52 Fox TD, et al; Plasmids can stably transform yeast mitochondria lacking endogenous mtDNA. (Proc Natl Acad Sci U S A, 1988 Oct, Abstract available) [MEDLINE]
53 Potapov AP, et al; The role of a template sugar-phosphate backbone in the ribosomal decoding mechanism. Comparative study of poly(U) and poly(dT) template activity. (J Mol Biol, 1988 Oct, Abstract available) [MEDLINE]
54 Fennerty AG, et al; The transfer factor and its subdivisions in patients with pulmonary emboli. (Eur Respir J, 1988 Feb, Abstract available) [MEDLINE]
55 Miyazaki M, et al; Peptide elongation factor 1 from yeasts: purification and biochemical characterization of peptide elongation factors 1 alpha and 1 beta (gamma) from Saccharomyces carlsbergensis and Schizosaccharomyces pombe [published erratum appears in J Biochem (Tokyo) 1988 May;103(5):900] (J Biochem (Tokyo), 1988 Mar, Abstract available) [MEDLINE]
56 Uritani M, et al; Role of yeast peptide elongation factor 3 (EF-3) at the AA-tRNA binding step. (J Biochem (Tokyo), 1988 Jul, Abstract available) [MEDLINE]
57 Cotes JE, et al; Lung function impairment as a guide to exercise limitation in work-related lung disorders. (Am Rev Respir Dis, 1988 May, Abstract available) [MEDLINE]
58 Kerr GD; Quality factors. (Health Phys, 1988 Aug, Abstract available) [MEDLINE]
59 Rooney RJ, et al; Transcriptional activity and factor binding are stimulated by separate and distinct sequences in the 5' flanking region of a mouse tRNAAsp gene. (Nucleic Acids Res, 1988 Mar, Abstract available) [MEDLINE]
60 Panniers R, et al; The effect of Mg2+ and guanine nucleotide exchange factor on the binding of guanine nucleotides to eukaryotic initiation factor 2. (J Biol Chem, 1988 Apr, Abstract available) [MEDLINE]
61 Shapiro AB, et al; Alteration of the nucleotide-binding site asymmetry of chloroplast coupling factor 1 by catalysis. (J Biol Chem, 1988 Oct, Abstract available) [MEDLINE]
62 Voigt G, et al; Measurements of transfer coefficients for 137Cs, 60Co, 54Mn, 22Na, 131I and 95mTc from feed into milk and beef. (Radiat Environ Biophys, 1988, Abstract available) [MEDLINE]
63 Chinn DJ, et al; Measurement technique influences the response of transfer factor (TICO) to salbutamol in patients with airflow limitation. (Eur Respir J, 1988 Jan, Abstract available) [MEDLINE]
64 Arnold GJ, et al; Functional dissection of 5' and 3' extragenic control regions of human tRNA(Val) genes reveals two different regulatory effects. (DNA, 1988 Mar, Abstract available) [MEDLINE]
65 Mizutani T, et al; Stronger affinity of reticulocyte release factor than natural suppressor tRNASer for the opal termination codon. (FEBS Lett, 1988 Jan, Abstract available) [MEDLINE]
66 Balmaceda JP, et al; Tubal embryo transfer as a treatment for infertility due to male factor. (Fertil Steril, 1988 Sep, Abstract available) [MEDLINE]
67 Sawadogo M; Multiple forms of the human gene-specific transcription factor USF. II. DNA binding properties and transcriptional activity of the purified HeLa USF. (J Biol Chem, 1988 Aug, Abstract available) [MEDLINE]
68 Kellerer AM, et al; Considerations on a revision of the quality factor. (Radiat Res, 1988 Jun, Abstract available) [MEDLINE]
69 Ogawa H, et al; Participation of suppressor-inducer cells in the suppression of adjuvant arthritis by transfer of spleen cells expanded by T cell growth factor. (Clin Exp Immunol, 1988 Jun, Abstract available) [MEDLINE]
70 Dean N, et al; Ordering promoter binding of class III transcription factors TFIIIC1 and TFIIIC2. (Mol Cell Biol, 1988 Aug, Abstract available) [MEDLINE]
71 Martin R, et al; Release factor competition is equivalent at strong and weakly suppressed nonsense codons. (Mol Gen Genet, 1988 Jul, Abstract available) [MEDLINE]
72 Curran JF, et al; Use of tRNA suppressors to probe regulation of Escherichia coli release factor 2. (J Mol Biol, 1988 Sep, Abstract available) [MEDLINE]
73 Calés C, et al; Differential subcellular distribution of guanine nucleotide exchange factor in suckling and adult rat brain. (Neurosci Lett, 1988 May, Abstract available) [MEDLINE]
74 Oehninger S, et al; In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosis. (J In Vitro Fert Embryo Transf, 1988 Oct, Abstract available) [MEDLINE]
75 Brady MS, et al; Method to determine effect of antibiotics at residue levels on R-factor transfer. (J Assoc Off Anal Chem, 1988 Mar, Abstract available) [MEDLINE]
76 Sampson JR, et al; Biochemical and physical characterization of an unmodified yeast phenylalanine transfer RNA transcribed in vitro. (Proc Natl Acad Sci U S A, 1988 Feb, Abstract available) [MEDLINE]
77 Liang JY, et al; Hydration of CO2 by carbonic anhydrase: intramolecular proton transfer between Zn2+-bound H2O and histidine 64 in human carbonic anhydrase II. (Biochemistry, 1988 Nov, Abstract available) [MEDLINE]
78 Hausner TP, et al; The allosteric three-site model for the ribosomal elongation cycle. New insights into the inhibition mechanisms of aminoglycosides, thiostrepton, and viomycin. (J Biol Chem, 1988 Sep, Abstract available) [MEDLINE]
79 Horvath D, et al; Sequences between the internal control regions of tRNAArg of Drosophila melanogaster influence stimulation of transcription of the 5' flanking DNA. (Nucleic Acids Res, 1988 Mar, Abstract available) [MEDLINE]
80 Ogasawara T, et al; Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli O157:H7 at the level of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes. (Microb Pathog, 1988 Feb, Abstract available) [MEDLINE]
81 Marschalek R, et al; Identification of a protein factor binding to the 5'-flanking region of a tRNA gene and being involved in modulation of tRNA gene transcription in vivo in Saccharomyces cerevisiae. (Nucleic Acids Res, 1988 Jul, Abstract available) [MEDLINE]
82 Houssier C, et al; Effect of uridine dethiolation in the anticodon triplet of tRNA(Glu) on its association with tRNA(Phe). (J Biomol Struct Dyn, 1988 Jun, Abstract available) [MEDLINE]
83 Ricker RD, et al; Separation of formyl-methionyl transfer RNA, methionyl transfer RNA, and transfer RNAfmet using mixed-mode high-performance liquid chromatography on C6-modified aminopropylsilyl-hypersil. (Anal Biochem, 1988 Nov, Abstract available) [MEDLINE]
84 Westhof E, et al; Restrained refinement of two crystalline forms of yeast aspartic acid and phenylalanine transfer RNA crystals. (Acta Crystallogr A, 1988 Mar, Abstract available) [MEDLINE]
85 Kim KE, et al; Functional analysis of the interaction of a tissue-specific factor with an upstream enhancer element of the rat prolactin gene. (Mol Endocrinol, 1988 Dec, Abstract available) [MEDLINE]
86 Berger JW, et al; Brownian dynamics simulations of intramolecular energy transfer. (Biophys Chem, 1988 Jul, Abstract available) [MEDLINE]
87 Venuti SE, et al; Tissue distribution, purification and characterization of rat phosphatidylinositol transfer protein. (Biochim Biophys Acta, 1988 Dec, Abstract available) [MEDLINE]
88 Christianson TW, et al; A tridecamer DNA sequence supports human mitochondrial RNA 3'-end formation in vitro. (Mol Cell Biol, 1988 Oct, Abstract available) [MEDLINE]
89 Cox S, et al; Regulation of polypeptide-chain initiation in rat skeletal muscle. Starvation does not alter the activity or phosphorylation state of initiation factor eIF-2. (FEBS Lett, 1988 Nov, Abstract available) [MEDLINE]
90 Britton J; Is the carbon monoxide transfer factor diminished in the presence of diabetic retinopathy in patients with insulin-dependent diabetes mellitus? (Eur Respir J, 1988 May, Abstract available) [MEDLINE]
91 Wolff C, et al; Evidence that the two amino termini of plasma fibronectin are in close proximity: a fluorescence energy transfer study. (Biochemistry, 1988 May, Abstract available) [MEDLINE]
92 Yovich JM, et al; Preliminary results using pentoxifylline in a pronuclear stage tubal transfer (PROST) program for severe male factor infertility. (Fertil Steril, 1988 Jul, Abstract available) [MEDLINE]
93 Bommer UA, et al; Identification of proteins of the 40 S ribosomal subunit involved in interaction with initiation factor eIF-2 in the quaternary initiation complex by means of monospecific antibodies. (FEBS Lett, 1988 Jun, Abstract available) [MEDLINE]
94 Bommer UA, et al; Affinity labeling by a photoreactive GTP analogue of the alpha-subunit of eukaryotic initiation factor eIF-2 in different initiation complexes. (Biochem Int, 1988 Mar, Abstract available) [MEDLINE]
95 Yamaguchi K, et al; Dependence of O2 transfer conductance of red blood cells on cellular dimensions. (Adv Exp Med Biol, 1988, Abstract available) [MEDLINE]
96 Forman R, et al; Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation. (Fertil Steril, 1988 Jan, Abstract available) [MEDLINE]
97 Van den Abbeel E, et al; Hyperstimulation: the need for cryopreservation of embryos. (Hum Reprod, 1988 Oct, Abstract available) [MEDLINE]
98 Kersten H; The nutrient factor queuine: biosynthesis, occurrence in transfer RNA and function. (Biofactors, 1988 Jan, Abstract available) [MEDLINE]
99 Thomas LK, et al; Codon choice and gene expression: synonymous codons differ in their ability to direct aminoacylated-transfer RNA binding to ribosomes in vitro. (Proc Natl Acad Sci U S A, 1988 Jun, Abstract available) [MEDLINE]
100 Hashiguchi R, et al; Dependence of instantaneous transfer function on regional ischemic myocardial volume. (Circ Res, 1988 Dec, Abstract available) [MEDLINE]
101 Garland F, et al; The MgADP-induced decrease of the SH1-SH2 fluorescence resonance energy transfer distance of myosin subfragment 1 occurs in two kinetic steps. (J Biol Chem, 1988 Aug, Abstract available) [MEDLINE]
102 Ann DK, et al; Retinol-regulated gene expression in human tracheobronchial epithelial cells. Enhanced expression of elongation factor EF-1 alpha. (J Biol Chem, 1988 Mar, Abstract available) [MEDLINE]
103 Sehgal A, et al; A constitutive promoter directs expression of the nerve growth factor receptor gene. (Mol Cell Biol, 1988 Aug, Abstract available) [MEDLINE]
104 Belgum JH, et al; Synaptic transfer of rod signals to horizontal and bipolar cells in the retina of the toad (Bufo marinus). (J Physiol (Lond), 1988 Feb, Abstract available) [MEDLINE]
105 Hara K, et al; Bipotential murine hemopoietic cell line (NFS-60) that is responsive to IL-3, GM-CSF, G-CSF, and erythropoietin. (Exp Hematol, 1988 May, Abstract available) [MEDLINE]
106 Picard A, et al; The cell cycle can occur in starfish oocytes and embryos without the production of transferable MPF (maturation-promoting factor). (Dev Biol, 1988 Jul, Abstract available) [MEDLINE]
107 Wolf D, et al; Retrovirus-mediated gene transfer of beta-nerve growth factor into mouse pituitary line AtT-20. (Mol Biol Med, 1988 Feb, Abstract available) [MEDLINE]
108 Zembala M, et al; T suppressor efferent circuit which affects contact sensitivity to picryl chloride: the late-acting, second nonspecific T suppressor factor bears I-A determinants which are responsible for the I-A genetic restriction in its interaction with its target cell. (Cell Immunol, 1988 Oct, Abstract available) [MEDLINE]
109 Nakano Y; Non-specific regulatory mechanism of contact sensitivity: the requirement of intermediate cells for non-specific suppressor factor (NSF) activity. (Immunology, 1988 Jun, Abstract available) [MEDLINE]
110 Zorn JR, et al; Ovarian stimulation for in-vitro fertilization combining administration of gonadotrophins and blockade of the pituitary with D-Trp6-LHRH microcapsules: pilot studies with two protocols. (Hum Reprod, 1988 Feb, Abstract available) [MEDLINE]
111 Ohki K, et al; Establishment and characterization of factor-dependent macrophage cell lines. (J Leukoc Biol, 1988 Dec, Abstract available) [MEDLINE]
112 Park MH, et al; Cell-free synthesis of deoxyhypusine. Separation of protein substrate and enzyme and identification of 1,3-diaminopropane as a product of spermidine cleavage. (J Biol Chem, 1988 Oct, Abstract available) [MEDLINE]
113 Killion JW, et al; Determinants of immunity to murine salmonellosis: studies involving immunization with lipopolysaccharide-lipid A-associated protein complexes in C3H/HeJ mice. (FEMS Microbiol Immunol, 1988 Jan, Abstract available) [MEDLINE]
114 Khan I, et al; Success rate in gamete intrafallopian transfer using low and high concentrations of washed spermatozoa. (Fertil Steril, 1988 Dec, Abstract available) [MEDLINE]
115 Crapo RO, et al; Variability of the single-breath carbon monoxide transfer factor as a function of inspired oxygen pressure. (Eur Respir J, 1988 Jun, Abstract available) [MEDLINE]
116 Haque A, et al; Tolerance in rats by transplacental transfer of Dipetalonema viteae microfilariae: recognition of putative tolerogen(s) by antibodies that inhibit antigen-specific lymphocyte proliferation. (Eur J Immunol, 1988 Aug, Abstract available) [MEDLINE]
117 Klingler K, et al; Transformation of single myeloid precursor cells by the malignant histiocytosis sarcoma virus (MHSV): generation of growth-factor-independent myeloid colonies and permanent cell lines. (J Cell Physiol, 1988 Apr, Abstract available) [MEDLINE]
118 Engelke DR; Interaction of tRNA transcription factors with satellite I DNA from Xenopus laevis. (Gene, 1988, Abstract available) [MEDLINE]
119 Peritz LN, et al; The human growth hormone gene contains both positive and negative control elements. (J Biol Chem, 1988 Apr, Abstract available) [MEDLINE]
120 Raffa RB, et al; The analgesic defect of C57BL/6J-bgJ/bgJ (beige-J: Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermates. (Life Sci, 1988, Abstract available) [MEDLINE]
121 Wong KK, et al; Glutathione reductase: solvent equilibrium and kinetic isotope effects. (Biochemistry, 1988 Sep, Abstract available) [MEDLINE]
122 Tsubura A, et al; Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo. (Cancer Res, 1988 Nov, Abstract available) [MEDLINE]
123 Oluwole SF, et al; Mechanisms of immunologic unresponsiveness induced by ultraviolet-irradiated donor-specific blood transfusions and peritransplant cyclosporine. (Transplantation, 1988 Sep, Abstract available) [MEDLINE]
124 Ng YC, et al; Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions. (Clin Exp Immunol, 1988 Mar, Abstract available) [MEDLINE]
125 Holt JC, et al; Occurrence of platelet basic protein, a precursor of low affinity platelet factor 4 and beta-thromboglobulin, in human platelets and megakaryocytes. (Exp Hematol, 1988 May, Abstract available) [MEDLINE]
126 Frey B, et al; New function of vitamin B12: cobamide-dependent reduction of epoxyqueuosine to queuosine in tRNAs of Escherichia coli and Salmonella typhimurium. (J Bacteriol, 1988 May, Abstract available) [MEDLINE]
127 Tsutsui K, et al; Effects of photoperiod and temperature on the binding of follicle-stimulating hormone (FSH) to testicular preparations and plasma FSH concentration in the Djungarian hamster, Phodopus sungorus. (Endocrinology, 1988 Mar, Abstract available) [MEDLINE]
128 Davies AM; The trigeminal system: an advantageous experimental model for studying neuronal development. (Development, 1988, Abstract available) [MEDLINE]
129 Carson WG Jr; The role of lateral extra-articular procedures for anterolateral rotatory instability. (Clin Sports Med, 1988 Oct, Abstract available) [MEDLINE]
130 Brittle MP, et al; Induced type-B reticulum cell neoplasia in mice III. The importance of T-cell proliferation and cellular relocation in accessory cell transformation. (Br J Cancer, 1988 Apr, Abstract available) [MEDLINE]
131 Jaffrin MY, et al; Analysis of ultrafiltration and mass transfer in a bioartificial pancreas. (J Biomech Eng, 1988 Feb, Abstract available) [MEDLINE]
132 Dorshkind K; IL-1 inhibits B cell differentiation in long term bone marrow cultures. (J Immunol, 1988 Jul, Abstract available) [MEDLINE]
133 Roy AL, et al; Natural mRNA is required for directing Met-tRNA(f) binding to 40S ribosomal subunits in animal cells: involvement of Co-eIF-2A in natural mRNA-directed initiation complex formation. (Biochemistry, 1988 Oct, Abstract available) [MEDLINE]
134 Goldman JA, et al; First trimester bleeding in clinical IVF pregnancies. (Hum Reprod, 1988 Aug, Abstract available) [MEDLINE]
135 Fukuzawa H, et al; Structure and organization of Marchantia polymorpha chloroplast genome. III. Gene organization of the large single copy region from rbcL to trnI(CAU). (J Mol Biol, 1988 Sep, Abstract available) [MEDLINE]
136 Rubin JS; Effect of gamma rays on efficiency of gene transfer in DNA repair-proficient and -deficient cell lines. (Somat Cell Mol Genet, 1988 Nov, Abstract available) [MEDLINE]
137 Calzone FJ, et al; Developmental appearance of factors that bind specifically to cis-regulatory sequences of a gene expressed in the sea urchin embryo. (Genes Dev, 1988 Sep, Abstract available) [MEDLINE]
138 Weber Benarous A, et al; Retroviral-mediated transfer and expression of human beta-globin genes in cultured murine and human erythroid cells. (J Biol Chem, 1988 May, Abstract available) [MEDLINE]
139 Karsenty G, et al; Point mutations and small substitution mutations in three different upstream elements inhibit the activity of the mouse alpha 2(I) collagen promoter. (J Biol Chem, 1988 Sep, Abstract available) [MEDLINE]
140 Brackenbush LW, et al; Microdosimetric basis for exposure limits. (Health Phys, 1988 Aug, Abstract available) [MEDLINE]
141 Yovich JL, et al; Hormonal profiles and embryo quality in women with severe endometriosis treated by in vitro fertilization and embryo transfer. (Fertil Steril, 1988 Aug, Abstract available) [MEDLINE]
142 Yovich JL, et al; The treatment of normospermic infertility by gamete intrafallopian transfer (GIFT). (Br J Obstet Gynaecol, 1988 Apr, Abstract available) [MEDLINE]
143 Brandt U, et al; Characterisation of binding of the methoxyacrylate inhibitors to mitochondrial cytochrome c reductase. (Eur J Biochem, 1988 May, Abstract available) [MEDLINE]
144 Kohl DH, et al; Proline metabolism in N2-fixing root nodules: energy transfer and regulation of purine synthesis. (Proc Natl Acad Sci U S A, 1988 Apr, Abstract available) [MEDLINE]
145 Dancis J, et al; Placental transport of riboflavin: differential rates of uptake at the maternal and fetal surfaces of the perfused human placenta. (Am J Obstet Gynecol, 1988 Jan, Abstract available) [MEDLINE]
146 Alizadeh Khiavi K, et al; Biochemical nature and cellular origin of amyloid enhancing factor (AEF) as determined by anti-AEF antibody. (Br J Exp Pathol, 1988 Oct, Abstract available) [MEDLINE]
147 Wong PC, et al; Gamete intrafallopian transfer (GIFT): an alternate method of conception in couples with unexplained infertility, endometriosis and oligo-asthenospermia. (Ann Acad Med Singapore, 1988 Apr, Abstract available) [MEDLINE]
148 Oremland EK; Work dynamics in family care of hemophilic children. (Soc Sci Med, 1988, Abstract available) [MEDLINE]
149 Radek JT, et al; A differential scanning calorimetric investigation of the domains of recombinant tissue plasminogen activator. (Arch Biochem Biophys, 1988 Dec, Abstract available) [MEDLINE]
150 Nickbarg EB, et al; Triosephosphate isomerase: removal of a putatively electrophilic histidine residue results in a subtle change in catalytic mechanism. (Biochemistry, 1988 Aug, Abstract available) [MEDLINE]
151 Méry J, et al; Tryptophan reduction and histidine racemization during deprotection by catalytic transfer hydrogenation of an analog of the luteinizing hormone releasing factor. (Int J Pept Protein Res, 1988 Apr, Abstract available) [MEDLINE]
152 Wang D, et al; Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. (J Virol, 1988 Nov, Abstract available) [MEDLINE]
153 Rapp G, et al; Cloning and sequence analysis of a cDNA from human ovarian granulosa cells encoding the C-terminal part of human elongation factor 2. (Biol Chem Hoppe Seyler, 1988 Apr, Abstract available) [MEDLINE]
154 Rogers KR, et al; Iron-sulfur centers involved in methanogenic electron transfer in Methanobacterium thermoautotrophicum (delta-H). (Biochem Biophys Res Commun, 1988 May, Abstract available) [MEDLINE]
155 Aurelian L, et al; Antigen-specific immune-suppressor factor in herpes simplex virus type 2 infections of UV B-irradiated mice. (J Virol, 1988 Jul, Abstract available) [MEDLINE]
156 Arean CO, et al; Ion binding to cytochrome c. (Eur J Biochem, 1988 May, Abstract available) [MEDLINE]
157 Feldman M, et al; The reversal of the metastatic phenotype by gene transfer. (Ciba Found Symp, 1988, Abstract available) [MEDLINE]
158 Kyle JW, et al; Expression of human cation-independent mannose 6-phosphate receptor cDNA in receptor-negative mouse P388D1 cells following gene transfer. (J Biol Chem, 1988 Nov, Abstract available) [MEDLINE]
159 Dieli F, et al; Role of macrophages in bypassing the inhibitory activity of Newcastle disease virus on the T-suppressor-cell circuit which regulates contact sensitivity to picryl chloride. (Cell Immunol, 1988 Feb, Abstract available) [MEDLINE]
160 Murphy GM, et al; Cholinergic urticaria, passive transfer experiments from human to monkey. (Dermatologica, 1988, Abstract available) [MEDLINE]
161 Terness P, et al; Induction of a suppressive serum factor, prevention of sensitization, and prolongation of kidney graft survival in rats by transfusion with antibody-coated blood cells. (Transplantation, 1988 Dec, Abstract available) [MEDLINE]
162 Angelillo M, et al; Absence of RT6+ T cells in diabetes-prone biobreeding/Worcester rats is due to genetic and cell developmental defects. (J Immunol, 1988 Dec, Abstract available) [MEDLINE]
163 Fabian I, et al; Therapeutic potential of recombinant granulocyte-macrophage colony-stimulating factor and interleukin-3 in murine B-cell leukemia. (Blood, 1988 Sep, Abstract available) [MEDLINE]
164 Sutedja TG, et al; Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia. (Thorax, 1988 Mar, Abstract available) [MEDLINE]
165 Cefalu E, et al; Successful gamete intrafallopian transfer following failed artificial insemination by donor: evidence for a defect in gamete transport? (Fertil Steril, 1988 Aug, Abstract available) [MEDLINE]
166 Fairchild RL, et al; Soluble factors in tolerance and contact sensitivity to 2,4-dinitro-fluorobenzene in mice. IX. A monoclonal T cell suppressor molecule is structurally and serologically related to the alpha/beta T cell receptor. (J Immunol, 1988 Nov, Abstract available) [MEDLINE]
167 Ishikawa Y, et al; A change in apolipoprotein B expression is required for the binding of apolipoprotein E to very low density lipoprotein. (J Biol Chem, 1988 Feb, Abstract available) [MEDLINE]
168 Mitra B, et al; Characterization of three-subunit chloroplast coupling factor. (Biochemistry, 1988 Jan, Abstract available) [MEDLINE]
169 Szöllösi D, et al; Remodeling of mouse thymocyte nuclei depends on the time of their transfer into activated, homologous oocytes. (J Cell Sci, 1988 Dec, Abstract available) [MEDLINE]
170 Amano M, et al; Characteristics of work actions of shoe manufacturing assembly line workers and a cross-sectional factor-control study on occupational cervicobrachial disorders. (Sangyo Igaku, 1988 Jan, Abstract available) [MEDLINE]
171 Murphy ME, et al; Comparative molecular model building of two serine proteinases from cytotoxic T lymphocytes. (Proteins, 1988, Abstract available) [MEDLINE]
172 James AL, et al; Bronchial responsiveness, lung mechanics, gas transfer, and corticosteroid response in patients with chronic airflow obstruction. (Thorax, 1988 Nov, Abstract available) [MEDLINE]
173 Wasserman H, et al; Air kerma rate constants for radionuclides. (Eur J Nucl Med, 1988, Abstract available) [MEDLINE]
174 Weir DC, et al; Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy [see comments] (Thorax, 1988 Sep, Abstract available) [MEDLINE]
175 Meyer P, et al; A genomic DNA segment from Petunia hybrida leads to increased transformation frequencies and simple integration patterns. (Proc Natl Acad Sci U S A, 1988 Nov, Abstract available) [MEDLINE]
176 Riddell FG, et al; Surface charge effects upon membrane transport processes: the effects of surface charge on the monensin-mediated transport of lithium ions through phospholipid bilayers studied by 7Li-NMR spectroscopy. (Biochim Biophys Acta, 1988 Nov, Abstract available) [MEDLINE]
177 Giaretti W, et al; Flow cytometric evaluation of cell cycle characteristics during in vitro differentiation of chick embryo chondrocytes. (Cytometry, 1988 Jul, Abstract available) [MEDLINE]
178 Corris PA, et al; Effects of diffuse pleural thickening on respiratory mechanics. (Eur Respir J, 1988 Mar, Abstract available) [MEDLINE]
179 Koga T, et al; Characterization of a low-molecular-weight growth inhibitor formed by density-inhibited, tumorigenic V79 Chinese hamster cells. (Cancer Res, 1988 Jul, Abstract available) [MEDLINE]
180 Ameratunga R, et al; The alveolar carbon monoxide uptake fraction: a simple, alternative measure of carbon monoxide transfer. (Eur Respir J, 1988 Feb, Abstract available) [MEDLINE]
181 Harriott Smith TG, et al; Suppression of contact hypersensitivity by short-term ultraviolet irradiation: I. Immunosuppression by serum from irradiated mice. (Clin Exp Immunol, 1988 Jan, Abstract available) [MEDLINE]
182 Conley J, et al; Surgery on the buccal fat pad in masseter transfer. (Arch Otolaryngol Head Neck Surg, 1988 Mar, Abstract available) [MEDLINE]
183 Liu YQ, et al; Wounding effects of small fragments of different shapes at different velocities on soft tissues of dogs. (J Trauma, 1988 Jan, Abstract available) [MEDLINE]
184 Cheng XY, et al; Wounding properties of steel pellets with different velocities and quality on soft tissue of dogs. (J Trauma, 1988 Jan, Abstract available) [MEDLINE]
185 Niven RW, et al; Solute absorption from the airways of the isolated rat lung. I. The use of absorption data to quantify drug dissolution or release in the respiratory tract. (Pharm Res, 1988 Sep, Abstract available) [MEDLINE]
186 Lavy G, et al; Hyaluronidase removal of the cumulus oophorus increases in vitro fertilization. (J In Vitro Fert Embryo Transf, 1988 Oct, Abstract available) [MEDLINE]
187 Myre M, et al; Clinical, functional and pathological correspondence in early stage idiopathic pulmonary fibrosis: evidence for small airway obstruction 1-2. (Respiration, 1988, Abstract available) [MEDLINE]
188 Cox RA, et al; Suppression of T-lymphocyte response by Coccidioides immitis antigen. (Infect Immun, 1988 Jun, Abstract available) [MEDLINE]
189 Freist W, et al; Isoleucyl-tRNA synthetase from baker's yeast and from Escherichia coli MRE 600. Discrimination of 20 amino acids in aminoacylation of tRNA(Ile)-C-C-A. (Eur J Biochem, 1988 Apr, Abstract available) [MEDLINE]
190 Tsai SC, et al; Stimulation of choleragen enzymatic activities by GTP and two soluble proteins purified from bovine brain. (J Biol Chem, 1988 Feb, Abstract available) [MEDLINE]
191 Smith TJ, et al; Hepatic N-acetyltransferases: selective inactivation in vivo by a carcinogenic N-arylhydroxamic acid. (Biochem Pharmacol, 1988 Feb, Abstract available) [MEDLINE]
192 Shaw RJ, et al; Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. (Thorax, 1988 Jun, Abstract available) [MEDLINE]
193 Soejima T, et al; Acquisition of repertoires of suppressor T cells under the influence of macrophages. (J Mol Cell Immunol, 1988, Abstract available) [MEDLINE]
194 Boudouresque F, et al; Maturation of the pituitary-adrenal function in rat fetuses. (Neuroendocrinology, 1988 Oct, Abstract available) [MEDLINE]
195 OConnor C, et al; Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis. (Thorax, 1988 May, Abstract available) [MEDLINE]
196 Kofron JL, et al; Coordination of manganous ion at the active site of pyruvate, phosphate dikinase: the complex of oxalate with the phosphorylated enzyme. (Biochemistry, 1988 Jun, Abstract available) [MEDLINE]
197 Courtright JB, et al; Alteration of bacterial DNA structure, gene expression, and plasmid encoded antibiotic resistance following exposure to enoxacin. (J Antimicrob Chemother, 1988 Feb, Abstract available) [MEDLINE]
198 Claesson HE, et al; Human endothelial cells stimulate leukotriene synthesis and convert granulocyte released leukotriene A4 into leukotrienes B4, C4, D4 and E4. (Eur J Biochem, 1988 Apr, Abstract available) [MEDLINE]
199 Gong SS, et al; Functional anatomy of the simian virus 40 late promoter. (Virology, 1988 Apr, Abstract available) [MEDLINE]
200 Stein DC, et al; Restriction of plasmid DNA during transformation but not conjugation in Neisseria gonorrhoeae. (Infect Immun, 1988 Jan, Abstract available) [MEDLINE]

NLM database Documents

Record 1 from database: MEDLINE
Return To Top

Title
Murine transfer factor. IV. Studies with genetically regulated immune responses.
Author
Rozzo SJ; Merryman CF; Kirkpatrick CH
Address
Conrad D. Stephenson Laboratory, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.
Source
Cell Immunol, 1988 Aug, 115:1, 130-45
Abstract
Transfer factor-containing dialysates from mice that were either high or low responders to GAT10, GLA5, or ovalbumin were assayed for their ability to transfer delayed hypersensitivity to murine recipients of either high or low responder phenotype. Dialysates from high responder strains contained transfer factor that would transfer delayed hypersensitivity to both high and low responder recipients. These transfers were not restricted by disparities at the MHC or Igh loci. Identically prepared materials from low responder donors contained little or no transfer factor activity and would not transfer delayed hypersensitivity to either high or low responder recipients. Thus, administration of transfer factor transfers the high responder phenotype to low responder recipients. The data also suggest that production of transfer factor is regulated by Ir genes but that the immunologic activities of transfer factor are not.
Language of Publication
English
Unique Identifier
88295138

Return To Top


MeSH Heading (Major)
Hypersensitivity, Delayed|ET/*GE/IM; Transfer Factor|*/AD/BI/GE
MeSH Heading
Animal; Carrier Proteins|IM; Dialysis; Dose-Response Relationship, Immunologic; H-2 Antigens|GE; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Mice, Inbred C57BL; Peptides|IM; Serum Albumin, Bovine|IM; Species Specificity; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0008-8749
Country of Publication
UNITED STATES


Record 2 from database: MEDLINE
Return To Top

Title
Transfer factor.
Author
Kirkpatrick CH
Address
Conrad D. Stephenson Laboratory, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
Source
J Allergy Clin Immunol, 1988 May, 81:5 Pt 1, 803-13
Abstract
It has been more than 30 years since Dr. H. S. Lawrence first reported that it was possible to transfer delayed-type hypersensitivity from sensitized donors to unsensitized recipients with lysates of blood leukocytes. During recent years, research from several laboratories has demonstrated that this effect is immunologically specific. Although the molecules that possess this activity have not been completely characterized, there is a significant body of evidence that they are small polypeptides and that they can interact with antigen molecules in an immunologically specific manner. Studies with immune responses that are under genetic control have demonstrated that the ability of an animal to produce transfer factor is genetically regulated but that transfer of delayed hypersensitivity with transfer factor is not genetically restricted. In fact, when mice of low-responder phenotypes are administered transfer factor from high-responder donors, they express delayed hypersensitivity responses that are comparable to the high responders. Clinical studies have demonstrated that transfer factor is an efficacious method for immunotherapy of certain viral and fungal infections.
Language of Publication
English
Unique Identifier
88228780

Return To Top


MeSH Heading (Major)
Transfer Factor|*/IM/TU
MeSH Heading
Animal; Human; Hypersensitivity, Delayed|IM; Mice; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0091-6749
Country of Publication
UNITED STATES


Record 3 from database: MEDLINE
Return To Top

Title
De novo initiation of specific cell-mediated immune responsiveness in chickens by transfer factor (specific immunity inducer) obtained from bovine colostrum and milk.
Author
Wilson GB; Poindexter C; Fort JD; Ludden KD
Address
Amtron, Inc., Charleston, South Carolina.
Source
Acta Virol, 1988 Jan, 32:1, 6-18
Abstract
Transfer factors (TF) were prepared from colostrum and milk of bovines previously immunized with antigens obtained from Coccidioides immitis, infectious bovine rhinotracheitis virus, or from the viral agents responsible for avian Newcastle disease, laryngotracheitis disease or infectious bursal disease. The ability of bovine TF to transfer specific cell-mediated immune responsiveness to a markedly xenogenic species was studied using specific pathogen free (SPF) and standard commercial (SC) chickens as model recipients. Cell-mediated immune responsiveness was documented using one or more of the following for each antigen (organism) studied: (a) an in vitro chicken leukocyte (heterophil) migration inhibition assay; (b) delayed-wattle reactivity; or (c) protection from clinical disease. Chicken TFs obtained from spleens of immune donors were evaluated in parallel to bovine TF's in selected comparative studies. Bovine TF also referred to as specific immunity inducer (SII), and chicken TF were found to initiate antigen-specific cell-mediated immunity de novo in previously non-immune SPF chickens as well as in SC chickens despite the presence of maternally acquired humoral antibody which may serve as a "barrier" to immunization of SC chickens when commercially available vaccines are administered by parenteral routes. Bovine TF's specific for laryngotracheitis virus or infectious bursal disease virus afforded protection equal to that found for commercially available vaccines. Bovine TF's action was rapid (less than a day) and of relatively long duration at least 35 days.
Language of Publication
English
Unique Identifier
88238284

Order full text for this document


MeSH Heading (Major)
Immunity, Cellular|*; Transfer Factor|BI/IP/*PD
MeSH Heading
Animal; Antigens, Viral|IM; Cattle; Chickens; Colostrum|IM; Female; Herpesvirus 1, Gallid|IM; Immunization; Infectious Bursal Disease Virus|IM; Male; Milk|IM; Newcastle Disease Virus|IM; Pregnancy; Species Specificity

Publication Type
JOURNAL ARTICLE
ISSN
0001-723X
Country of Publication
CZECHOSLOVAKIA


Record 4 from database: MEDLINE
Order full text for this document

Title
Chromatographic and enzymatic effects on transfer factor-like activity from human leukocytes and porcine spleen dialysate.
Author
Karhumäki E; Marnela KM; Krohn K
Address
Institute of Biomedical Sciences, University of Tampere, Finland.
Source
Int J Biochem, 1988, 20:10, 1067-72
Abstract
1. The effect of dialysable transfer factor (TFd), derived from human leukocytes or porcine spleen cells, was measured using Listeria resistance in mice. 2. The molecular weight range of substance(s) containing TF-like activity is in the less than 3500 MW dialysis fraction on the basis of the capacity of peritoneal macrophages to produce superoxide anion (O2-). This biological activity is removed by heating at 56 degrees C. 3. After Sephadex G-10 chromatography of dialysates the significant activities are found in fractions III and IV of human leukocyte dialysate and in fractions of II and III of porcine spleen dialysate. 4. From enzymatic studies, most of the protective activity of both human leukocyte and porcine spleen dialysate is based on the action of small-molecular weight structures containing peptides and/or polynucleotides.
Language of Publication
English
Unique Identifier
89252383

Order full text for this document


MeSH Heading (Major)
Leukocytes|*AN; Spleen|*AN; Transfer Factor|*IP/PD
MeSH Heading
Animal; Chromatography, Gel; Dialysis|MT; Drug Resistance, Microbial|DE; Enzymes; Heat; Human; Listeria|DE; Listeria Infections|PC; Mice; Molecular Weight; Support, Non-U.S. Gov't; Swine

Publication Type
JOURNAL ARTICLE
ISSN
0020-711X
Country of Publication
ENGLAND


Record 5 from database: MEDLINE
Order full text for this document

Title
Transfer factor in Hodgkin's disease: a randomized clinical and immunological study.
Author
Hancock BW; Bruce L; Sokol RJ; Clark A
Address
University Department of Medicine, Royal Hallamshire Hospital, Sheffield, U.K.
Source
Eur J Cancer Clin Oncol, 1988 May, 24:5, 929-33
Abstract
Transfer factor (TF) was prepared from buffy coats obtained from 493 units of blood taken from healthy donors, including individuals convalescent from various viral infections. It was administered to 22 of 47 patients with Hodgkin's disease undergoing treatment and consenting to take part in this randomized study to determine if TF would enhance their immunity and/or reduce the incidence of subsequent infections. Skin test reactivity was markedly enhanced in those patients receiving TF as opposed to placebo but other immunological assessments showed no significant differences between the groups. TF was not shown to be of benefit in the prevention of infections (including varicella/zoster).
Language of Publication
English
Unique Identifier
89005279

Order full text for this document


MeSH Heading (Major)
Hodgkin Disease|*IM; Transfer Factor|*TU
MeSH Heading
B-Lymphocytes|IM; Blood Cell Count; Cell Migration Inhibition; Chickenpox|PC; Clinical Trials; Double-Blind Method; Human; Immunity, Cellular; Immunoglobulins|AN; Leukocytes|IM; Lymphocyte Transformation; Receptors, Fc|AN; Support, Non-U.S. Gov't; T-Lymphocytes|IM

Publication Type
CLINICAL TRIAL; JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
ISSN
0277-5379
Country of Publication
ENGLAND


Record 6 from database: MEDLINE
Order full text for this document

Title
Varicella-zoster virus IgG antibodies during primoinfection in competent and transfer factor modulated immunocompromised host: comparison of three indirect assays.
Author
Zachar V; Mayer V; Schmidtmayerová H
Address
Institute of Virology, Slovak Academy of Sciences, Bratislaya, Czechoslovakia.
Source
Acta Virol, 1988 May, 32:3, 243-51
Abstract
Ten patients with acute leukaemia and next three with Hodgkin's or non-Hodgkin's lymphoma, suffering from varicella-zoster-virus (VZV) primoinfection, were given 1 to 2 doses of ultrafiltrate of the human leukocytes lysate (LLU) containing transfer factor (TF) activity (1 dose being equivalent to the product of 10(8) leukocytes). Only LLU administered to patients with acute lymphocytic leukaemia (ALL) at early phases of the illness (days 1 and 2) displayed a notable benefit on the clinical course of varicella. No influence upon the infection, on the other hand, was observed following LLU administration to subjects with lymphoma. The convalescent levels of IgG antibodies to VZV, as detected by indirect immunoperoxidase assay to membrane antigen (IPAMA), demonstrated no significant difference between infected competent and immunocompromised untreated and LLU treated individuals. The performance characteristics of IPAMA are compared with indirect immunofluorescence method (IFA) and non-competitive enzyme-linked immunosorbent assay (ELISA) on the same panel of specimens.
Language of Publication
English
Unique Identifier
89022589

Order full text for this document


MeSH Heading (Major)
Antibodies, Viral|*AN; Chickenpox|ET/*IM/TH; Herpesvirus 3, Human|*IM
MeSH Heading
Comparative Study; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Human; IgG|AN; Immunoenzyme Techniques; Leukemia|CO; Lymphoma|CO; Transfer Factor|TU

Publication Type
JOURNAL ARTICLE
ISSN
0001-723X
Country of Publication
CZECHOSLOVAKIA


Record 7 from database: MEDLINE
Order full text for this document

Title
A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanoma.
Author
Miller LL; Spitler LE; Allen RE; Minor DR
Address
Paul M. Aggelar Memorial Laboratory, Children's Hospital of San Francisco, California.
Source
Cancer, 1988 Apr, 61:8, 1543-9
Abstract
One hundred and sixty-eight evaluable patients participated in a randomized, double-blind study of transfer factor (TF) versus placebo as surgical adjuvant therapy of Stage I and Stage II malignant melanoma. Eighty-five patients received TF prepared from the leukocytes of healthy volunteer donors; eighty-three participants received placebo. Therapy was initiated within 90 days of resection of all evident tumor and continued until 2 years of disease-free survival or the occurrence of unresectable dissemination of melanoma. Known prognostic variables were similarly distributed in the treatment and control groups, documenting the randomization efficacy. Three endpoints were analyzed: disease-free interval, time to Stage III metastasis, and survival. After a median follow-up period of 24.75 months, there was a trend in favor of the placebo group with regard to all three endpoints and this was significant (P less than or equal to 0.05) for time to Stage III metastasis. These findings indicate that TF is not effective as surgical adjuvant therapy of malignant melanoma.
Language of Publication
English
Unique Identifier
88164707

Order full text for this document


MeSH Heading (Major)
Melanoma|SU/*TH; Transfer Factor|*TU
MeSH Heading
Clinical Trials; Combined Modality Therapy; Double-Blind Method; Human; Random Allocation; Support, Non-U.S. Gov't

Publication Type
CLINICAL TRIAL; JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
ISSN
0008-543X
Country of Publication
UNITED STATES


Record 8 from database: MEDLINE
Order full text for this document

Title
Evidence for protein-catalyzed transfer of platelet activating factor by macrophage cytosol.
Author
Banks JB; Wykle RL; OFlaherty JT; Lumb RH
Address
Biochemistry Group, Western Carolina University, Cullowhee, NC 28723.
Source
Biochim Biophys Acta, 1988 Jul, 961:1, 48-52
Abstract
Platelet activating factor (PAF) is a potent, proinflammatory lipid. PAF is synthesized in response to stimuli and is rapidly destroyed by specific acetylhydrolases. In order to express its biological activity, PAF and its metabolites are transported among subcellular membranes by as yet unexplained mechanisms. We report here an assay system using methylcarbamyl-PAF (CPAF, 1-O-hexadecyl-2-O-(N-methylcarbamyl)-sn-glycero-3-phosphocholine) and a vesicle-extrusion technique for examining protein-catalyzed intermembrane transfer of CPAF, and demonstrate the presence of proteins catalyzing the separate transfer of CPAF and diacyl phosphatidylcholine in macrophage cytosol. The CPAF transfer activity is heat- and trypsin-sensitive and elutes from gel-filtration columns well separated from proteins catalyzing the transfer of phosphatidylcholine.
Language of Publication
English
Unique Identifier
88252202

Order full text for this document


MeSH Heading (Major)
Macrophages|*ME; Phospholipid Ethers|*ME; Platelet Activating Factor|*ME; Proteins|*ME
MeSH Heading
Animal; Biological Transport; Cattle; Cytosol|ME; Intracellular Membranes|ME; Kinetics; Organ Specificity; Rabbits; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-3002
Country of Publication
NETHERLANDS


Record 9 from database: MEDLINE
Order full text for this document

Title
Affinity labeling at the A-site of Escherichia coli ribosomes by a non-hydrolyzable gamma-amide analog of GTP.
Author
Babkina GT; Jonák J; Karpova GG; Knorre DG; Rychlík I; Vladimirov SN
Address
Institute of Bioorganic Chemistry, Siberian Division of the Academy of Sciences, Novosibirsk, U.S.S.R.
Source
Biochimie, 1988 May, 70:5, 597-603
Abstract
gamma-Amides of GTP and affinity and photoaffinity derivatives of gamma-amides of GTP: gamma-anilide of GTP, gamma-(4-azido)anilide of GTP, gamma-[N-(4-azidobenzyl)-N-methyl]amide of GTP, gamma[4-N-(2-chloroethyl)-N-methylaminobenzyl]amide of GTP and gamma-[4-N-(2-oxoethyl)-N-methylaminobenzyl]amide of GTP substituted efficiently for GTP in the EF-Tu-dependent transfer of aminoacyl-tRNA to the ribosome but, in contrast to GTP, they were not hydrolyzed in this process. They represent a new class of non-hydrolyzable GTP analogs with preserved gamma-phosphodiester bond. The radioactive analog of GTP: gamma-[4-N-(2-chloroethyl)-N-methylamino[14C]benzyl]amide of GTP was used as an affinity labeling probe for the identification of components of the GTPase center formed in the EF-Tu-dependent transfer reaction of aminoacyl-tRNA to the ribosomal A-site. Within a six-component complex of poly(U)-programmed E. coli ribosomes with elongation factor Tu, Phe-tRNA(Phe) (at the A-site), tRNA(Phe) (at the P-site) and the [14C]GTP analog, mainly the ribosomal 23S RNA and to a lesser extent the ribosomal proteins L17, L21, S16, S21 and the ribosomal 16S RNA were labeled by the reagent. No significant modification of EF-Tu was detected.
Language of Publication
English
Unique Identifier
89000961

Order full text for this document


MeSH Heading (Major)
Affinity Labels|*ME; Escherichia coli|*ME; Guanosine Triphosphate|*AA/ME; Ribosomes|*ME
MeSH Heading
Amides|ME; Binding Sites; GTP Phosphohydrolase|ME; Hydrolysis; Peptide Elongation Factor Tu|PH; Peptides|BI; Photochemistry; RNA, Transfer, Amino Acyl|ME

Publication Type
JOURNAL ARTICLE
ISSN
0300-9084
Country of Publication
FRANCE


Record 10 from database: MEDLINE
Order full text for this document

Title
Fluorescent modification of the cysteine 202 residue of Escherichia coli transcription termination factor rho.
Author
Seifried SE; Wang Y; von Hippel PH
Address
Institute of Molecular Biology, University of Oregon, Eugene 97403.
Source
J Biol Chem, 1988 Sep, 263:27, 13511-4
Abstract
The lone cysteine residue (Cys-202) of transcription termination factor rho has been modified with the sulfhydryl-specific dyes 5-iodoacetamidofluorescein and 5-(2-[iodoacetyl)amino)ethyl)aminonaphthalene-1-sulfonic acid. Labeling with both dyes is specific for the Cys-202 residue and is at least 90% complete. Rho protein is an RNA-dependent ATPase and exists as a hexamer of identical subunits in its activated (RNA-liganded) form. We find that chemical modification of rho at Cys-202 does not significantly change the properties of the protein; subunit assembly, RNA binding, and poly(rC)-activated ATP hydrolysis are all relatively unperturbed by the covalent attachment of these fluorescent moieties. On the other hand, the spectral, quenching, and anisotropy properties of the fluorescent groups are all significantly modified by attachment to the protein. No energy transfer is seen between fluorescein-labeled subunits within rho hexamers, indicating that the Cys-202 residues on these subunits are located at least 40 A apart. These fluorescently labeled rho molecules should represent useful probes to study the conformations and inter- and intrasubunit geometries of this termination factor at various stages of its interaction with nascent RNA transcripts.
Language of Publication
English
Unique Identifier
88330870

Order full text for this document


MeSH Heading (Major)
Cysteine|*; Escherichia coli|*AN; Fluorescent Dyes|*; Rho Factor|*/ME/PD; Transcription Factors|*/ME/PD
MeSH Heading
Adenosinetriphosphatase|ME; Chemistry; Cross-Linking Reagents; Energy Transfer; Fluoresceins; Macromolecular Systems; Naphthalenesulfonates; RNA|ME; Spectrophotometry; Sulfhydryl Reagents; Support, U.S. Gov't, P.H.S.; Transcription, Genetic|DE

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 11 from database: MEDLINE
Order full text for this document

Title
Adult chronic granulomatosis disease-like neutrophil granulocyte disorder corrected by dialysable leukocyte extract.
Author
Lukács K; Szabó G; Schröder I; Szegedi G
Address
3rd Department of Medicine, University Medical School, Debrechen, Hungary.
Source
Allergol Immunopathol (Madr), 1988 Mar, 16:2, 121-5
Abstract
A 47 year old female presented with a septic clinical picture including fever, abscesses, late cachexia, and unmanageable by disease. Similar characteristics to chronic granulomatosis disease (CGD) seriously decreased intracellular killing activity and chemiluminescence, granulomas in the histology, and the role of genetic factors were found, suggesting that our case is CGD-like disorder, manifested in an adult. Dialysable leukocyte extract (DLE) therapy, complemented with fresh normal plasma, resulted in a striking clinical improvement and there was an increase in the in vitro PMNL intracellular killing activity, too. Although it is generally accepted that DLE derives from monocytes and lymphocytes, it is possible that DLE is a family of DNA-oligopeptide molecules, including factors derived from PMNLs which are capable of influencing PMNL function, transferring information from normal cells. Our results also suggest that it would be worth trying DLE in patients with classic CGD.
Language of Publication
English
Unique Identifier
88279301

Order full text for this document


MeSH Heading (Major)
Neutrophils|IM/*PA; Phagocyte Bactericidal Dysfunction|CO/*TH; Transfer Factor|IP/*TU
MeSH Heading
Abscess|ET; Case Report; Chemotaxis, Leukocyte; Female; Human; Leukocytes|AN; Middle Age; Phagocytosis; Rosette Formation

Publication Type
JOURNAL ARTICLE
ISSN
0301-0546
Country of Publication
SPAIN


Record 12 from database: MEDLINE
Order full text for this document

Title
Growth factors modulate junctional cell-to-cell communication.
Author
Maldonado PE; Rose B; Loewenstein WR
Address
Department of Physiology and Biophysics, University of Miami School of Medicine, Florida 33101.
Source
J Membr Biol, 1988 Dec, 106:3, 203-10
Abstract
The epidermal growth factor (EGF) and the platelet-derived growth factor (PDGF) inhibit gap junctional communication in the mammalian cell lines NRK and BalbC 3T3: cell-to-cell transfer of a 400-dalton tracer molecule is reduced and junctional conductance is reduced. The inhibition of cell-to-cell transfer is reversible and dose dependent; half-maximal effects are obtained at 10(-9) and 10(-11) M concentrations of EGF and PDGF, respectively. The response of junctional conductance is detectable within 2 min of EGF application and reaches a maximum within 10 min. It is among the earliest cellular responses to this growth factor and may be significant in the regulation of growth. The response is lacking in EGF receptor-deficient NIH 3T3 cells. The transforming factor beta (TGF beta) enhances junctional communication in BalbC 3T3: cell-to-cell transfer is increased over a period of 8 hr. But in NRK cells, where it upregulates EGF receptors, TGF beta reduces junctional communication synergistically with EGF.
Language of Publication
English
Unique Identifier
89216868

Order full text for this document


MeSH Heading (Major)
Cell Communication|*; Growth Substances|*PH; Intercellular Junctions|*PH
MeSH Heading
Animal; Cell Membrane Permeability; Cells, Cultured; Mice; Microelectrodes; Platelet-Derived Growth Factor; Rats; Receptors, Cell Surface|PH; Receptors, Epidermal Growth Factor-Urogastrone|PH; Support, U.S. Gov't, P.H.S.; Transforming Growth Factors|PH

Publication Type
JOURNAL ARTICLE
ISSN
0022-2631
Country of Publication
UNITED STATES


Record 13 from database: MEDLINE
Order full text for this document

Title
The elongation factor EF-Tu from E. coli binds to the upstream activator region of the tRNA-tufB operon.
Author
Vijgenboom E; Nilsson L; Bosch L
Address
Department of Biochemistry, University of Leiden, The Netherlands.
Source
Nucleic Acids Res, 1988 Nov, 16:21, 10183-97
Abstract
The polypeptide chain elongation factor EF-Tu of Escherichia coli is encoded by two genes, tufA and tufB, located in two different operons. Experiments in which either tufA or tufB was inactivated demonstrated that expression of the tRNA-tufB operon is dependent on a functioning tufA and thus on EF-Tu (1, to be published). In order to study a possible role of EF-Tu as trans-activator of the tRNA-tufB operon, we have investigated in vitro binding of an EF-Tu. GDP preparation to various DNA fragments of the operon. We demonstrate that specific binding occurs to a cis-acting region delimited from position -134 to the promoter, previously shown to enhance tufB transcription. Electrophoretic retardation assays reveal the formation of maximally three protein/DNA complexes, indicating that more than one protein molecule can bind to the DNA. The EF-Tu preparation used was obtained by affinity chromatography and appeared to be 95% pure. It lost its DNA binding activity upon further purification. That EF-Tu is nonetheless involved in the DNA binding is suggested by the observation that none of the three complexes is formed in the presence of kirromycin, an antibiotic that binds EF-Tu with high specificity. If so, EF-Tu.GDP most likely binds to the activator region of the tRNA-tufB operon in combination with another non-identified protein or component.
Language of Publication
English
Unique Identifier
89057457

Order full text for this document


MeSH Heading (Major)
Escherichia coli|*GE/ME; Gene Expression Regulation|*; Genes, Bacterial|*; Genes, Structural|*; Operon|*; Peptide Elongation Factor Tu|*GE/ME; RNA, Transfer|*GE
MeSH Heading
DNA, Bacterial|GE/ME; Kinetics; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0305-1048
Country of Publication
ENGLAND


Record 14 from database: MEDLINE
Order full text for this document

Title
Transfer of functional EGF receptors to an IL3-dependent cell line.
Author
Collins MK; Downward J; Miyajima A; Maruyama K; Arai K; Mulligan RC
Address
Whitehead Institute, Cambridge, Massachusetts 02142.
Source
J Cell Physiol, 1988 Nov, 137:2, 293-8
Abstract
Epidermal growth factor (EGF) is a small protein that acts as a mitogen for various epidermal, epithelial, and fibroblastic cells that bear specific EGF receptors. The molecule that binds EGF is a 175-kD transmembrane protein, with an extracellular ligand binding domain and an intracellular domain that possesses tyrosine kinase activity, thought to be involved in the mitogenic signalling process. Here we have constructed a recombinant murine retrovirus that transduces a human cDNA encoding the 175-kD protein and used this retrovirus to infect BAF3, a murine, bone marrow-derived cell line, which is dependent on the haematopoietic factor interleukin-3 (IL3) for its growth in culture. The EGF receptors expressed in the infected cells exhibit two affinity states, as well as EGF-stimulated autophosphorylation. Furthermore, EGF can replace IL3 in supporting short-term proliferation of these cells. These data identify functional properties of the EGF receptor upon expression of the 175-kD EGF binding protein in a haemotopoietic cell that does not express endogenous receptors. They also suggest that gene transfer of growth factor receptors to heterologous cells may allow novel growth stimuli to be exploited.
Language of Publication
English
Unique Identifier
89054145

Order full text for this document


MeSH Heading (Major)
Interleukin-3|*PD; Receptors, Epidermal Growth Factor-Urogastrone|GE/*ME
MeSH Heading
Animal; Cell Line; DNA|ME; Epidermal Growth Factor-Urogastrone|PD; Mice; Molecular Weight; Protein-Tyrosine Kinase|ME; Retroviridae|GE; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Transduction, Genetic

Publication Type
JOURNAL ARTICLE
ISSN
0021-9541
Country of Publication
UNITED STATES


Record 15 from database: MEDLINE
Order full text for this document

Title
Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems.
Author
Chinali G; Nyssen E; Di Giambattista M; Cocito C
Address
Istituto di Strutture Biologiche ed Ultrastruttura Cellulare, Ila FacoltÄa di Medicina, UniversitÄa di Napoli, Italy.
Source
Biochim Biophys Acta, 1988 Nov, 951:1, 42-52
Abstract
Erythromycin (a 14-membered macrolide) and virginiamycin S (a type B synergimycin) block protein biosynthesis in bacteria, but are virtually inactive on poly(U)-directed poly(Phe) synthesis. We have recently shown, however, that these antibiotics inhibit the in vitro polypeptide synthesis directed by synthetic copolymers: this effect is analyzed further in the present work. We were unable to find any consistent alteration produced by these antibiotics on coupled and uncoupled EF-G- and EF-Tu-dependent GTPases, on the EF-Tu-directed binding of aminoacyl-tRNA to ribosomes, and on the EF-G- and GTP-mediated translocation of peptidyl-tRNA bound to poly(U,C).ribosome complexes. With these complexes, the peptidyl transfer reaction, as measured by peptidylpuromycin synthesis, was 10-30% inhibited by virginiamycin S and erythromycin. A direct relationship between the virginiamycin S- and erythromycin-promoted inhibition of poly(A,C)-directed polypeptide synthesis, on the one hand, and the EF-G concentration and the rate of the polymerization reaction, on the other hand, was observed, in agreement with a postulated reversible inhibitor action of these antibiotics. The increased inhibitory activity, which was observed during the first 4-6 rounds of elongation, in the presence of virginiamycin S or erythromycin, was suggestive of a specific action of these antibiotics on the correct positioning of peptidyl-tRNA at the P site. The marked stimulation of premature release of peptidyl-tRNA from poly(A,C).ribosome complexes can be referred to an altered interaction of the C-terminal aminoacyl residue of the growing peptidyl chain with the ribosome. We conclude that the action of virginiamycin S and erythromycin entails a template-dependent alteration of the interaction of peptidyl-tRNA with the donor site of peptidyltransferase, which may lead to a transient functional block of the ribosome and in some instances to a premature release of peptidyl-tRNA and termination of the elongation process.
Language of Publication
English
Unique Identifier
89051018

Order full text for this document


MeSH Heading (Major)
Erythromycin|*PD; Escherichia coli|DE/*ME; Peptides|*BI; Virginiamycin|*PD
MeSH Heading
Guanosine Triphosphate|ME; GTP Phosphohydrolase|ME; Peptide Chain Elongation|DE; Peptide Elongation Factor Tu|PD; Peptide Elongation Factors|PD; Poly A|ME; Poly C|ME; Poly U|ME; Puromycin|ME; Ribosomes|ME; RNA, Transfer, Amino Acyl|ME; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0006-3002
Country of Publication
NETHERLANDS


Record 16 from database: MEDLINE
Order full text for this document

Title
Negative correlation between the abundance of Escherichia coli aminoacyl-tRNA families and their affinities for elongation factor Tu-GTP.
Author
Jakubowski H
Address
Department of Microbiology and Molecular Genetics, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark 07103.
Source
J Theor Biol, 1988 Aug, 133:3, 363-70
Abstract
The number of aminoacyl-tRNA molecules in Escherichia coli cells varies by about one order of magnitude from 730 (glutaminyl-tRNA) to 7900 (valyl-tRNA). Relative affinities of E. coli aminoacyl-tRNA for elongation factor Tu-GTP vary also by about one order of magnitude from 2.08 (glutaminyl-tRNA) to 0.15 (valyl-tRNA). The relationship between the abundance of all 20 aminoacyl-tRNA families in 5 E. coli strains and their affinities for elongation factor Tu-GTP was examined by statistical methods. Negative correlation between the two parameters was found. The correlation coefficient was -0.62 to -0.52 with significance level 0.01. Regression analysis give the following formula for the relation between relative abundance of aminoacyl-tRNA families (x) and their relative affinities for elongation factor Tu-GTP (y): y = 1.25 - 0.25x. The analyses indicate that those aminoacyl-tRNA families that are present in cells in low copy number exhibit higher affinity than the more abundant aminoacyl-tRNA families for elongation factor Tu-GTP. The bacterial protein biosynthetic apparatus evolved in such a way as to compensate for a low copy number of some aminoacyl-tRNAs by tight binding of the aminoacyl-tRNA to elongation factor Tu-GTP. This may assure adequate supply of low copy number aminoacyl-tRNAs under conditions of limitation in elongation factor Tu-GTP, e.g. during stringent response, and is consistent with the idea of elongation factor Tu-GTP modulating translational efficiencies of aminoacyl-tRNAs.
Language of Publication
English
Unique Identifier
89180173

Order full text for this document


MeSH Heading (Major)
Escherichia coli|GE/*ME; Guanosine Triphosphate|*ME; Peptide Elongation Factor Tu|*ME; RNA, Bacterial|*ME; RNA, Transfer, Amino Acyl|*ME
MeSH Heading
Kinetics; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0022-5193
Country of Publication
ENGLAND


Record 17 from database: MEDLINE
Order full text for this document

Title
Control of the tRNA-tufB operon in Escherichia coli. 3. Feedback inhibition of tufB expression by an EF-Tu with a deletion in the guanine-nucleotide-binding domain.
Author
Van Delft JH; Bosch L
Address
Department of Biochemistry, University of Leiden, The Netherlands.
Source
Eur J Biochem, 1988 Aug, 175:2, 375-8
Abstract
The expression of tufB, one of the two EF-Tu-encoding genes in Escherichia coli, is under autogenous control. Feedback inhibition of tufB expression by plasmid-borne EF-Tu has been used to answer the question of whether or not the integrity of the guanine-nucleotide-binding domain of EF-Tu is required for the autoregulatory role of the factor protein. We show that a large deletion of tufB, causing the elimination of an 81-amino-acid segment from the plasmid-borne EF-Tu, does not abolish tufB repression. We conclude that the autoregulation of the cellular EF-Tu level is not dependent on an intact guanine-nucleotide-binding domain and does not require binding of GTP to EF-Tu. The repressor activity of the deletion derivative of EF-Tu can be measured despite a rapid disappearance of the (altered) mutant protein from the soluble cytoplasmic fraction of the cell. Degradation and assembly in larger complexes are responsible for this disappearance.
Language of Publication
English
Unique Identifier
88296503

Order full text for this document


MeSH Heading (Major)
Chromosome Deletion|*; Escherichia coli|*GE; G-Proteins|*GE; Genes, Bacterial|*; Genes, Structural|*; Operon|*; Peptide Elongation Factor Tu|*GE; RNA, Transfer|*GE
MeSH Heading
Feedback; Gene Expression Regulation; Guanosine Diphosphate|ME; Macromolecular Systems; Protein Conformation; RNA, Bacterial|GE; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0014-2956
Country of Publication
GERMANY, WEST


Record 18 from database: MEDLINE
Order full text for this document

Title
Zone-interference gel electrophoresis: a new method for studying weak protein-nucleic acid complexes under native equilibrium conditions.
Author
Abrahams JP; Kraal B; Bosch L
Address
Department of Biochemistry, Leiden University, The Netherlands.
Source
Nucleic Acids Res, 1988 Nov, 16:21, 10099-108
Abstract
A new and general electrophoresis method is described for the determination of dissociation constants of weak macromolecular complexes in the range of 10(-6) to 10(-4) M. The method is based on the measurement of the migration distance of a macromolecular complex in rapid dynamic equilibrium as a function of the interacting ligand concentration in a surrounding zone. Special advantages of the method are: its high sensitivity (dependent on the autoradiography, immunoblotting or staining technique used), its speed (electrophoresis time 20 min), and the independence of the Kd determination on the sample concentration of macromolecules. The latter is of great value for labile macromolecules: unknown partial inactivation does not influence the measurement. Studying the interactions between elongation factor EF-Tu and tRNA from E. coli we found for EF-Tu.GTP.aurodox.aminocyl-tRNA a Kd of 3 microM and for EF-Tu.GDP.aurodox.aminoacyl-tRNA a Kd of 11 microM at 9 degrees C.
Language of Publication
English
Unique Identifier
89057451

Order full text for this document


MeSH Heading (Major)
Nucleic Acids|*ME; Proteins|*ME
MeSH Heading
Antibiotics|ME; Electrophoresis|MT; Guanosine Triphosphate|ME; Kinetics; Models, Theoretical; Peptide Elongation Factor Tu|ME; Protein Binding; Pyridones|ME; RNA, Transfer, Amino Acyl|ME; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0305-1048
Country of Publication
ENGLAND


Record 19 from database: MEDLINE
Order full text for this document

Title
A yeast sigma composite element, TY3, has properties of a retrotransposon.
Author
Clark DJ; Bilanchone VW; Haywood LJ; Dildine SL; Sandmeyer SB
Address
Department of Microbiology and Molecular Genetics, College of Medicine, University of California, Irvine 92717.
Source
J Biol Chem, 1988 Jan, 263:3, 1413-23
Abstract
Sigma is a 340- or 341-base pair repetitive element which is located almost exclusively within 19 base pairs of the 5' ends of various tRNA genes in the Saccharomyces cerevisiae genome. Although most sigma elements characterized to date are isolated insertions, a few of the elements occur relatively closely spaced. One of these pairs is a direct repeat of the sigma element separated by an internal domain 4.7 kilobase pairs in length. Not only does this structure resemble a composite transposable element, but regions within the sigma elements and intervening domain are homologous to conserved regions in retroviruses and retrotransposons of yeast and other organisms. Two features suggest that the sigma elements and intervening DNA transposed in a concerted event: only one of the two sigma elements is associated with a tRNA gene, and only the outside ends of the two elements are flanked by the 5-base pair direct repeats that usually flank individual sigma insertions. Examination of genomic DNA from five laboratory strains indicates that the 4.7 kilobase pair internal domain is present in one to four copies per haploid genome and that the genomic location of this domain differs from strain to strain. In addition, Northern blot analysis showed the presence of a 5.2 kilobase poly(A) transcript which hybridizes to both sigma and internal domain-specific probes. The existence of this composite element may suggest new ways to consider the mechanisms by which retrotransposons select their targets.
Language of Publication
English
Unique Identifier
88087281

Order full text for this document


MeSH Heading (Major)
DNA Transposable Elements|*; Saccharomyces cerevisiae|*GE; Sigma Factor|*AN; Transcription Factors|*AN
MeSH Heading
Base Sequence; DNA Restriction Enzymes|ME; Molecular Sequence Data; Nucleic Acid Hybridization; Poly A|ME; Repetitive Sequences, Nucleic Acid; Retroviridae|GE; RNA|ME; RNA, Transfer, Cys|AN; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Transcription, Genetic

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 20 from database: MEDLINE
Order full text for this document

Title
Control of the tRNA-tufB operon in Escherichia coli. 2. Mechanisms of the feedback inhibition of tufB expression studied in vivo and in vitro.
Author
Van Delft JH; Talens A; De Jong PJ; Schmidt DS; Bosch L
Address
Department of Biochemistry, University of Leiden, The Netherlands.
Source
Eur J Biochem, 1988 Aug, 175:2, 363-74
Abstract
The mechanism underlying feedback inhibition of tufB expression has been studied in vivo by gene-dosage experiments and by gene and operon fusions involving lacZ. Raising the cellular EF-Tu content, by introducing a multicopy plasmid encoding EF-TuA into the cell, repressed the level of EF-TuB but left the content of tRNA(Thr)3, encoded by the tRNA-tufB operon, unaffected. This indicates that autoregulation of chromosomal tufB expression does not occur by modulating transcription initiation at the promoter of the tRNA-tufB operon. This conclusion is further substantiated by experiments with a tRNA':lacZ operon fusion. The molecular ratio of chromosome-borne tufA and tufB transcripts also remained unaltered under conditions of excess EF-Tu, though experiments with a tRNA-tufB':lacZ operon fusion showed a decrease of tufB transcripts. Our data further exclude drastic effects of the autogenous repressor on processing of the contranscript of the operon into monocistronic tufB RNA and on alteration of EF-TuB turnover. Two possible mechanisms remain, which cannot yet be decided between. One is modulation of EF-Tu by transcription termination either directly or indirectly by affecting antitermination. The second is translational repression. In vitro translation of transcripts derived from SP6 clones did not reveal any feedback inhibition of EF-TuB synthesis. Surprisingly, addition of EF-Tu to a coupled transcription/translation systems was found to block transcription initiation at the primary promoter of the tRNA-tufB operon by over 90%. Although this in vitro effect of EF-Tu could not be demonstrated in vivo, possibly because of a difference in higher-order structure between plasmid-borne and chromosome-borne DNA, it indicates that under certain conditions EF-Tu binds very specifically to the tRNA-tufB operon promoter or its upstream region.
Language of Publication
English
Unique Identifier
88296502

Order full text for this document


MeSH Heading (Major)
Escherichia coli|*GE; Gene Expression Regulation|*; Genes, Bacterial|*; Genes, Structural|*; Operon|*; Peptide Elongation Factor Tu|*GE; RNA, Transfer|*GE
MeSH Heading
Cloning, Molecular; DNA, Superhelical|GE; Feedback; Plasmids; RNA, Bacterial|GE; Support, Non-U.S. Gov't; Templates; Transcription, Genetic; Translation, Genetic

Publication Type
JOURNAL ARTICLE
ISSN
0014-2956
Country of Publication
GERMANY, WEST


Record 21 from database: MEDLINE
Order full text for this document

Title
Control of the tRNA-tufB operon in Escherichia coli. 1. rRNA gene dosage effects and growth-rate-dependent regulation.
Author
Van Delft JH; Verbeek HM; De Jong PJ; Schmidt DS; Talens A; Bosch L
Address
Department of Biochemistry, University of Leiden, The Netherlands.
Source
Eur J Biochem, 1988 Aug, 175:2, 355-62
Abstract
'Ribosome feedback' effects on the expression of the genes specifying tRNA and EF-Tu in E. coli have been studied at increased rrnB doses (rRNA gene doses). We confirm previous observations that the introduction into the cell of a multicopy plasmid carrying the rrnB operon reduces the cellular content of most tRNAs, including those encoded by the tRNA-tufB operon, but leaves the 5S rRNA content unaffected. Increase of the dosage of intact, but not of deleted rRNA genes, causes a slight drop in total EF-Tu that can be fully accounted for by a decrease in EF-TuB level. The drop in EF-TuB content (approx. 25%) is much smaller than that in tRNA content (approx. 80%). The synthesis rate of total EF-Tu is hardly affected, indicating that the turnover of EF-Tu has not changed. The ratio of tRNA over tuf RNA synthesis rates remains the same after elevation of rrnB dosage. Considering the large decrease in tRNA content this means that both RNA synthesis rates decrease to approximately the same extent. The relatively small drop in EF-Tu synthesis must be due, therefore, to an enhancement of the number of EF-Tu molecules synthesized per mRNA molecule. Apparently a post-transcriptional mechanism, regulating EF-Tu synthesis, becomes operative under these conditions. Growth-rate-dependent regulation of the tRNA-tufB operon has been studied using lysogens carrying tRNA':lacZ and tRNA-tufB':lacZ operon fusions and a tufB':lacZ' gene fusion. These experiments show that the cellular contents of tRNA, tufB RNA and EF-TuB vary in direct proportion to the growth rate. This indicates that growth rate control of tRNA-tufB operon transcription resembles that of stable RNA operons and not of r-protein operons, and that the read-through of the terminator at the end of the tRNA gene cluster remains unaltered.
Language of Publication
English
Unique Identifier
88296501

Order full text for this document


MeSH Heading (Major)
Escherichia coli|GD/*GE; Genes, Bacterial|*; Genes, Structural|*; Operon|*; Peptide Elongation Factor Tu|*GE; RNA, Ribosomal|*GE; RNA, Transfer|*GE
MeSH Heading
Feedback; Plasmids; RNA, Bacterial|GE; RNA, Ribosomal, 5S|GE; Support, Non-U.S. Gov't; Transcription, Genetic; Translation, Genetic

Publication Type
JOURNAL ARTICLE
ISSN
0014-2956
Country of Publication
GERMANY, WEST


Record 22 from database: MEDLINE
Order full text for this document

Title
Sigma elements are position-specific for many different yeast tRNA genes.
Author
Sandmeyer SB; Bilanchone VW; Clark DJ; Morcos P; Carle GF; Brodeur GM
Address
Department of Microbiology and Molecular Genetics, California College of Medicine, University of California, Irvine 92717.
Source
Nucleic Acids Res, 1988 Feb, 16:4, 1499-515
Abstract
We determined the DNA sequence of seventeen sigma elements and flanking regions in order to investigate the extent of the association between the yeast repetitive element, sigma, and tRNA genes. Fifteen of seventeen sigma elements analyzed begin at position -19 to -16 with respect to the 5' end of a tRNA-coding sequence. This region is close to the initiation point of tRNA gene transcription and contains a sequence which is modestly conserved for a number of tRNA genes. Two pairs of identical sigma elements occur as the long terminal repeats of a sequence which, together with flanking sigma elements, has the structural properties of a retrotransposon; this element has been named Ty3 (manuscript submitted). Hybridization analysis of yeast chromosomal DNA separated by orthogonal field alternation gel electrophoresis (OFAGE) showed that Ty3 and isolated sigma elements are distributed over many chromosomes in the yeast genome.
Language of Publication
English
Unique Identifier
88157710

Order full text for this document


MeSH Heading (Major)
Genes, Fungal|*; RNA, Transfer|*GE; Saccharomyces cerevisiae|*GE; Sigma Factor|*GE; Transcription Factors|*GE
MeSH Heading
Base Sequence; Chromosome Mapping; Cloning, Molecular; Comparative Study; Molecular Sequence Data; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0305-1048
Country of Publication
ENGLAND


Record 23 from database: MEDLINE
Order full text for this document

Title
The development of new immunotherapies for the treatment of cancer using interleukin-2. A review.
Author
Rosenberg SA
Address
Surgery Branch, National Cancer Institute, Bethesda, MD 20014.
Source
Ann Surg, 1988 Aug, 208:2, 121-35
Abstract
Recent increases in knowledge of cellular immunology, combined with developments in biotechnology, have provided new opportunities for the development of immunotherapies for the treatment of cancer in humans. One approach to therapy is that of adoptive immunotherapy, that is, the transfer to the tumor bearing host of lymphoid cells with antitumor reactivity that can mediate antitumor responses. Several lymphocyte subpopulations have now been identified that may be suitable for use in adoptive immunotherapy. Resting lymphocytes incubated in interleukin-2 (IL-2) give rise to lymphokine activated killer (LAK) cells that can lyse malignant cells, but not normal cells. Clinical studies in patients with advanced cancer have revealed that treatment with high dose IL-2 alone or in combination with LAK cells can mediate the complete or partial regression of cancer in selected patients. Other approaches are currently undergoing investigation, including the adoptive transfer of tumor infiltrating lymphocytes, which, in animal models, have antitumor reactivity 50-100 times more potent than do LAK cells. Other new approaches to immunotherapy include the use of combination of lymphokines, such as the use of tumor necrosis factor or alpha interferon in conjunction with IL-2. The availability of recombinant lymphokines that provide large amounts of biologically active materials can hopefully lead to the development of effective new therapies for cancer in humans.
Language of Publication
English
Unique Identifier
88293049

Order full text for this document


MeSH Heading (Major)
Immunotherapy|AE/*MT; Neoplasms|*TH
MeSH Heading
Animal; Human; Immunization, Passive; Interferon Type I|TU; Interleukin-2|TU; Killer Cells|IM; Lymphocytes|IM; Lymphokines|IM; Mice; Neoplasms, Experimental|TH; Tumor Necrosis Factor|TU

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0003-4932
Country of Publication
UNITED STATES


Record 24 from database: MEDLINE
Order full text for this document

Title
Interaction of elongation factors EF-G and EF-Tu with a conserved loop in 23S RNA.
Author
Moazed D; Robertson JM; Noller HF
Address
Thimann Laboratories, University of California, Santa Cruz 95064.
Source
Nature, 1988 Jul, 334:6180, 362-4
Abstract
The elongation factors EF-Tu and EF-G interact with ribosomes during protein synthesis: EF-Tu presents incoming aminoacyl transfer RNA to the programmed ribosome as an EF-Tu-GTP-tRNA ternary complex and EF-G promotes translocation of peptidyl-tRNA and its associated messenger RNA from the A to the P site after peptidyl transfer. Both events are accompanied by ribosome-dependent GTP hydrolysis. Here we use chemical probes to investigate the possible interaction of these factors with ribosomal RNA in E. coli ribosomes. We observe EF-G-dependent footprints in vitro and in vivo around position 1,067 in domain II of 23S rRNA, and in the loop around position 2,660 in domain VI.EF-Tu gives an overlapping footprint in vitro at positions 2,655 and 2,661, but shows no effect at position 1,067. The 1,067 region is the site of interaction of the antibiotic thiostrepton, which prevents formation of the EF-G-GTP-ribosome complex and is a site for interaction with the GTPase-related protein L11 (ref. 3). The universally conserved loop in the 2,660 region is the site of attack by the RNA-directed cytotoxins alpha-sarcin and ricin, whose effects abolish translation and include the loss of elongation factor-dependent functions in eukaryotic ribosomes.
Language of Publication
English
Unique Identifier
88276133

Order full text for this document


MeSH Heading (Major)
Peptide Elongation Factor Tu|*ME; Peptide Elongation Factors|*ME; RNA, Bacterial|*ME; RNA, Ribosomal|*ME; RNA, Ribosomal, 23S|*ME
MeSH Heading
Escherichia coli|GE; Nucleic Acid Conformation; Ribosomes|ME; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0028-0836
Country of Publication
ENGLAND


Record 25 from database: MEDLINE
Order full text for this document

Title
A conserved epitope on several human vitamin K-dependent proteins. Location of the antigenic site and influence of metal ions on antibody binding.
Author
Church WR; Messier T; Howard PR; Amiral J; Meyer D; Mann KG
Address
Department of Biochemistry, University of Vermont, Burlington 05405.
Source
J Biol Chem, 1988 May, 263:13, 6259-67
Abstract
A murine monoclonal antibody (designated H-11) produced by injecting mice with purified human protein C was found to bind several human vitamin K-dependent proteins. Using a solid-phase competitive radioimmunoassay with antibody immobilized onto microtiter plates, binding of 125I-labeled protein C to the antibody was inhibited by increasing amounts of protein C, prothrombin, and Factors X and VII over a concentration range of 1 X 10(-8) to 1 X 10(-6) M. Other vitamin K-dependent proteins including Factor IX and protein S did not inhibit or inhibited only at the highest concentration binding of radiolabeled protein C to the immobilized antibody. Chemical treatment of prothrombin with a variety of agents including denaturation by sodium dodecyl sulfate, reduction with mercaptoethanol followed by carboxymethylation with iodoacetic acid, citraconylation of lysine residues, removal of metal ion with EDTA, or heat decarboxylation did not destroy the antigenic site recognized by the antibody as measured by immunoblotting of prothrombin or prothrombin derivative immobilized onto nitrocellulose. Immunoblotting of purified vitamin K-dependent polypeptides with the monoclonal antibody following sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrophoretic transfer to nitrocellulose indicated that the antigenic site was found on the light chains of protein C and Factor X. Chymotrypsin digestion of prothrombin and isolation on QAE-Sephadex of the peptide representing amino-terminal residues 1-44 of prothrombin further localized the antigenic site recognized by the monoclonal antibody to the highly conserved gamma-carboxyglutamic acid-containing domain. The exact location of the antigenic determinant for antibody H-11 was established using synthetic peptides. Antibody H-11 bound specifically to synthetic peptides corresponding to residues 1-12 of Factor VII and 1-22 of protein C. Comparison of protein sequences of bovine and human vitamin K-dependent proteins suggests that the sequence Phe-Leu-Glu-Glu-Xaa-Arg/Lys is required for antibody binding. The glutamic acid residues in this peptide segment are the first 2 gamma-carboxyglutamic acid residues near the amino-terminal end in the native proteins. Increasing concentrations of Ca2+, Mg2+, or Mn2+ partially inhibited binding of 125I-protein C to the antibody in a solid-phase assay system with half-maximal binding observed at divalent metal ion concentrations of 2, 4, and 0.6 mM, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)
Language of Publication
English
Unique Identifier
88198170

Order full text for this document


MeSH Heading (Major)
Antibodies, Monoclonal|*; Antibody Specificity|*; Blood Proteins|*AN; Carrier Proteins|*AN; Epitopes|*AN; Metals|*ME; Vitamin K|*AN
MeSH Heading
Animal; Factor IX|AN; Factor VII|AN; Factor X|AN; Glycoproteins|AN; Human; Mice; Protein C|AN/IM; Prothrombin|AN; Radioimmunoassay; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 26 from database: MEDLINE
Order full text for this document

Title
Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
Author
Kosano H; Takatani O
Address
Third Department of Internal Medicine, National Defense Medical College, Japan.
Source
Cancer Res, 1988 Nov, 48:21, 6033-6
Abstract
The effects of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (ET-18-OCH3), an alkyl lysophospholipid derivative, on the binding of epidermal growth factor (EGF) to human breast cancer cell lines (MCF-7, ZR-75-1, and BT-20), the human epidermoid cancer cell line (A431), and the rat fibroblast cell line (NIH3T3) were investigated. The addition of 10 micrograms/ml ET-18-OCH3 to the growth medium reduced the binding of EGF to hormone-dependent breast cancer cell lines (MCF-7 and ZR-75-1) and A431 but did not change that to the hormone-independent breast cancer cell line (BT-20). ET-18-OCH3 suppressed the EGF-binding prior to the onset of its inhibitory action on cell growth in MCF-7 and ZR-75-1. Scatchard plot analysis demonstrated that ET-18-OCH3 reduced the number of EGF receptor sites without affecting the affinity of EGF receptors in MCF-7 and ZR-75-1. Both EGF-binding and cell growth in NIH3T3 were not changed by treatment with 10 micrograms/ml ET-18-OCH3. These results suggest that ET-18-OCH3 inhibits the growth of hormone-dependent breast cancer cell lines (MCF-7 and ZR-75-1) by reducing the binding capacity of EGF receptors and consequently by disturbing the transfer of a variety of growth-promoting signals.
Language of Publication
English
Unique Identifier
89002775

Order full text for this document


MeSH Heading (Major)
Antineoplastic Agents|*PD; Breast Neoplasms|*ME; Epidermal Growth Factor-Urogastrone|*ME; Phospholipid Ethers|*PD
MeSH Heading
Female; Human; Phosphatidylcholines|PD; Platelet Activating Factor|PD; Protein Kinase C|PH; Receptors, Epidermal Growth Factor-Urogastrone|AN; Tumor Cells, Cultured

Publication Type
JOURNAL ARTICLE
ISSN
0008-5472
Country of Publication
UNITED STATES


Record 27 from database: MEDLINE
Order full text for this document

Title
Heat shock response of Pseudomonas aeruginosa.
Author
Allan B; Linseman M; MacDonald LA; Lam JS; Kropinski AM
Address
Department of Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada.
Source
J Bacteriol, 1988 Aug, 170:8, 3668-74
Abstract
The general properties of the heat shock response in Pseudomonas aeruginosa were characterized. The transfer of cells from 30 to 45 degrees C repressed the synthesis of many cellular proteins and led to the enhanced production of 17 proteins. With antibodies raised against the Escherichia coli proteins, two polypeptides of P. aeruginosa with apparent molecular weights of 76,000 and 61,000 (76K and 61K proteins) were shown to be analogous to the DnaK and GroEL heat shock proteins of E. coli due to their immunologic cross-reactivity. The major sigma factor (sigma 87) of P. aeruginosa was shown to be a heat shock protein that was immunologically related to the sigma 70 of E. coli by using polyclonal antisera. A hybridoma was produced, and the monoclonal antibody MP-S-1 was specific for the sigma 87 and did not cross-react with sigma 70 of E. coli. A smaller 40K protein was immunoprecipitated with RNA polymerase antisera from cells that had been heat shocked. The 40K protein was also associated with RNA polymerase which had been purified from heat-shocked cells and may be the heat shock sigma factor of P. aeruginosa. Exposure to ethanol resulted in the production of seven new proteins, three of which appeared to be heat shock proteins.
Language of Publication
English
Unique Identifier
88298679

Order full text for this document


MeSH Heading (Major)
Heat-Shock Proteins|*BI/IM; Pseudomonas aeruginosa|GE/*ME; Sigma Factor|AN/*BI/IM; Transcription Factors|*BI
MeSH Heading
Animal; Antibodies, Monoclonal|IM; Cross Reactions; Electrophoresis, Polyacrylamide Gel; Escherichia coli|ME; Ethanol|PD; Heat; Hybridomas; Immunoassay; Support, Non-U.S. Gov't; Transcription, Genetic

Publication Type
JOURNAL ARTICLE
ISSN
0021-9193
Country of Publication
UNITED STATES


Record 28 from database: MEDLINE
Order full text for this document

Title
IGF receptors in myocardial capillary endothelium: potential regulation of IGF-I transport to cardiac muscle.
Author
Bar RS; Boes M; Sandra A
Address
Veterans Administration Hospital, Department of Internal Medicine, University of Iowa, Iowa City 52242.
Source
Biochem Biophys Res Commun, 1988 Apr, 152:1, 93-8
Abstract
Beating rat hearts were perfused with 125I-IGF-II alone or 125I-IGF-II and unlabeled IGF-II or insulin, then prepared for radioautography. Maximal 125I-IGF-II grain counts over capillaries were decreased in a dose-dependent manner by unlabeled IGF-II but were unaffected by coperfusion with insulin. To determine a potential role for capillary receptors in the transfer of circulating IGF to cardiac muscle, the effects of sequential loss of capillary IGF binding sites was determined. For IGF-I, loss of capillary binding sites by trypsin perfusion was accompanied by proportional decreases in the subsequent appearance of IGF-I in cardiac muscle. In contrast, similar decrements of capillary IGF-II binding did not affect muscle levels of IGF-II. We conclude that capillary endothelium of the intact heart possesses distinct IGF-I and IGF-II binding sites, with the capillary IGF-I binding sites being of potential importance in the transfer of vascular IGF-I to subendothelial cardiac muscle.
Language of Publication
English
Unique Identifier
88192684

Order full text for this document


MeSH Heading (Major)
Endothelium, Vascular|*ME; Insulin-Like Growth Factor I|*ME; Myocardium|*ME; Receptors, Insulin|*ME; Somatomedins|*ME
MeSH Heading
Animal; Capillaries|ME; Cells, Cultured; Coronary Vessels|ME; In Vitro; Kinetics; Rats; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-291X
Country of Publication
UNITED STATES


Record 29 from database: MEDLINE
Order full text for this document

Title
Effects of epidermal growth factor, insulin and insulin-like growth factor I on rat pancreatic acinar cells cultured in serum-free medium.
Author
Brannon PM; Hirschi K; Korc M
Address
Department of Nutrition and Food Science, University of Arizona, Tucson 85721.
Source
Pancreas, 1988, 3:1, 41-8
Abstract
The effects of epidermal growth factor (EGF), insulin, and insulin-like growth factor I (IGF-I) were examined alone and in combination on rat pancreatic acinar cells cultured 48 h in serum free medium. IGF-I at a concentration of 2.7 nM maintained viability of cultured acinar cells comparably to EGF. In contrast, insulin was less effective in maintaining acinar viability, even at high concentrations (170nM). There were no additive or interactive effects of these growth factors on acinar viability. EGF significantly increased [3H]-phenylalanine incorporation into acinar protein and the specific activity of phenylalanine-acylated transfer RNA (tRNAphe), but did not change the apparent rate of protein synthesis when compared with insulin of IGF-I. EGF with insulin, IGF-I, or both resulted in significantly lower specific activities of tRNAphe when compared to EGF alone, but all had comparable rates of total phe-incorporation. Acinar cells readily degraded insulin, but not EGF or IGF-I. These results demonstrate some specificity in the acinar requirement for growth factors (EGF = IGF-I greater than insulin) in maintaining viability in culture.
Language of Publication
English
Unique Identifier
88203576

Order full text for this document


MeSH Heading (Major)
Epidermal Growth Factor-Urogastrone|*PD; Insulin|*PD; Insulin-Like Growth Factor I|*PD; Pancreas|*DE/ME; Somatomedins|*PD
MeSH Heading
Animal; Cell Survival|DE; Cells, Cultured; Comparative Study; Culture Media; Male; Rats; Rats, Inbred Strains; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0885-3177
Country of Publication
UNITED STATES


Record 30 from database: MEDLINE
Order full text for this document

Title
Biochemical and pharmacological characterization of human embryo-derived platelet activating factor.
Author
Collier M; ONeill C; Ammit AJ; Saunders DM
Address
Human Reproduction Unit, Royal North Shore Hospital, St Leonards, NSW, Australia.
Source
Hum Reprod, 1988 Nov, 3:8, 993-8
Abstract
The soluble platelet activating factor (PAF) produced by mouse embryos was shown to have properties similar to 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphocholine (PAF-acether). In this study PAF was extracted from the medium in which human embryos were cultured for approximately 18 h prior to transfer. The extracted embryo-derived PAF moved on silica thin layer chromatograms with the same RF of 0.26 +/- 0.03 (n = 26) as PAF-acether. Embryo-derived PAF or PAF-acether activity was assayed by monitoring the decrease in the proportion of single platelets in rabbit whole blood due to aggregation on incubation at 37 degrees C. The two agonists were said to be of the same activity, if they induced the same degree of platelet aggregation after 15 min incubation. PAF-acether (93 nM) and embryo-derived PAF of similar activity induced an identical time response of platelet aggregation, the response being maximal by 6 min. PAF-acether, over the range 5.6-200 nM, induced a decrease that was linear when plotted on a log-log scale. Embryo-derived PAF and PAF-acether (184 nM) gave identical dose responses when serially diluted to 16 nM. Pharmacologically, the action of embryo-derived PAF and PAF-acether (46 nM) on platelet aggregation was significantly inhibited by 3.75 microM of the PAF-specific receptor inhibitor, SRI 63-441, and completely inhibited at 15 microM SRI 63-441. Embryo-derived PAF and PAF-acether (184 nM) were inactivated to the same degree by incubation with 5-13 IU/ml phospholipase A2 (pA2).(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
89079863

Order full text for this document


MeSH Heading (Major)
Embryo|*AN/ME; Platelet Activating Factor|*AN/BI/IP
MeSH Heading
Animal; Biological Assay; Female; Human; Mice; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0268-1161
Country of Publication
ENGLAND


Record 31 from database: MEDLINE
Order full text for this document

Title
Expression of functional human EGF receptor on murine bone marrow cells.
Author
von Rüden T; Wagner EF
Address
European Molecular Biology Laboratory, Heidelberg, FRG.
Source
EMBO J, 1988 Sep, 7:9, 2749-56
Abstract
The human epidermal growth factor-receptor (EGF-R) was introduced into primary mouse bone marrow cells (BMC), utilizing retrovirus mediated gene transfer. Cultivation of infected BMC in the presence of interleukin-3 (IL-3) led to the outgrowth of IL-3 dependent myeloid cells, which efficiently expressed functional EGF-R, exhibiting its two characteristic affinity states. EGF acts on these cells synergistically with IL-3 in stimulating DNA synthesis and cell proliferation even under IL-3 saturation conditions. However, EGF was not sufficient to replace the requirement for IL-3. In contrast, EGF was able to maintain proliferation of a factor-dependent hemopoietic cell line (FDC-P1) infected with the EGF-R retrovirus in the absence of IL-3, but these cells did not respond to EGF in the presence of IL-3. No influence of EGF on IL-3 induced mast cell differentiation of BMC expressing the EGF-R could be observed by histological criteria. These data show that the expression of EGF-R alone is not sufficient to induce or maintain cell proliferation in IL-3 dependent bone marrow derived cells, although it can do so in established hemopoietic cell lines.
Language of Publication
English
Unique Identifier
89030639

Order full text for this document


MeSH Heading (Major)
Bone Marrow|*CY/ME; Gene Expression Regulation|*; Receptors, Epidermal Growth Factor-Urogastrone|*BI/GE; Transfection|*
MeSH Heading
Animal; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cells, Cultured; Comparative Study; DNA|BI; Fluorescent Antibody Technique; Genetic Vectors; Hematopoietic Stem Cells|CY/ME; Histocytochemistry; Interleukin-3|PH; Mice; Mice, Inbred C57BL; Retroviridae; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0261-4189
Country of Publication
ENGLAND


Record 32 from database: MEDLINE
Order full text for this document

Title
An inhibitory monoclonal antibody to factor X that blocks prothrombin activation but not prothrombinase enzyme assembly.
Author
Church WR; Messier TL; Tucker MM; Mann KG
Address
Department of Biochemistry, University of Vermont, Burlington 05405.
Source
Blood, 1988 Dec, 72:6, 1911-21
Abstract
A monoclonal antibody (designated alpha BFX-2b) prepared against bovine factor X inhibited factor X activity in human, bovine, porcine, rabbit, and canine plasma. In assays using purified prothrombinase components, factor Xa, factor Va, phospholipid vesicles, and calcium ion with the fluorescent active site thrombin inhibitor dansylarginyl-N-(3-ethyl-1,5-pentanediyl)amide, the antibody inhibited the conversion of prothrombin to thrombin. Antibody alpha BFX-2b also blocked prothrombinase cleavage of the macromolecular substrates prethrombin 1 and prethrombin 2 but did not inhibit factor Xa hydrolysis of the synthetic substrate benzoyl-Ile-Glu-Gly-Arg-p-nitroanilide. The antibody also prevented the inactivation of factor Xa by antithrombin III but did not prevent the inactivation by soybean trypsin inhibitor. Antibody alpha BFX-2b bound factor Xa with a stoichiometry of 1:1 and an apparent dissociation constant of 9.0 x 10(-11) mol/L as estimated from its inhibition of prothrombinase activity. Antibody alpha BFX-2b did not prevent binding of factor Xa to factor Va-phospholipid as measured by using fluorescence polarization or high-pressure liquid gel chromatography with the fluorescent Factor Xa analogue dansyl-glutamyl-glycyl-arginyl-Xa. Immunoblotting of factor X following electrophoresis on sodium dodecyl sulphate-polyacrylamide gels and transfer to nitrocellulose indicated that the antigenic determinant recognized by antibody alpha BFX-2b was found on the heavy chain of factors X and Xa. From these observations it can be concluded that antibody alpha BFX-2b recognizes a highly conserved epitope on the factor X heavy chain that is remote from the topographic sites required for prothrombinase complex assembly and substrate hydrolysis but may be located at or near a portion of the macromolecular substrate binding site.
Language of Publication
English
Unique Identifier
89062726

Order full text for this document


MeSH Heading (Major)
Antibodies, Monoclonal|*IM; Factor X|AI/*IM; Prothrombin|*ME; Thromboplastin|AI/*ME
MeSH Heading
Animal; Antithrombin III|ME; Cattle; Dogs; Enzyme Precursors|ME; Epitopes|IM; Oligopeptides|ME; Protein Conformation; Rabbits; Serine Proteinases|AI; Species Specificity; Support, U.S. Gov't, P.H.S.; Swine

Publication Type
JOURNAL ARTICLE
ISSN
0006-4971
Country of Publication
UNITED STATES


Record 33 from database: MEDLINE
Order full text for this document

Title
Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses.
Author
Robertson B; Dostal K; Daynes RA
Address
Department of Pathology, University of Utah Medical Center, Salt Lake City 84132.
Source
J Immunol, 1988 Jun, 140:12, 4300-7
Abstract
Administration of the pituitary hormone alpha-melanocyte-stimulating hormone (alpha-MSH) to mice was found to inhibit a number of IL-1 and TNF-inducible biologic responses in situ. The ability of either IL-1 or TNF to cause fever, enhance plasma levels of acute phase proteins, and increase the numbers of peripheral blood neutrophils was inhibited by the simultaneous peripheral administration of this neuropeptide. In addition, alpha-MSH reversed the depressive influences of IL-1 or TNF on the effector phase of contact hypersensitivity (CH) responses in animals given an adoptive transfer of primed lymphocytes from hapten-sensitized donors. Intracerebral injection of nanogram quantities of alpha-MSH inhibited the ability of peripherally administered IL-1 or TNF to induce both fever and neutrophilia without affecting the increase in plasma levels of serum amyloid P and fibrinogen. Also, nanogram quantities of alpha-MSH given intracerebrally to normal mice did not reverse the depressed CH responses observed after peripheral IL-1 or TNF administration. These findings suggest that both fever and neutrophilia are linked to the direct action of IL-1 or TNF on the brain. This was supported by the observation that an intracerebral injection of IL-1 or TNF in low doses increased core body temperature and circulating neutrophil numbers without affecting plasma levels of acute phase proteins or CH responsiveness. Our results provide additional support for the hypothesis that bidirectional control exists between elements of the neuroendocrine and immune systems.
Language of Publication
English
Unique Identifier
88229144

Order full text for this document


MeSH Heading (Major)
alpha-MSH|AA/*AD; Amyloid Protein SAA|*ME; Fever|*CI/PC; Fibrinogen|*ME; Interleukin-1|AD/*AI; Tumor Necrosis Factor|AD/*AI
MeSH Heading
Animal; Anti-Inflammatory Agents, Non-Steroidal|AD; Brain|DE; Dermatitis, Contact|ET/PC; Female; Injections, Intravenous; Injections, Intraventricular; Leukocyte Count|DE; Male; Mice; Mice, Inbred C3H; Neutrophils|DE; Recombinant Proteins|AD; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0022-1767
Country of Publication
UNITED STATES


Record 34 from database: MEDLINE
Order full text for this document

Title
Comparison of mouse pro-1 and pro-2 transfectants for responses to tumor promoters and antipromoters.
Author
Colburn NH; Smith BM; Wendel EJ; Nakamura Y; Winterstein D
Address
Cell Biology Section, National Cancer Institute, Frederick, Maryland 21701.
Source
Cancer Res, 1988 Nov, 48:21, 6076-80
Abstract
A previous report demonstrated that mouse JB6 cells transformed to promotion sensitive (P+) phenotype by transfection with an activated promotion sensitivity (pro) gene showed both evidence for the presence of the transfected gene and sensitivity to phorbol ester induced transformation similar to that observed in parental P+ cells. In addition, pro-1 and pro-2 transfectants were similar to each other in phorbol ester response. The current report extends these findings to ask whether pro-1 or pro-2 transfectants are also sensitive to promotion of transformation by other classes of tumor promoters such as epidermal growth factor (EGF), lanthanides, and phthalate esters and to inhibition of phorbol ester promoted transformation by several classes of antipromoters. The results showed that both pro-1 and pro-2 transfectants resembled parental P+ cells in sensitivity to promotion of anchorage independent transformation by lanthanides and by diethylhexylphthalate. In addition both pro-1 and pro-2 transfectants showed inhibition of phorbol ester induced transformation by antipromoters ganglioside GT1b, ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid, and forskolin. Thus the pathways implicated by these inducers and inhibitors of transformation appear similar to those implicated for parental P+ cells and similar when controlled by pro-1 or pro-2. The single differential response was that of EGF-induced transformation. pro-2 transfectants but not pro-1 transfectants were sensitive to EGF-induced neoplastic transformation. The nonresponsiveness could not be attributed to lack of EGF receptors since 125I-EGF binding to pro-1 transfectants was similar to that for pro-2 transfectants and parental P+ cells. Thus pro genes transfer responsiveness to a C-kinase mediated promotion of transformation pathway and to putatively non-C kinase pathways triggered by lanthanides or phthalate esters, but not necessarily to an EGF receptor kinase mediated pathway.
Language of Publication
English
Unique Identifier
89002783

Order full text for this document


MeSH Heading (Major)
Cell Transformation, Neoplastic|*DE; Transfection|*
MeSH Heading
Animal; Cell Line; Comparative Study; Diethylhexyl Phthalate|TO; Egtazic Acid|PD; Epidermal Growth Factor-Urogastrone|ME/PD; Mice; Mice, Inbred BALB C; Protein Kinase C|PH; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Tetradecanoylphorbol Acetate

Publication Type
JOURNAL ARTICLE
ISSN
0008-5472
Country of Publication
UNITED STATES


Record 35 from database: MEDLINE
Order full text for this document

Title
Activation of phospholipase D by chemotactic peptide in HL-60 granulocytes.
Author
Pai JK; Siegel MI; Egan RW; Billah MM
Address
Department of Allergy and Inflammation, Schering-Plough Corporation, Bloomfield, NJ 07003.
Source
Biochem Biophys Res Commun, 1988 Jan, 150:1, 355-64
Abstract
Activation of phospholipase D (PLD) has been investigated in dimethylsulfoxide differentiated HL-60 granulocytes labeled in endogenous 1-0-alkyl-2-acyl-sn-glycero-3-phosphocholine (alkyl-PC) by incubation with [3H]alkyl-lysoPC. Stimulation of these labeled cells with the chemotactic peptide, N-formyl-Met-Leu-Phe (fMLP), induces rapid generation of [3H]phosphatidic acid (PA) and slower formation of [3H]diglyceride, suggesting hydrolysis of alkyl-PC by PLD. A unique feature of PLD is its ability to transfer the phosphatidyl moiety of phospholipids to alcohols (transphosphatidylation). This characteristic has been exploited to identify PLD activity. For example, when ethanol is present during stimulation of the HL-60 cells, [3H]phosphatidylethanol (PEt) is formed with a concomitant decrease in [3H]PA. Cells incubated with [32P]orthophosphate to label the terminal phosphate of ATP do not incorporate 32P into PEt, consistent with the [3H]PEt not being synthesized from [3H]diglyceride. In contrast, [3H]PA arises from both PLD and diglyceride kinase activities. Furthermore, PEt synthesis closely parallels PA formation and both are inhibited by an fMLP receptor antagonist, suggesting that both PA and PEt are derived from agonist-stimulated PLD action. These observations are consistent with phospholipase D-catalyzed breakdown of alkyl-PC in fMLP- stimulated granulocytes.
Language of Publication
English
Unique Identifier
88106608

Order full text for this document


MeSH Heading (Major)
Granulocytes|DE/*EN; N-Formylmethionine Leucyl-Phenylalanine|*PD; Phospholipase D|*ME; Phospholipases|*ME
MeSH Heading
Diglycerides|ME; Enzyme Activation; Ethanol|ME/PD; Human; Kinetics; Leukemia, Myeloid|EN; Lysophosphatidylcholines|ME; Oligopeptides|PD; Phosphates|ME; Phosphatidic Acids|BI; Phospholipid Ethers|ME; Platelet Activating Factor|AA/ME; Tumor Cells, Cultured

Publication Type
JOURNAL ARTICLE
ISSN
0006-291X
Country of Publication
UNITED STATES


Record 36 from database: MEDLINE
Order full text for this document

Title
Elevated plasma atrial natriuretic factor and vasopressin in high-altitude pulmonary edema.
Author
Cosby RL; Sophocles AM; Durr JA; Perrinjaquet CL; Yee B; Schrier RW
Address
University of Colorado School of Medicine.
Source
Ann Intern Med, 1988 Nov, 109:10, 796-9
Abstract
A diagnosis of acute high-altitude pulmonary edema was made in five male skiers (age, 35.0 +/- 1.8 years) by history and physical examination and was confirmed by a characteristic chest radiogram showing alveolar infiltrates associated with a normal cardiac silhouette. Five healthy age- and sex-matched subjects with similar physical activity at the same altitude served as controls. Plasma sodium was 135.0 +/- 1.5 mmol/L in the acutely ill patients compared with 144.0 +/- 3.3 mmol/L in the controls (P less than 0.025). Mean plasma atrial natriuretic factor immunoreactivity averaged 17.6 +/- 5.6 pmol/L in patients with high-altitude pulmonary edema compared with 6.8 +/- 0.7 pmol/L in the controls at the same altitude (P less than 0.05). Elevated atrial natriuretic factor levels normalized to 7.5 +/- 1.9 pmol/L (P less than 0.05) during recovery in Denver (altitude, 1600 meters) 24 hours later. Plasma arginine vasopressin levels were 1.8 +/- 0.37 pmol/L in patients with high-altitude pulmonary edema at diagnosis compared with 0.92 +/- 0.28 pmol/L in controls (P = 0.07). The inappropriately elevated arginine vasopressin levels decreased to 1.29 +/- 0.37 pmol/L during recovery (P less than 0.025), but the lowered plasma sodium concentration had not normalized by discharge within 24-hours of transfer to Denver and averaged 135.8 +/- 1.2 mmol/L. The pathophysiologic implications of these findings are discussed.
Language of Publication
English
Unique Identifier
89048658

Order full text for this document


MeSH Heading (Major)
Altitude Sickness|*BL; Anoxia|*BL; Argipressin|*BL; Atrial Natriuretic Factor|*BL; Pulmonary Edema|*BL/ET
MeSH Heading
Acute Disease; Adult; Aldosterone|BL; Blood Urea Nitrogen; Creatinine|BL; Human; Male; Renin|BL; Sodium|BL; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0003-4819
Country of Publication
UNITED STATES


Record 37 from database: MEDLINE
Order full text for this document

Title
Tumor necrosis factor (cachectin) mediates induction of cachexia by cord factor from mycobacteria.
Author
Silva CL; Faccioli LH
Address
Department of Parasitology, Microbiology and Immunology, School of Medicine of RibeirÃao Preto, University of SÃao Paulo, Brazil.
Source
Infect Immun, 1988 Dec, 56:12, 3067-71
Abstract
The mechanism by which cord factor (CF), a toxic glycolipid from mycobacteria, induces cachexia was studied in BALB/c mice. Body weight was markedly reduced 48 h after CF administration; the animals became severely wasted and exhibited hypertriglyceridemia, hypoglycemia, and high levels of tumor necrosis factor (TNF) in plasma. After CF administration, a transferable factor which caused cachexia and hypertriglyceridemia in recipient mice was detected in the blood. Dexamethasone partially inhibited the cachexia-inducing action of CF. Conditioned medium from adherent peritoneal cell cultures incubated with CF produced the same wasting symptoms when inoculated intravenously into mice. These studies also demonstrated that adherent peritoneal cells produced a humoral factor in response to CF which was related to CF-induced cachexia. Antiserum to recombinant TNF-alpha prevented the cachectin action in passive-transfer experiments. Our findings indicate that cachectin (TNF) plays a role as a central mediator of the wasting induced by CF.
Language of Publication
English
Unique Identifier
89032595

Order full text for this document


MeSH Heading (Major)
Cachexia|*ET/PP; Cord Factors|*PD; Glycolipids|*PD; Tumor Necrosis Factor|*PH
MeSH Heading
Animal; Dexamethasone|PD; Macrophages|PH; Mice; Mice, Inbred BALB C; Mycobacterium bovis; Support, Non-U.S. Gov't; Triglycerides|BL

Publication Type
JOURNAL ARTICLE
ISSN
0019-9567
Country of Publication
UNITED STATES


Record 38 from database: MEDLINE
Order full text for this document

Title
Factor XIII cross-linking of fibronectin at cellular matrix assembly sites.
Author
Barry EL; Mosher DF
Address
Department of Physiological Chemistry, University of Wisconsin Medical School, Madison 53706.
Source
J Biol Chem, 1988 Jul, 263:21, 10464-9
Abstract
We describe the effect of activated Factor XIII (Factor XIIIa, plasma transglutaminase) on the incorporation of plasma fibronectin into extracellular matrix by cultured human fibroblasts. In the absence of added Factor XIIIa, fibronectin binds to cultured fibroblast cell layers and is assembled into disulfide-bonded multimers of the extracellular matrix. When Factor XIIIa was included in the binding medium of skin fibroblasts, accumulation of 125I-fibronectin in the deoxycholate-insoluble matrix was increased. Fibronectin accumulating in the cell layer was cross-linked into nonreducible high molecular weight aggregates. The 70-kDa amino-terminal fragment of fibronectin inhibited the binding and cross-linking of 125I-fibronectin to cell layers, whereas fibrinogen had little effect. When 125I-fibronectin was incubated with isolated matrices or with cell layers pretreated with cytochalasin B, it did not bind and could not be cross-linked by Factor XIIIa into the matrix. HT-1080 human fibrosarcoma cells bound exogenous fibronectin following treatment with dexamethasone; Factor XIIIa cross-linked the bound fibronectin and caused its efficient transfer to the deoxycholate-insoluble matrix. These results indicate that exogenous fibronectin is susceptible to Factor XIIIa-catalyzed cross-linking at cellular sites of matrix assembly. Thus, Factor XIIIa-mediated fibronectin cross-linking complements disulfide-bonded multimer formation in the stabilization of assembling fibronectin molecules and thus enhances the formation of extracellular matrix.
Language of Publication
English
Unique Identifier
88273153

Order full text for this document


MeSH Heading (Major)
Extracellular Matrix|*ME; Factor XIII|*ME; Fibronectins|*ME
MeSH Heading
Cell Line; Cross-Linking Reagents; Fibroblasts|ME; Human; Kinetics; Male; Molecular Weight; Skin; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 39 from database: MEDLINE
Order full text for this document

Title
Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation.
Author
Hamel E; Katoh F; Mueller G; Birchmeier W; Yamasaki H
Address
International Agency for Research on Cancer, Lyon, France.
Source
Cancer Res, 1988 May, 48:10, 2832-6
Abstract
We have tested transforming growth factor beta (TGF beta) in the two-stage BALB/c 3T3 cell transformation assay for possible tumor-promoting activity, since it has several effects similar to those of tumor-promoting phorbol esters. After initiation of BALB/c 3T3 cells with 3-methylchol-anthrene, treatment with TGF beta at 1 ng/ml alone or in combination with epidermal growth factor (EGF) for 4 weeks enhanced the number of transformed foci by 5- to 6-fold in comparison with uninitiated cells. Initiation treatment alone induced no or very few transformed foci in several assays. Treatment with phorbol-12,13-didecanoate (PDD) at 100 ng/ml for 4 weeks enhanced the number of transformed foci in initiated BALB/c 3T3 cells by 4- to 5-fold in comparison with uninitiated cells. Thus, TGF beta at 1 ng/ml is as potent as PDD at 100 ng/ml for tumor-promoting activity in the two-stage BALB/c 3T3 cell transformation assay. The enhancing effect of TGF beta was dose-related in the dose range tested (0.03-1 ng/ml) and was not reversible. Some of the foci induced by combined MCA-TGF beta-EGF treatment were cloned, and eight out of nine clones tested produced tumors in nude mice. TGF beta (1 ng/ml) plus EGF (2 ng/ml) increased the saturation density to a similar extent as PDD (100 ng/ml) but did not affect the growth of BALB/c 3T3 cells. We observed no change in junctional intercellular communication, as measured by the dye transfer method, when cells were treated with TGF beta during the two-stage BALB/c 3T3 cell transformation assay. Nevertheless, there was selective communication between transformed and surrounding nontransformed cells; MCA-TGF beta transformed cells intercommunicated among themselves but not with surrounding nontransformed cells. Our results indicate that TGF beta has potent tumor-promoting activity in vitro, but that this activity is not mediated by a complete blockage of intercellular communication, as is suggested for phorbol ester tumor promoters.
Language of Publication
English
Unique Identifier
88194347

Order full text for this document


MeSH Heading (Major)
Cell Transformation, Neoplastic|*DE; Peptides|*PD
MeSH Heading
Animal; Cell Communication|DE; Cell Line; Dose-Response Relationship, Drug; Epidermal Growth Factor-Urogastrone|PD; Methylcholanthrene; Mice; Phorbol Esters|PD; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0008-5472
Country of Publication
UNITED STATES


Record 40 from database: MEDLINE
Order full text for this document

Title
The effect of tumor necrosis factor/cachectin on follicle-stimulating hormone-induced aromatase activity in cultured rat granulosa cells.
Author
Emoto N; Baird A
Address
Laboratories for Neuroendocrinology, Salk Institute, La Jolla, CA 92037.
Source
Biochem Biophys Res Commun, 1988 Jun, 153:2, 792-8
Abstract
We investigated the effects of tumor necrosis factor (TNF)/cachectin on follicle-stimulating hormone (FSH)-induced aromatase activity in cultured rat granulosa cells using the stereospecific transfer of 3H from [1 beta-3H] androstenedione into 3H2O. TNF (10 pg/ml-10 ng/ml) inhibited FSH (250 ng/ml)-induced aromatase activity in a concentration-dependent manner, and 10 ng/ml of TNF completely abolished the FSH-induced aromatase activity. A time course analysis of the effects of TNF showed that TNF had no effect on induced aromatase activity, but inhibited the further induction of the enzyme by FSH. TNF (10 ng/ml) also inhibited the ability of TGF beta (1 ng/ml) to enhance aromatase activity and increase progesterone synthesis. Thus, TNF is a component of the complex array of proteins that modulate ovarian function and, as such, may play a physiological role in the regulation of the granulosa cell. In view of its association with cachexia, it may also play a pathophysiological role in the suppression of reproductive function during chronic illness.
Language of Publication
English
Unique Identifier
88251418

Order full text for this document


MeSH Heading (Major)
Aromatase|*ME; FSH|*PD; Granulosa Cells|*ME; Tumor Necrosis Factor|*PD
MeSH Heading
Animal; Cells, Cultured; Female; In Vitro; Peptides|PD; Progesterone|BI; Rats; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0006-291X
Country of Publication
UNITED STATES


Record 41 from database: MEDLINE
Order full text for this document

Title
Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.
Author
Hermansson M; Nistér M; Betsholtz C; Heldin CH; Westermark B; Funa K
Address
Ludwig Institute for Cancer Research, Uppsala Branch, University Hospital, Sweden.
Source
Proc Natl Acad Sci U S A, 1988 Oct, 85:20, 7748-52
Abstract
The genes for platelet-derived growth factor (PDGF) A chain, B chain/c-sis, and the PDGF receptor are expressed in human malignant glioma cell lines. In the present investigation we have studied the expression of these genes in biopsy specimens from human glioblastomas. Hyperplasia of the vascular endothelium is a prominent characteristic of human glioblastoma multiforme and simian sarcoma virus-induced gliomas in primates. RNA transfer blot analysis of biopsies from glioblastoma multiforme showed transcripts for PDGF A and B chains and the PDGF receptor. Tissue sections from this tumor examined by in situ hybridization techniques revealed that the proliferating vascular endothelial cells contained large quantities of mRNA for PDGF B chain/c-sis and its receptor and, to a lesser extent, for PDGF A chain. In contrast, the tumor cells expressed more mRNA for PDGF A chain than for PDGF B chain and PDGF receptor. The latter two were also expressed at higher levels in glioma cells than in glial cells of nontumorous human brain tissue. Thus, an autocrine stimulation by the PDGF B chain/c-sis product via its receptor, evoked by interaction with surrounding glioma cells, could be the mechanism behind the pathological proliferation of endothelial cells characteristically found in this type of malignancy.
Language of Publication
English
Unique Identifier
89017275

Order full text for this document


MeSH Heading (Major)
Brain Neoplasms|*GE/PA; Endothelium, Vascular|*PA; Glioblastoma|*GE/PA; Platelet-Derived Growth Factor|*GE; Receptors, Cell Surface|*GE
MeSH Heading
Animal; Blotting, Northern; Cell Division; Gene Expression Regulation; Glioma|GE/PA; Human; Hyperplasia; Immunoenzyme Techniques; Immunohistochemistry; Nucleic Acid Hybridization; RNA, Messenger|BI; Support, Non-U.S. Gov't; Tumor Cells, Cultured

Publication Type
JOURNAL ARTICLE
ISSN
0027-8424
Country of Publication
UNITED STATES


Record 42 from database: MEDLINE
Order full text for this document

Title
Induction of maturation in cumulus cell-enclosed mouse oocytes by follicle-stimulating hormone and epidermal growth factor: evidence for a positive stimulus of somatic cell origin.
Author
Downs SM; Daniel SA; Eppig JJ
Address
Jackson Laboratory, Bar Harbor, Maine 04609.
Source
J Exp Zool, 1988 Jan, 245:1, 86-96
Abstract
The efficacy of follicle-stimulating hormone (FSH), epidermal growth factor (EGF), and dibutyryl cGMP (dbcGMP) as inducers of germinal vesicle breakdown (GVBD) in cumulus cell-enclosed mouse oocytes was examined when meiotic arrest was maintained in vitro with purines, dibutyryl cAMP (dbcAMP), or the phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine (IBMX). When FSH was added to hypoxanthine (HX)-containing medium, the effect on oocyte maturation was at first inhibitory and later stimulatory. EGF stimulated GVBD at all time points tested. FSH and EGF also induced GVBD when oocytes were arrested with dbcAMP, IBMX, or guanosine. Dibutyryl cGMP stimulated GVBD when meiotic arrest was maintained with HX, but not when oocytes were meiotically arrested with guanosine, and was inhibitory in dbcAMP-supplemented medium. FSH and dbcGMP produced a transient delay of oocyte maturation in control medium, but the FSH effect was much more pronounced. EGF had no effect on maturation kinetics. The actions of FSH and EGF required the presence of cumulus cells. Both agents significantly stimulated cAMP production in oocyte-cumulus cell complexes. A brief exposure of complexes to a high concentration of dbcAMP induced GVBD, suggesting that FSH and EGF may act via a cAMP-dependent process. The frequency of FSH- and EGF-induced GVBD in cumulus cell-enclosed oocytes was significantly higher than the frequency of GVBD when oocytes were cultured while denuded of cumulus cells. of maturation is apparently not mediated solely by oocyte-cumulus cell uncoupling and termination of the transfer of an inhibitory meiotic signal from cumulus cells to the oocyte. The data suggest the generation of a positive signal within cumulus cells in response to hormone treatment that acts upon the oocyte to stimulate GVBD in the continued presence of inhibitory factors.
Language of Publication
English
Unique Identifier
88171350

Order full text for this document


MeSH Heading (Major)
Epidermal Growth Factor-Urogastrone|*PD; FSH|*PD; Oocytes|*CY/DE
MeSH Heading
Animal; Bucladesine|PD; Dibutyryl Cyclic GMP|PD; Guanosine|PD; Kinetics; Meiosis|DE; Mice; Mice, Inbred Strains; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0022-104X
Country of Publication
UNITED STATES


Record 43 from database: MEDLINE
Order full text for this document

Title
A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen.
Author
Jones FS; Burgoon MP; Hoffman S; Crossin KL; Cunningham BA; Edelman GM
Address
Rockefeller University, New York, NY 10021.
Source
Proc Natl Acad Sci U S A, 1988 Apr, 85:7, 2186-90
Abstract
Cytotactin is an extracellular glycoprotein that influences neuron-glia interactions. It has been shown to appear in multiple forms that are differentially expressed in neural and non-neural tissues during vertebrate development. We report here the isolation and characterization of a cytotactin cDNA clone (lambda C801) that encodes 933 amino acids, equivalent to about half of a cytotactin polypeptide. Clone lambda C801 is an authentic cytotactin cDNA: it encodes a polypeptide that reacts with a monoclonal anti-cytotactin antibody and its deduced amino acid sequence is identical for 15 amino acids to the directly determined sequence of a CNBr fragment that reacted with the same antibody. Southern blot analyses with fragments of lambda C801 suggested that there may be only one cytotactin gene, but RNA transfer blots detected multiple mRNAs ranging in size from 6.5 to 8.0 kilobases. An 8.0-kilobase message and a Mr 240,000 cytotactin polypeptide were present in embryonic gizzard but not brain, while a 7.2-kilobase message and a Mr 220,000 polypeptide were present in brain but not gizzard. These results indicate that differential splicing of primary transcripts of the cytotactin gene yields various site-specific polypeptides. Sequence analyses of lambda C801 indicated that it specifies a region with extensive similarities to other proteins: the sequence begins with four consecutive epidermal growth factor-like repeats that are followed by eight segments that closely resemble each other and the type III repeats in fibronectin, and it ends with a 66 amino acid sequence similar to part of the beta and gamma chains of fibrinogen. One fibronectin-like repeat contains a single Arg-Gly-Asp sequence. The similarities with all three of these apparently unrelated proteins are extensive, suggesting that cytotactin has an evolutionary and possibly a functional relationship to each.
Language of Publication
English
Unique Identifier
88176910

Order full text for this document


MeSH Heading (Major)
Glycoproteins|*GE
MeSH Heading
Amino Acid Sequence; Animal; Base Sequence; Chick Embryo; Comparative Study; DNA|GE; Epidermal Growth Factor-Urogastrone|GE; Fibrinogen|GE; Fibronectins|GE; Molecular Sequence Data; Sequence Homology, Nucleic Acid; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0027-8424
Country of Publication
UNITED STATES


Record 44 from database: MEDLINE
Order full text for this document

Title
The product of the F plasmid transfer operon gene, traF, is a periplasmic protein.
Author
Wu JH; Kathir P; Ippen Ihler K
Address
Department of Medical Microbiology and Immunology, Texas A & M University, College Station 77843.
Source
J Bacteriol, 1988 Aug, 170:8, 3633-9
Abstract
The products of clones carrying the F plasmid transfer operon gene, traF, were analyzed. Proteins expressed in maxicells were labeled with [35S]methionine and examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. Clones carrying the wild-type traF gene expressed two polypeptide products that were not products of clones containing the traF13 amber mutation. These migrated with apparent molecular weights (Ma) of 27,000 and 25,000. A pulse-chase experiment suggested that the larger product was a precursor of the smaller one. In the presence of ethanol, the Ma-27,000 polypeptide accumulated and the Ma-25,000 product was not expressed. These results indicated that the traF protein undergoes proteolytic processing associated with export. Cell fractionation experiments further indicated that the greatest concentration of the mature (Ma 25,000) TraF protein was located in the periplasm. The DNA sequence of traF and the position of the transition mutation in traF13 DNA were also determined. Sequence analysis suggested that traF would be expressed as a 247-amino-acid, Mr-28,006 polypeptide. The 19 amino acids at the amino terminus of this polypeptide appear to constitute a typical membrane leader peptide, while the remainder of the molecule (Mr 25,942) is predicted to be primarily hydrophilic in character.
Language of Publication
English
Unique Identifier
88298674

Order full text for this document


MeSH Heading (Major)
Bacterial Proteins|AN/*GE; Escherichia coli|AN/*GE; F Factor|*; Operon|*
MeSH Heading
Autoradiography; Base Sequence; Cell Fractionation; Electrophoresis, Polyacrylamide Gel; Genes, Bacterial; Molecular Sequence Data; Mutation; Protein Precursors|AN; Sequence Homology, Nucleic Acid; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0021-9193
Country of Publication
UNITED STATES


Record 45 from database: MEDLINE
Order full text for this document

Title
Immunologic and clinical studies on murine experimental autoimmune gastritis induced by neonatal thymectomy.
Author
Fukuma K; Sakaguchi S; Kuribayashi K; Chen WL; Morishita R; Sekita K; Uchino H; Masuda T
Address
Department of Immunobiology, Faculty of Medicine, Kyoto University, Japan.
Source
Gastroenterology, 1988 Feb, 94:2, 274-83
Abstract
Experimental autoimmune gastritis (AIG), defined by the appearance of auto antibodies to parietal cells, was induced by neonatal thymectomy in BALB/c nu/+mice 3 days after birth. Vitamin B12 absorption and intrinsic factor in the stomach extract decreased compared with those in AIG-negative control groups. No decrease of the serum A/G ratio in AIG-bearing mice was observed. Although development of anemia, as evaluated by a decrease in hematocrit value, was poor until 12 mo of age and the gastric mucosa was hypertrophic, the AIG resembled human pernicious anemia rather than Ménétrier's disease. Adoptive transfer of spleen cells, but not sera, of AIG-bearing nu/+ into BALB/c nu/nu mice caused AIG in all animals 1 mo later, indicating the involvement of lymphocytes in the induction mechanism of AIG. Cytofluorometric and immunohistochemical analysis of lymphocytes in the gastric mucosa revealed T-cell infiltration at an early stage (1.5-3 mo) followed by B cell infiltration (6 mo). When the fraction enriched with parietal cells, which were intensively stained with sera of AIG-bearing mice and fluorescent antibody to mouse immunoglobulin G, was injected into the foot pads of AIG-bearing nude mice, typical delayed-type hypersensitivity reaction was observed in all animals. This was not seen in the mice injected with the cell fraction enriched with chief cells, although a few of them were stained by the immunofluorescent technique. Thus, the delayed-type hypersensitivity reaction seems to be directly involved in the mechanism of tissue damage.
Language of Publication
English
Unique Identifier
88084259

Order full text for this document


MeSH Heading (Major)
Autoimmune Diseases|*IM/ME/PA; Gastritis|*IM/ME/PA
MeSH Heading
Anemia, Pernicious|IM/PA; Animal; Animals, Newborn; Antigen-Antibody Complex|AN; Autoantibodies|AN; Disease Models, Animal; Female; Gastric Mucosa|IM/PA; Hypersensitivity, Delayed; Immunization, Passive; Intrinsic Factor|ME; Lymphocytes|CL/IM; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Parietal Cells, Gastric|IM; Support, Non-U.S. Gov't; Thymectomy; Vitamin B 12|ME

Publication Type
JOURNAL ARTICLE
ISSN
0016-5085
Country of Publication
UNITED STATES


Record 46 from database: MEDLINE
Order full text for this document

Title
R-plasmids in Salmonella isolates from sporadic cases of gastroenteritis.
Author
Filetici E; Martini A; Magni L; Fantasia M
Address
Laboratorio di Batteriologia e Micologia Medica, Istituto Superiore di SanitÄa, Rome, Italy.
Source
Eur J Epidemiol, 1988 Sep, 4:3, 366-70
Abstract
Five-hundred and twenty seven strains of Salmonella isolated from different patients admitted to hospitals in Rome from 1982 to 1985 were screened for their resistance to antimicrobial drugs. Sixty-one strains (11.6%) were found to be resistant to two or more antibiotics; the most frequent resistances were to sulfathiazole, streptomycin, tetracycline, chloramphenicol and ampicillin. Of the thirty-eight strains showing resistance to three or more antibiotics, 17 were able to transfer their resistance to E. coli K 12. The isolates were heterogeneous in plasmid population: only few strains harbored a sole plasmid, most harbored many plasmids ranging between 20 and 120 megadaltons in weight. Most strains were found to carry a conjugative plasmid of incompatibility group Inc H of 100-120 megadaltons and Inc I alpha of 60-70 megadaltons.
Language of Publication
English
Unique Identifier
89031155

Order full text for this document


MeSH Heading (Major)
R Factors|*GE; Salmonella|DE/*GE
MeSH Heading
Antibiotics|PD; Colicins|BI; Drug Resistance, Microbial; Escherichia coli|DE/GE; F Factor|DE; Gastroenteritis|MI; Human; In Vitro

Publication Type
JOURNAL ARTICLE
ISSN
0393-2990
Country of Publication
ITALY


Record 47 from database: MEDLINE
Order full text for this document

Title
The effects of alpha-human atrial natriuretic polypeptide on steroidogenesis by fetal zone cells of the human fetal adrenal gland.
Author
Carr BR; Mason JI
Address
Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas 75235.
Source
Am J Obstet Gynecol, 1988 Dec, 159:6, 1361-5
Abstract
The human fetal adrenal gland is primarily composed of fetal zone cells, which exhibit a high rate of steroidogenesis and a rapid growth rate during fetal life. alpha-Human atrial natriuretic polypeptide has been shown to inhibit basal and adrenocorticotropic hormone-stimulated steroidogenesis in the human adult and in some human adrenal adenoma cells. The purpose of this investigation was to determine the effect of atrial natriuretic polypeptide on steroidogenesis by fetal zone cells. Dispersed fetal zone cells were incubated in Krebs-Ringer's medium with adrenocorticotropic hormone, forskolin, 22R-hydroxycholesterol, or dibutyryl cyclic adenosine monophosphate and in the presence of atrial natriuretic polypeptide. The medium was analyzed for content of dehydroepiandrosterone sulfate and cortisol by radioimmunoassay. The addition of adrenocorticotropic hormone, forskolin, 22R-hydroxycholesterol, or dibutyryl cyclic adenosine monophosphate increased the secretion of dehydroepiandrosterone sulfate and cortisol twofold to threefold and twofold to sixfold, respectively, above basal rates. Atrial natriuretic polypeptide significantly inhibited basal dehydroepiandrosterone sulfate and cortisol secretion. When cells were incubated in the presence of adrenocorticotropic hormone, forskolin, 22R-hydroxycholesterol, or dibutyryl cyclic adenosine monophosphate plus atrial natriuretic polypeptide, cortisol secretion was inhibited 50% to 90% and dehydroepiandrosterone sulfate was inhibited 25% to 50%. Atrial natriuretic polypeptide had no effect on the metabolism of progesterone tagged with carbon 14 in fetal zone cells. In conclusion, atrial natriuretic polypeptide inhibited basal and adrenocorticotropic hormone-stimulated steroid secretion by fetal zone cells. Furthermore, these results suggested that the action of atrial natriuretic polypeptide was by inhibition of cholesterol side-chain cleavage or transfer of cholesterol to the mitochondrion.
Language of Publication
English
Unique Identifier
89086498

Order full text for this document


MeSH Heading (Major)
Adrenal Glands|CY/*EM/ME; Atrial Natriuretic Factor|*PD; Fetus|*ME; Peptide Fragments|*PD; Steroids|*BI
MeSH Heading
Bucladesine|PD; Cells, Cultured; Corticotropin|PD; Forskolin|PD; Human; Hydroxycholesterols|PD; Progesterone|ME; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0002-9378
Country of Publication
UNITED STATES


Record 48 from database: MEDLINE
Order full text for this document

Title
Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice.
Author
Miyawaki S; Nakamura Y; Takeshita T; Yoshida H; Shibata Y; Mitsuoka S
Address
Research Laboratories, Nippon Shinyaku Co., Ltd., Kyoto, Japan.
Source
Lab Anim Sci, 1988 Jun, 38:3, 266-72
Abstract
MRL-lpr, Yaa males were developed by the transfer of the Yaa gene from BXSB males to the MRL-lpr strain. The early-onset autoimmune disease of MRL-lpr males was accelerated further by the action of Yaa. All the serological parameters of autoimmune disease examined, i.e., anti-DNA antibodies, rheumatoid factors and circulating immune complexes were elevated earlier in MRL-lpr, Yaa males than in MRL-lpr males. Consequently, the MRL-lpr, Yaa males showed the clinical signs of an earlier and more rapidly progressive glomerulonephritis as compared with MRL-lpr males. The lifespan of MRL-lpr, Yaa males was shortened by about 50% in comparison to MRL-lpr males, with 90% of MRL-lpr, Yaa males dead by about 4 months of age. The clinical features and overall intensity of the autoimmune responses in the terminal stages appeared to be similar in both MRL-lpr, Yaa and MRL-lpr males. Thus, Yaa appeared merely to accelerate the disease course of MRL-lpr males, without altering the essential nature of the disease.
Language of Publication
English
Unique Identifier
88317514

Order full text for this document


MeSH Heading (Major)
Autoimmune Diseases|GE/IM/MO/*VE; Mice, Inbred Strains|*; Mice, Transgenic|*; Rodent Diseases|*GE/IM/MO
MeSH Heading
Animal; Antibodies|AN; Antigen-Antibody Complex|AN; Comparative Study; DNA|IM; DNA, Single-Stranded|IM; Female; Glomerulonephritis|VE; Immune Complex Diseases|VE; Lymph Nodes|PA; Lymphocyte Transformation; Male; Mice; Mice, Inbred C57BL; Rheumatoid Factor|AN; T-Lymphocytes|IM

Publication Type
JOURNAL ARTICLE
ISSN
0023-6764
Country of Publication
UNITED STATES


Record 49 from database: MEDLINE
Order full text for this document

Title
Effect of the vasodilator peptides calcitonin gene-related peptide and atriopeptin on rabbit microvascular blood flow. Preliminary communication.
Author
Knight KR; Martin TJ; Coe SA; OBrien BM
Address
Microsurgery Research Centre, St Vincent's Hospital, Melbourne, Australia.
Source
Br J Plast Surg, 1988 Mar, 41:2, 147-9
Abstract
A neuropeptide known as calcitonin gene-related peptide (CGRP) has been shown to have vasodilatory properties in the rabbit epigastric island flap of almost equivalent potency to prostacyclin. The latter is currently regarded as the most potent vasodilator yet to be isolated. CGRP, with its longer-lasting effect in blood and its ability to overcome noradrenaline-induced vasospasm, may be promising for use during or after ischaemic flap transfer or replantation. Another known vasodilatory peptide, atriopeptin, was not as potent in the microvascular bed of the cutaneous flap as in major blood vessels.
Language of Publication
English
Unique Identifier
88164093

Order full text for this document


MeSH Heading (Major)
Atrial Natriuretic Factor|*PD; Neuropeptides|*PD; Surgical Flaps|*; Vasodilator Agents|*PD
MeSH Heading
Animal; Microcirculation|DE; Rabbits; Regional Blood Flow|DE; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0007-1226
Country of Publication
SCOTLAND


Record 50 from database: MEDLINE
Order full text for this document

Title
An ELISA for IgA, IgG and IgM-RF measurement. I. Parameters of the assay.
Author
Ruschen S; Lemm G; Warnatz H
Address
Dept. Rheumatology and Clinical Immunology, Katholisches Krankenhaus Essen-Werden.
Source
Scand J Rheumatol Suppl, 1988, 75:, 32-5
Abstract
A simple and rapid solid phase ELISA for the stepless determination of IgA, IgG and IgM-RF was developed. The ELISA works with Fc parts of human IgG as antigen. Specificity, validity and precision were tested. RF complex dissociation by urea and separation by gel filtration was performed in several samples to obtain information of the transfer of non-RF-IgG by pentameric IgM-RF. The RF-ELISA may give better information on the significance of RF of the three Ig classes in the clinical course of RA.
Language of Publication
English
Unique Identifier
89186687

Order full text for this document


MeSH Heading (Major)
Enzyme-Linked Immunosorbent Assay|*MT; IgA|*IM; IgG|*IM; IgM|*IM; Rheumatoid Factor|*AN
MeSH Heading
Calibration; False Positive Reactions; Human; Sensitivity and Specificity; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0301-3847
Country of Publication
SWEDEN


Record 51 from database: MEDLINE
Order full text for this document

Title
Evidence that DNA helicase I and oriT site-specific nicking are both functions of the F TraI protein.
Author
Traxler BA; Minkley EG Jr
Address
Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213.
Source
J Mol Biol, 1988 Nov, 204:1, 205-9
Abstract
Site-specific and strand-specific nicking at the origin of transfer (oriT) of the F sex factor is the initial step in conjugal DNA metabolism. Then, DNA helicase I, the product of the traI gene, processively unwinds the plasmid from the nick site to generate the single strand of DNA that is transferred to the recipient. The nick at oriT is produced by the combined action of two Tra proteins, TraY and TraZ. The traZ gene was never precisely mapped, as no available point mutation uniquely affected TraZ-dependent oriT nicking. With several new mutations, we have demonstrated that TraZ activity is dependent upon traI DNA sequences. The simplest interpretation of this finding is that the F TraI protein is bifunctional, with DNA unwinding and site-specific DNA nicking activities.
Language of Publication
English
Unique Identifier
89110998

Order full text for this document


MeSH Heading (Major)
Bacterial Proteins|*GE; DNA Helicases|*GE; F Factor|*
MeSH Heading
Binding Sites; Conjugation, Genetic; DNA, Bacterial|ME; Genes, Bacterial; Mutation; Plasmids; Support, U.S. Gov't, P.H.S.; Transfection

Publication Type
JOURNAL ARTICLE
ISSN
0022-2836
Country of Publication
ENGLAND


Record 52 from database: MEDLINE
Order full text for this document

Title
Plasmids can stably transform yeast mitochondria lacking endogenous mtDNA.
Author
Fox TD; Sanford JC; McMullin TW
Address
Section of Genetics and Development, Cornell University, Ithaca, NY 14853.
Source
Proc Natl Acad Sci U S A, 1988 Oct, 85:19, 7288-92
Abstract
The mitochondrial gene oxi1, carried on a bacterial plasmid, has been used to transform the mitochondria of a yeast strain lacking mtDNA (rho0). The plasmid DNA behaved in a manner entirely consistent with the known properties of normal yeast rho- mtDNA after its introduction by high-velocity microprojectile bombardment. Like the mtDNA sequences retained in natural rho- strains, the plasmid DNA in the transformants was reiterated into concatemers whose size was indistinguishable from that of wild-type mtDNA. The oxi1 sequences in the transformants were surrounded by restriction sites derived from the plasmid that were not present in wild-type mtDNA. oxi1 genetic information in these "synthetic rho-" strains could be expressed in diploids either after "marker rescue" by recombination with rho+ mtDNA carrying an appropriate oxi1 point mutation or in trans during the growth of diploids heteroplasmic for both the plasmid-derived oxi1 sequences and rho+ mtDNA with oxi1 deleted. The ability to generate such "synthetic rho-" strains by transformation will allow transfer of mutations generated in vitro to wild-type rho+ mtDNA as well as examination of the function of altered genes in trans.
Language of Publication
English
Unique Identifier
89017183

Order full text for this document


MeSH Heading (Major)
DNA, Mitochondrial|*DF; Plasmids|*; Saccharomyces cerevisiae|*GE; Transformation, Genetic|*
MeSH Heading
Deoxyribonucleases, Type II Site-Specific|ME; Rho Factor; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0027-8424
Country of Publication
UNITED STATES


Record 53 from database: MEDLINE
Order full text for this document

Title
The role of a template sugar-phosphate backbone in the ribosomal decoding mechanism. Comparative study of poly(U) and poly(dT) template activity.
Author
Potapov AP; Soldatkin KA; Soldatkin AP; Elskaya AV
Address
Institute of Molecular Biology and Genetics, Ukrainian SSR Academy of Sciences, Kiev, U.S.S.R.
Source
J Mol Biol, 1988 Oct, 203:4, 885-93
Abstract
To study the role of a template sugar-phosphate backbone in the ribosomal decoding process, poly(U), poly(dT) and poly(dU)-directed cell-free amino acid incorporation was investigated under the influence of neomycin and high concentrations of Mg2+. The specificity of a factor-dependent translation system of Escherichia coli was shown to change according to the principle: "either ribo- or deoxyribopolynucleotide messenger". Poly(dT) is shown to be effectively translated in the absence of elongation factors, both at low (2 degrees C) and high (37 degrees C) temperature. Neomycin inhibits factor-free poly(dT) translation. Little or no poly(U) translation is observed in this system. A chromatographic analysis of the oligophenylalanine residues synthesized seems to show that translocation is the main step responsible for ribosome specificity to the ribo- or deoxyribopolynucleotide template in both factor-dependent and factor-free translation systems.
Language of Publication
English
Unique Identifier
89094865

Order full text for this document


MeSH Heading (Major)
Poly T|*GE; Poly U|*GE; Polydeoxyribonucleotides|*GE; Ribosomes|*; RNA, Transfer, Amino Acid-Specific|*GE; RNA, Transfer, Phe|*GE; Translation, Genetic|*
MeSH Heading
Cell-Free System; Escherichia coli; Kinetics; Peptides|BI; RNA, Bacterial|GE; RNA, Messenger|GE

Publication Type
JOURNAL ARTICLE
ISSN
0022-2836
Country of Publication
ENGLAND


Record 54 from database: MEDLINE
Order full text for this document

Title
The transfer factor and its subdivisions in patients with pulmonary emboli.
Author
Fennerty AG; Gunawardena KA; Smith AP
Address
Department of Chest Diseases, Llandough Hospital, Penarth, South Glamorgan.
Source
Eur Respir J, 1988 Feb, 1:2, 98-101
Abstract
The carbon monoxide transfer factor and its subdivisions, the pulmonary membrane diffusing capacity and the pulmonary capillary volume were measured in fourteen subjects following submassive pulmonary emboli, as demonstrated by a ventilation-perfusion scan, and in fourteen matched controls. Transfer factor and alveolar volume were significantly lower in patients with pulmonary emboli (p less than 0.02). Patients were given six weeks anticoagulant therapy and the measurements repeated three months later. There was a significant increase in the transfer factor and the alveolar volume (p less than 0.01) and the membrane diffusing capacity (p less than 0.05). It has previously been assumed that the reduction in the transfer factor following a pulmonary embolus is due to a reduction in the pulmonary capillary volume. Results of this study however, suggest that it is more likely to be due to a loss of alveolar volume, at least in subjects with submassive emboli.
Language of Publication
English
Unique Identifier
88196315

Order full text for this document


MeSH Heading (Major)
Carbon Monoxide|*PH; Pulmonary Circulation|*; Pulmonary Diffusing Capacity|*; Pulmonary Embolism|*PP
MeSH Heading
Adult; Breath Tests; Capillaries|PP; Female; Human; Lung Volume Measurements; Male; Middle Age; Pulmonary Alveoli|PP

Publication Type
JOURNAL ARTICLE
ISSN
0903-1936
Country of Publication
DENMARK


Record 55 from database: MEDLINE
Order full text for this document

Title
Peptide elongation factor 1 from yeasts: purification and biochemical characterization of peptide elongation factors 1 alpha and 1 beta (gamma) from Saccharomyces carlsbergensis and Schizosaccharomyces pombe [published erratum appears in J Biochem (Tokyo) 1988 May;103(5):900]
Author
Miyazaki M; Uritani M; Fujimura K; Yamakatsu H; Kageyama T; Takahashi K
Address
Department of Molecular Biology, School of Science, Nagoya University, Aichi.
Source
J Biochem (Tokyo), 1988 Mar, 103:3, 508-21
Abstract
Cytoplasmic elongation factor 1 alpha (EF-1 alpha) [corrected] was purified to homogeneity in high yield from the two different yeasts Saccharomyces carlsbergensis (S. carls.) and Schizosaccharomyces pombe (S. pombe). The purification was easily achieved by CM-Sephadex column chromatography of the breakthrough fractions from DEAE-Sephadex chromatography of cell-free extracts. The basic proteins have a molecular weight of 47,000 for the S. carls. factor and of 49,000 for the S. pombe factor. While the purified yeast EF-1 alpha s function analogously to other eukaryotic factors and the E. coli EF-Tu in Phe-tRNA binding and polyphenylalanine synthesis, the yeast factor unusually hydrolyzed GTP on yeast ribosomes upon addition of Phe-tRNA in the absence of poly(U) as mRNA. This novelty is probably owing to the yeast ribosomes, which are assumed to lack elongation factor 3-equivalent component(s). Trypsin and chymotrypsin selectively cleaved the two yeast factors to generate resistant fragments with the same molecular weight of 43,000 (by trypsin) and of 44,000 (by chymotrypsin), respectively. Those cleavage sites were characteristically protected by the presence of several ligands bound to EF-1 alpha such as GDP, GTP, and aminoacyl-tRNA. Based on the sequence analysis of the fragments generated by the two proteases, the partial amino acid sequence of the S. carls. EF-1 alpha was deduced to be in accordance with the N-terminal region covering positions (1) to 94 and two Lys residues at the C-terminal end of the predicted total sequence of the Saccharomyces cerevisiae (S. cerev.) factor derived from DNA analysis, except for a few N-terminal residues, confirming the predicted S. cerev. sequence at the protein level. EF-1 beta and EF-1 beta gamma were isolated and highly purified as biologically active entities from the two yeasts. EF-1 beta s from the two yeasts have the same molecular weight of 27,000, whereas component gamma of the S. carls. EF-1 beta gamma showed a higher molecular weight (47,000) than that of the S. pombe factor (40,000). It was also shown that a stoichiometric complex was formed between EF-1 alpha and EF-1 beta gamma from S. pombe. Furthermore, a considerable amount of Phe-tRNA binding activity was distributed in the EF-1H (probably EF-1 alpha beta gamma) fraction from freshly prepared cell-free extracts of yeast.
Language of Publication
English
Unique Identifier
88273078

Order full text for this document


MeSH Heading (Major)
Peptide Elongation Factors|AN/*IP; Saccharomyces|*AN; Saccharomycetales|*AN; Schizosaccharomyces|*AN
MeSH Heading
Amino Acid Sequence; Amino Acids|AN; Chymotrypsin|ME; GTP Phosphohydrolase|ME; Molecular Weight; Ribosomes|ME; RNA, Transfer, Phe|ME; Support, Non-U.S. Gov't; Trypsin|ME

Publication Type
JOURNAL ARTICLE
ISSN
0021-924X
Country of Publication
JAPAN


Record 56 from database: MEDLINE
Order full text for this document

Title
Role of yeast peptide elongation factor 3 (EF-3) at the AA-tRNA binding step.
Author
Uritani M; Miyazaki M
Address
Department of Molecular Biology, School of Science, Nagoya University, Aichi.
Source
J Biochem (Tokyo), 1988 Jul, 104:1, 118-26
Abstract
The stimulatory effect of peptide elongation factor 3 (EF-3), which is uniquely required for the yeast elongation cycle, on the step of binding of aminoacyl-tRNA (AA-tRNA) to ribosomes has been investigated in detail. Yeast EF-1 alpha apparently functions in a stoichiometric manner in the binding reaction of AA-tRNA to the ribosomes. The addition of EF-3 and ATP to this binding system strikingly stimulated the binding reaction, and the stimulated reaction proceeded catalytically with respect to both EF-1 alpha and EF-3, accompanied by ATP hydrolysis, indicating that EF-3 stimulated the AA-tRNA binding reaction by releasing EF-1 alpha from the ribosomal complex, thus recycling it. This binding stimulation by EF-3 was in many respects distinct from that by EF-1 beta gamma. The idea that EF-3 may participate in the regeneration of GTP from ATP and the formed GDP, as indicated by the findings that the addition of EF-3 along with ATP allowed the AA-tRNA binding and Phe polymerization reactions to proceed even in the presence of GDP in place of GTP, was not verified by the results of direct measurement of [32P]GTP formation from [gamma-32P]ATP and GDP under various conditions. Examination of the stability of the bound AA-tRNA disclosed the different binding states of AA-tRNA on ribosomes between in the cases of the complexes formed with EF-1 alpha alone, or factor-independently, and with EF-1 alpha and EF-3.(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
89123207

Order full text for this document


MeSH Heading (Major)
Amino Acid Activation|*; Peptide Elongation Factors|*ME; RNA, Transfer, Amino Acyl|*ME
MeSH Heading
Kinetics; Paromomycin|PD; Poly U; Protein Binding; Ribosomes|ME; RNA, Transfer, Phe|ME; Saccharomyces cerevisiae|GE; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0021-924X
Country of Publication
JAPAN


Record 57 from database: MEDLINE
Order full text for this document

Title
Lung function impairment as a guide to exercise limitation in work-related lung disorders.
Author
Cotes JE; Zejda J; King B
Address
Department of Occupational Health and Hygiene, Medical School, Newcastle upon Tyne, United Kingdom.
Source
Am Rev Respir Dis, 1988 May, 137:5, 1089-93
Abstract
The hypothesis that exercise limitation of respiratory origin can be predicted accurately from the lung function impairment has been tested using maximal oxygen uptake (VO2max) as the dependent variable in a multiple regression analysis. The subjects were 157 men who met objective criteria for exercise being limited by respiratory impairment. VO2max (mean value, 1.38 L min-1) was described by FEV1 and single-breath lung transfer factor (diffusing capacity) for carbon monoxide (TL') singly or in combination, but the accuracy was poor (at best, standard error of the estimate, 0.36 L min-1; r2, 29.1%). FEV1 could be replaced by FVC and FEV1/FVC. Description of VO2max was improved by also including in the equation the variables age, fat-free mass, and submaximal exercise ventilation (VE). Transfer factor did not then contribute significantly. VO2max as percent of predicted (mean value of 60%) was described by %FVC or %FEV1, but the accuracy was poor (SEE, 16.0%; r2, 14%). Prediction was improved somewhat by the alternative use of inspiratory vital capacity and FEV1/FVC. Transfer factor did not contribute additional information; however, inclusion of VE materially improved the accuracy (SEE, 12.9%; r2, 44%). Among a subgroup of 35 men whose lung disease was due to asbestos, %TL' or transfer factor measured using a multibreath estimate of residual volume (%TLCO) made a small contribution to the explained variance, e.g.: %VO2max = 0.44% FEV1 -0.78 VE + 0.16% TLCO + 52.3 SEE 7.27%. This equation also described the %VO2max of all subjects (SEE, 13%).(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
89060655

Order full text for this document


MeSH Heading (Major)
Exertion|*; Lung Diseases|DI/*PP; Occupational Diseases|DI/*PP; Respiratory Function Tests|*
MeSH Heading
Adult; Forced Expiratory Volume; Human; Male; Middle Age; Oxygen Consumption; Pulmonary Diffusing Capacity; Support, Non-U.S. Gov't; Vital Capacity

Publication Type
JOURNAL ARTICLE
ISSN
0003-0805
Country of Publication
UNITED STATES


Record 58 from database: MEDLINE
Order full text for this document

Title
Quality factors.
Author
Kerr GD
Address
Health and Safety Research Division, Oak Ridge National Laboratory, TN 37830.
Source
Health Phys, 1988 Aug, 55:2, 241-9
Abstract
The quality factor, Q, is a dimensionless modifier used in converting absorbed dose, expressed in gray (or rad), to dose equivalent, expressed in sievert (or rem). The dose equivalent is used in radiation protection to account for the biological effectiveness of different kinds of radiation. The quality factor is related to both linear energy transfer (LET) and relative biological effectiveness (RBE). The RBE obtained from biological experiments depends in a complex way on the observed biological effect, the specific test organism and the experimental conditions. Judgment is involved, therefore, in the choice of Q. Questions regarding the adequacy of current Q values for neutrons were first raised in a 1980 statement by the National Council on Radiation Protection and Measurements (NCRP) and later in a 1985 statement by the International Commission on Radiological Protection (ICRP). In 1980, the NCRP alerted the technical community to the possibility of a future increase between a factor of 3 to 10 in the Q for neutrons, and in 1985, the ICRP suggested an increase by a factor of 2 in Q for fast neutrons. Both these advisory groups are now recommending essentially the same guidance with regard to Q for neutrons: an increase by a factor of 2. The Q for neutrons is based on a large, albeit unfocused, body of experimental data. In spite of the lack of focus, the data supporting a change in the neutron quality factor are substantial. However, the proposed doubling of Q for neutrons is clouded by other issues regarding its application. These issues are discussed, together with the current database for the neutron quality factor. Improvements are needed to provide better guidance with regard to both Q for neutrons and its application in radiation protection.
Language of Publication
English
Unique Identifier
88314580

Order full text for this document


MeSH Heading (Major)
Dose-Response Relationship, Radiation|*; Radiation Monitoring|*ST
MeSH Heading
Animal; Energy Transfer; Human; Maximum Permissible Exposure Level; Mutagenicity Tests; Neoplasms, Radiation-Induced; Neutrons; Relative Biological Effectiveness; Support, U.S. Gov't, Non-P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0017-9078
Country of Publication
UNITED STATES


Record 59 from database: MEDLINE
Order full text for this document

Title
Transcriptional activity and factor binding are stimulated by separate and distinct sequences in the 5' flanking region of a mouse tRNAAsp gene.
Author
Rooney RJ; Harding JD
Address
Department of Biological Sciences, Columbia University, New York, NY 10027.
Source
Nucleic Acids Res, 1988 Mar, 16:6, 2509-21
Abstract
The transcriptional properties of two cloned mouse tRNAAsp genes were examined in vitro. The tRNA(2Asp) gene displays a five fold greater transcriptional activity than the tRNA(1Asp) gene and a greater ability to form stable complexes with transcription factors. Transcription of a hybrid gene with swapped 5' flanking sequences and of 5' flanking region deletion mutants demonstrates that the differential transcription of the genes results from stimulatory sequences in the 5' flanking region of the tRNA(2Asp) gene. Distal sequences including those between positions -53 and -31 stimulate transcription but do not affect factor binding. Proximal sequences between positions -9 and -1 enhance factor binding. Thus, binding of transcription factors and later steps required for transcription can be modulated by separate and distinct 5' flanking sequence motifs in eukaryotic tRNA genes.
Language of Publication
English
Unique Identifier
88203196

Order full text for this document


MeSH Heading (Major)
Regulatory Sequences, Nucleic Acid|*; RNA, Transfer, Amino Acid-Specific|*GE; RNA, Transfer, Asp|*GE; Transcription Factors|*ME; Transcription, Genetic|*
MeSH Heading
Animal; Base Sequence; DNA Mutational Analysis; Gene Expression Regulation; In Vitro; Mice; Molecular Sequence Data; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0305-1048
Country of Publication
ENGLAND


Record 60 from database: MEDLINE
Order full text for this document

Title
The effect of Mg2+ and guanine nucleotide exchange factor on the binding of guanine nucleotides to eukaryotic initiation factor 2.
Author
Panniers R; Rowlands AG; Henshaw EC
Address
University of Rochester Cancer Center, New York 14642.
Source
J Biol Chem, 1988 Apr, 263:12, 5519-25
Abstract
A major site of regulation of polypeptide chain initiation is the binding of Met-tRNA to 40 S ribosomal subunits which is mediated by eukaryotic initiation factor 2 (eIF-2). The formation of ternary complex, eIF-2.GTP.Met-tRNA, is potently inhibited by GDP. Measurement of the parameters for guanine nucleotide binding to eIF-2 is critical to understanding the control of protein synthesis by fluctuations in cellular energy levels. We have compared the dissociation constants (Kd) of eIF-2.GDP and eIF-2.GTP and find that GDP has a 400-fold higher affinity for GDP than GTP. The Kd for GDP is almost an order of magnitude less than has been reported previously. The difference between the Kd values for the two nucleotides is the result of a faster rate constant for GTP release, the rate constants for binding being approximately equal. This combination of rate constants and low levels of contaminating GDP in preparations of GTP can explain the apparently unstable nature of eIF-2.GTP observed by others. Mg2+ stabilizes binary complexes slowing the rates of release of nucleotide from both eIF-2.GDP and eIF-2.GTP. The competition between GTP and GDP for binding to eIF-2.guanine nucleotide exchange factor complex has been measured. A 10-fold higher GTP concentration than GDP is required to reduce [32P] GDP binding to eIF-2.guanine nucleotide exchange factor complex by 50%. The relevance of this competition to the regulation of protein synthesis by energy levels is discussed.
Language of Publication
English
Unique Identifier
88186859

Order full text for this document


MeSH Heading (Major)
Guanine Nucleotides|*ME; Magnesium|*PD; Peptide Initiation Factors|*ME; Proteins|*ME/*PD
MeSH Heading
Animal; Carcinoma, Ehrlich Tumor|AN; Comparative Study; Guanosine Diphosphate|ME; Guanosine Triphosphate|ME; Kinetics; RNA, Transfer, Met|ME; Support, U.S. Gov't, P.H.S.; Temperature

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 61 from database: MEDLINE
Order full text for this document

Title
Alteration of the nucleotide-binding site asymmetry of chloroplast coupling factor 1 by catalysis.
Author
Shapiro AB; McCarty RE
Address
Division of Biological Sciences, Cornell University, Ithaca, New York 14853.
Source
J Biol Chem, 1988 Oct, 263:28, 14160-5
Abstract
Fluorescence resonance energy transfer was used to show that ATP hydrolysis induces a change in the properties of two nucleotide-binding sites in isolated chloroplast coupling factor 1 (CF1). The fluorescence donor was Lucifer Yellow vinyl sulfone (4-amino-N-[3-(vinylsulfonyl)phenyl]naphthalimide- 3,6-disulfonate), covalently bound to a unique site on the alpha subunit between nucleotide-binding sites 2 and 3. The fluorescence acceptor was the ATP analog 2'(3')-trinitrophenyladenosine 5'-triphosphate (TNP-ATP), incorporated specifically into nucleotide-binding site 1. Energy transfer from Lucifer Yellow to TNP-ATP in site 1 was greater if catalysis occurred before TNP-ATP was incorporated than if no catalysis occurred, indicating that one of the nucleotide-binding sites near the Lucifer Yellow had changed its properties to those of site 1 as a result of catalysis. The amount of energy transfer increased with the degree of substrate excess during catalysis, as expected if catalysis were required for the new site 1 location. ADP, which binds to CF1, but is not a substrate for hydrolysis, caused little energy transfer. Titration of site 3 with TNP-ATP showed greater energy transfer from Lucifer Yellow when catalysis had not occurred, indicating that sites 1 and 3 switched properties as a result of catalysis. The amount of energy transfer declined exponentially with time between removal of substrate and addition of TNP-ATP to site 1, with a half-time of 1.5-2 h at room temperature. This result suggests that the change that results in switching of nucleotide-binding sites 1 and 3 relaxes in the absence of substrate. Our results show that the asymmetry of the nucleotide-binding sites of CF1 is not a permanent feature of the molecule.
Language of Publication
English
Unique Identifier
89008254

Order full text for this document


MeSH Heading (Major)
Adenosine Triphosphate|*ME; H(+)-Transporting ATP Synthase|*ME; Plants|*EN
MeSH Heading
Binding Sites; Chloroplasts|EN; Isoquinolines|PD; Kinetics; Protein Binding; Spectrometry, Fluorescence; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 62 from database: MEDLINE
Order full text for this document

Title
Measurements of transfer coefficients for 137Cs, 60Co, 54Mn, 22Na, 131I and 95mTc from feed into milk and beef.
Author
Voigt G; Henrichs K; Pröhl G; Paretzke HG
Address
Gesellschaft fÂur Strahlen- und Umweltforschung (GSF) MÂunchen, Institut fÂur Strahlenschutz, Neuherberg, Federal Republic of Germany.
Source
Radiat Environ Biophys, 1988, 27:2, 143-52
Abstract
The transfer in cattle of the radionuclides 137Cs, 60Co, 54Mn, 22Na, 131I and 95mTc was studied experimentally to determine transfer coefficients from feed to milk and meat. Special interest was kept on normal feeding and maintenance conditions used in Germany. The radionuclides were incorporated into fodder plants through root uptake and thus available in a chemical form resulting from the contamination of agricultural soil. This permitted realistic simulation of the soil-plant-animal food chain. The equilibrium transfer coefficients for milk were calculated to be 22Na: 0.016 +/- 0.002 d/l, 60Co: less than or equal to 0.0002 d/l, 54Mn: less than or equal to 0.0005 d/l, and 137Cs: 0.0022 +/- 0.0002 d/l. The equilibrium transfer coefficients for meat were calculated to be 22Na: 0.01 +/- 0.002 d/kg, 60Co: less than or equal to 0.00013 d/kg, 54Mn: less than or equal to 0.0005 d/kg, and 137Cs: 0.0062 +/- 0.0006 d/kg. A single dose of 131I was orally administered three times in the chemical form of iodide. Models were applied to obtain parameters for a quantitative description of the iodine metabolism. The equilibrium transfer factor for 131I in this chemical form to milk was calculated to be 0.009 +/- 0.0014 d/l. For 95mTc only an upper limit of the transfer factor of 1.7.10(-4) d/l could be estimated because of the small amount of radioactivity available.
Language of Publication
English
Unique Identifier
88277137

Order full text for this document


MeSH Heading (Major)
Animal Feed|*; Meat|*; Milk|*ME; Radioisotopes|*ME
MeSH Heading
Animal; Cattle; Cesium Radioisotopes|ME; Cobalt Radioisotopes|ME; Environmental Exposure; Half-Life; Iodine Radioisotopes|ME; Manganese|ME; Mathematics; Sodium Radioisotopes|ME; Soil Pollutants, Radioactive; Technetium|ME; Tissue Distribution

Publication Type
JOURNAL ARTICLE
ISSN
0301-634X
Country of Publication
GERMANY, WEST


Record 63 from database: MEDLINE
Order full text for this document

Title
Measurement technique influences the response of transfer factor (TICO) to salbutamol in patients with airflow limitation.
Author
Chinn DJ; Askew J; Rowley L; Cotes JE
Address
Department of Occupational Health and Hygiene, Medical School, Newcastle upon Tyne.
Source
Eur Respir J, 1988 Jan, 1:1, 15-21
Abstract
Single-breath transfer factor obtained using a multibreath estimate of alveolar volume (TI) was measured before and after salbutamol in twenty patients with reversible airflow limitation. The effective breathholding time was calculated by four methods due respectively to Ogilvie and colleagues as modified by the American Thoracic Society (ATS), ATS Epidemiological Standardization Project (ESP), Jones and Meade in which allowance was made for the time of sample collection and a simplified method in which the allowance for sampling was in terms of volume, not time. Two patients could perform the test procedure only after salbutamol. Amongst the remainder the transfer factor calculated using a single-breath estimate of alveolar volume (TI') was on average 12% less than TI. Carbon monoxide transfer coefficient (KCO), TI and TI' were highest by the ESP method and lowest by the Ogilvie method. Inhalation of salbutamol (200 gamma) did not affect TI' by any method or TI and KCO by the Jones and Meade method but results by the other methods were reduced; in the case of the modified Ogilvie method the reduction was 3.9%. This error was due to overestimation of effective breathholding time by neglecting the reduction of 39% which occurred in the time of sample collection. The time of inspiration was unchanged whilst the time of deadspace washout was reduced by 16%. After bronchodilatation the absence of a change in TI' was due to the overestimation of effective breathholding time being offset by an increase in the proportion of alveolar volume measured by the single-breath procedure.(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
88211814

Order full text for this document


MeSH Heading (Major)
Albuterol|*PD; Carbon Monoxide|*; Lung Diseases, Obstructive|*PP; Pulmonary Diffusing Capacity|*
MeSH Heading
Adult; Aged; Breath Tests; Female; Human; Male; Methods; Middle Age; Occupational Diseases|PP; Pulmonary Alveoli|PP; Spirometry; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0903-1936
Country of Publication
DENMARK


Record 64 from database: MEDLINE
Order full text for this document

Title
Functional dissection of 5' and 3' extragenic control regions of human tRNA(Val) genes reveals two different regulatory effects.
Author
Arnold GJ; Schmutzler C; Gross HJ
Address
Institut fÂur Biochemie, Bayerische Julius-Maximilians-UniversitÂat, WÂuzburg, FRG.
Source
DNA, 1988 Mar, 7:2, 87-97
Abstract
Two natural human tRNA(Val) genes, pHtV1 and pHtV3, differ in their transcription efficiency by an order of magnitude. The extragenic control regions (ECRs) responsible for this effect were compared with respect to the kinetics and thermodynamics of transcription complex formation. The 5' ECR of pHtV1 acts by increasing both the rate of stable complex formation and the equilibrium constant of association between tDNA and at least one transcription factor present in the stable complex. The stability of the preinitiation complexes is not affected by ECRs. For the formation of a stable preinitiation complex, we suggest a two-step mechanism, comprising (i) the ECR-controlled association of at least one transcription factor (TFIIIC) with the tDNA, and (ii) an ECR-independent conformational change of this tDNA-protein complex. The function of 3' ECRs could be discriminated from the 5' ECR-mediated effects by transcriptional analysis of two chimeric constructs derived from pHtV1 and pHtV3. Surprisingly, the pHtV1 3' ECR causes an eight-fold increase of transcription efficiency, although it has only minor influence on stable preinitiation complex formation. Instead, this ECR stimulates transcription by promoting the transition of the preinitiation complex into an activity synthesizing transcription complex. This novel function of a 3' ECR contributes an additional regulatory level for tRNA gene expression.
Language of Publication
English
Unique Identifier
88195782

Order full text for this document


MeSH Heading (Major)
Gene Expression Regulation|*; RNA, Transfer, Amino Acid-Specific|*GE; RNA, Transfer, Val|*GE
MeSH Heading
Base Sequence; Binding, Competitive; Cloning, Molecular; Human; Kinetics; Plasmids; Support, Non-U.S. Gov't; Temperature; Transcription, Genetic

Publication Type
JOURNAL ARTICLE
ISSN
0198-0238
Country of Publication
UNITED STATES


Record 65 from database: MEDLINE
Order full text for this document

Title
Stronger affinity of reticulocyte release factor than natural suppressor tRNASer for the opal termination codon.
Author
Mizutani T; Hitaka T
Address
Faculty of Pharmaceutical Sciences, Nagoya City University, Japan.
Source
FEBS Lett, 1988 Jan, 226:2, 227-31
Abstract
Animal natural suppressor tRNA did not affect the release reaction of reticulocyte release factor (RF) at the same concentration of tRNA (both estimated as being present at a similar level of 3-5 X 10(-8) M in vivo); even at a 10-fold greater concentration the tRNA did not prevent the release reaction with RF. In order to confirm this result, the Ka values were determined. The Ka value between RF and UGA was 1.26 X 10(6) M-1 and that between the suppressor tRNA and UGA amounted to 8 X 10(3) M-1. This result showed that RF had a 150-fold stronger affinity than suppressor tRNA for the opal termination codon. Incorporation of phosphoserine into phosphoprotein via phosphoseryl-tRNA was inhibited by addition of RF to the reaction mixture. These results suggest that animal natural suppressor tRNA in the normal state does not perform its suppressor function, except in special cases where mRNA has the context structure near the opal termination codon (UGA).
Language of Publication
English
Unique Identifier
88112188

Order full text for this document


MeSH Heading (Major)
Codon|*; Reticulocytes|*ME; RNA, Messenger|*; RNA, Transfer, Amino Acid-Specific|*ME; RNA, Transfer, Ser|*ME; Suppression, Genetic|*
MeSH Heading
Animal; Kinetics; Phosphoproteins|BI; Phosphoserine|ME; Rabbits; Ribosomes|ME; RNA, Transfer, Met|ME

Publication Type
JOURNAL ARTICLE
ISSN
0014-5793
Country of Publication
NETHERLANDS


Record 66 from database: MEDLINE
Order full text for this document

Title
Tubal embryo transfer as a treatment for infertility due to male factor.
Author
Balmaceda JP; Gastaldi C; Remohi J; Borrero C; Ord T; Asch RH
Address
Department of Obstetrics and Gynecology, University of California, Irvine, Orange.
Source
Fertil Steril, 1988 Sep, 50:3, 476-9
Abstract
Transvaginal follicular aspiration (TVA) with ultrasonically guided needles allows the transfer of in vitro generated embryos to the fallopian tubes (TET), performing only one surgical procedure in the process. Up to now, this approach has been used to treat 16 couples with infertility due to severe male factor. Follicular development was induced with a combination of clomiphene citrate and human menopausal gonadotropin (hMG) or follicle-stimulating hormone and hMG. Follicles were aspirated by TVA 36 hours after an injection of human chorionic gonadotropin 10,000 IU intramuscularly. A total of 169 oocytes were recovered (10.5 +/- 6.9 X +/- SD) from the 16 patients. There was failure of fertilization in 6 cases. In the remaining 10, a TET was performed 44 to 50 hours after TVA, utilizing embryos at the pronuclear stage. Six pregnancies resulted from the 10 transfers. This technique combines the advantages of proof of fertilization with a more adequate tubal embryo development and entrance to the uterine cavity that may determine and increase chance of implantation.
Language of Publication
English
Unique Identifier
88313117

Order full text for this document


MeSH Heading (Major)
Embryo Transfer|*MT; Fallopian Tubes|*; Infertility, Female|PA/*TH
MeSH Heading
Adult; Cell Count; Female; Fertilization in Vitro; Gonadotropins, Chorionic|TU; Human; Oocytes|PA; Ovarian Follicle|SU; Pregnancy; Suction; Vagina

Publication Type
JOURNAL ARTICLE
ISSN
0015-0282
Country of Publication
UNITED STATES


Record 67 from database: MEDLINE
Order full text for this document

Title
Multiple forms of the human gene-specific transcription factor USF. II. DNA binding properties and transcriptional activity of the purified HeLa USF.
Author
Sawadogo M
Address
Laboratory of Biochemistry and Molecular Biology, Rockefeller University, New York, New York 10021-6399.
Source
J Biol Chem, 1988 Aug, 263:24, 11994-2001
Abstract
The gene-specific upstream stimulatory transcription factor (USF) is required for maximal expression of the adenovirus major late promoter in vivo as well as in vitro. We have examined the DNA binding and transcriptional properties of USF purified to near-homogeneity from HeLa cell nuclei (Sawadogo, M., Van Dyke, M. W., Gregor, P. D., and Roeder, R. G. (1988) J. Biol. Chem. 263, 11985-11993). The 44-and 43,000-dalton forms of USF displayed identical affinities for the major late promoter upstream sequence. Specific binding parameters were greatly influenced by neighboring sequences, but not by the topological state of the DNA. The dissociation rate was highly dependent upon the concentration of competitor DNA, indicating that USF can efficiently transfer from one binding site to another by passing through a doubly bound intermediate state (direct transfer mechanism). Transcription stimulation by purified USF showed titration curves identical to those observed with cruder preparations of the transcription factor. However, the overall stimulation observed at saturating USF concentration was significantly lower with the purified protein. By contrast, interaction with TATA box-binding RNA polymerase II transcription factor D was observed with both USF-containing fractions. This could suggest the existence of two different mechanisms for upstream sequence-dependent transcription stimulation, where one critical component (or some necessary modification of the upstream factor itself) may be missing in reactions reconstituted with purified USF.
Language of Publication
English
Unique Identifier
88298883

Order full text for this document


MeSH Heading (Major)
Adenoviridae|*GE; DNA, Viral|*ME; Promoter Regions (Genetics)|*; Transcription Factors|*ME; Transcription, Genetic|*
MeSH Heading
Binding, Competitive; Cell Nucleus|AN; Hela Cells|AN; Human; Kinetics; Magnesium|PD; Molecular Weight; Plasmids; Potassium Chloride|PD; Regulatory Sequences, Nucleic Acid; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 68 from database: MEDLINE
Order full text for this document

Title
Considerations on a revision of the quality factor.
Author
Kellerer AM; Hahn K
Address
Institut fÂur Medizinische Strahlenkunde, UniversitÂat WÂurzburg, Federal Republic of Germany.
Source
Radiat Res, 1988 Jun, 114:3, 480-8
Abstract
A modified analytical expression is proposed for the revised quality factor that has been suggested by a liaison group of ICRP and ICRU. With this modification one obtains, for sparsely ionizing radiation, a quality factor which is proportional to the dose average of lineal energy, y. It is shown that the proposed relation between the quality factor and lineal energy can be translated into a largely equivalent dependence on LET. The choice between the reference parameters LET or y is therefore a secondary problem in an impending revision of the quality factor.
Language of Publication
English
Unique Identifier
88234926

Order full text for this document


MeSH Heading (Major)
Radiation Dosage|*
MeSH Heading
Energy Transfer; Relative Biological Effectiveness; Support, Non-U.S. Gov't; Weights and Measures

Publication Type
JOURNAL ARTICLE
ISSN
0033-7587
Country of Publication
UNITED STATES


Record 69 from database: MEDLINE
Order full text for this document

Title
Participation of suppressor-inducer cells in the suppression of adjuvant arthritis by transfer of spleen cells expanded by T cell growth factor.
Author
Ogawa H; Tsunematsu T
Address
Third Division of Internal Medicine, Shimane Medical University, Izumo, Japan.
Source
Clin Exp Immunol, 1988 Jun, 72:3, 476-80
Abstract
We attempted to elucidate the mechanism of action of T cell growth factor (TCGF)-expanded cells after stimulation with concanavalin A (Con A), a process which reduces the severity of adjuvant arthritis (AA), as seen in transferred syngeneic rats. TCGF-expanded cells were fractionated by Percoll density gradient or by the panning method, before the transfer. Transfer of cells with a density of between 1070 and 1079 suppressed AA most effectively, compared with other fractions with a density of less than 1070. A large number of the cells with density 1070-1079 were of the W3/25 phenotype. The transfer of W3/25 positive cells obtained by the panning method from TCGF-expanded cells reduced AA but not W3/25 negative cells. The suppressor function of TCGF-expanded cells was examined in an assay system in vitro. The addition of Con A-stimulated cells to the assay culture (but not expanded with TCGF), suppressed both the proliferation of spleen cells stimulated with Con A and the IgG production stimulated with lipopolysaccharide. The addition of TCGF-expanded cells to the assay culture had no effect on these responses. Thus, the W3/25 cells in the TCGF-expanded cells seem to function as suppressor-inducer cells, affect the presuppressor cells of the recipient rat and differentiate to suppressor effector cells.
Language of Publication
English
Unique Identifier
89003728

Order full text for this document


MeSH Heading (Major)
Arthritis|*PC; Arthritis, Adjuvant|IM/*PC; Immune Tolerance|*; Interleukin-2|*PD; T-Lymphocytes|*IM
MeSH Heading
Animal; Cell Separation|MT; Centrifugation, Density Gradient; Female; Rats; Rats, Inbred Lew; Spleen|IM/TR; Support, Non-U.S. Gov't; T-Lymphocytes, Helper-Inducer|IM; T-Lymphocytes, Suppressor-Effector|IM

Publication Type
JOURNAL ARTICLE
ISSN
0009-9104
Country of Publication
ENGLAND


Record 70 from database: MEDLINE
Order full text for this document

Title
Ordering promoter binding of class III transcription factors TFIIIC1 and TFIIIC2.
Author
Dean N; Berk AJ
Address
Molecular Biology Institute, University of California, Los Angeles 90024.
Source
Mol Cell Biol, 1988 Aug, 8:8, 3017-25
Abstract
The separation of the mammalian class III transcription factor TFIIIC into two functional components, termed TFIIIC1 and TFIIIC2, enabled an analysis of their functions in transcription initiation. Template competition assays were used to define the order with which these factors interact in vitro to form stable preinitiation complexes on the adenovirus VAI and Drosophila melanogaster tRNA(Arg) genes. The interaction between these genes and TFIIIC2, the factor that binds with high affinity to the B block, was both necessary and sufficient for template commitment. When either the VAI or tRNA(Arg) gene was preincubated with TFIIIC2 alone, transcription of a second gene added subsequently was excluded, indicating that TFIIIC2 bound stably to the first template. Furthermore, the interaction between TFIIIC2 and these genes must occur prior to that of TFIIIC1 or TFIIIB. Once TFIIIC2 was bound, TFIIIC1 could bind to the tRNA(Arg) and VAI genes, although its interaction with the VAI gene was less stable than that with the tRNA(Arg) gene. TFIIIB activity bound stably to the complex of both genes with TFIIIC2. These results demonstrate that TFIIIC2 is the first transcription factor to bind to these genes and that TFIIIB and TFIIIC1 can then interact in either order to form a preinitiation complex.
Language of Publication
English
Unique Identifier
89096886

Order full text for this document


MeSH Heading (Major)
Promoter Regions (Genetics)|*; Transcription Factors|IP/*ME
MeSH Heading
Adenoviridae|GE; Animal; Cell Line; Cell Nucleus|ME; Drosophila melanogaster|GE; Genes; Genes, Viral; Human; Plasmids; Protein Binding; RNA, Transfer, Arg|GE; Support, U.S. Gov't, P.H.S.; Transcription, Genetic

Publication Type
JOURNAL ARTICLE
ISSN
0270-7306
Country of Publication
UNITED STATES


Record 71 from database: MEDLINE
Order full text for this document

Title
Release factor competition is equivalent at strong and weakly suppressed nonsense codons.
Author
Martin R; Hearn M; Jenny P; Gallant J
Address
Department of Genetics, University of Washington, Seattle 98195.
Source
Mol Gen Genet, 1988 Jul, 213:1, 144-9
Abstract
We have compared the competition between strong or weak suppressor tRNAs and translational release factors (RF) at nonsense codons in the lacI gene of Escherichia coli. Using the F'lacIZ fusions developed by Miller and coworkers, UAG, UAA, and UGA codons at positions 189 and 220 were efficiently suppressed by plasmid-borne tRNA(trp) suppressors cognate to each nonsense triplet. Introduction of a compatible RF 1 plasmid competed at UAG and UAA but not UGA codons. An RF2 expressing plasmid competed at UAA and UGA but had little effect at UAG. Release factor competition against weak suppressors was measured using combinations of noncognate suppressors and nonsense codons. In each case, release factor plasmids behaved identically towards poorly suppressed codons as they did when the same codons were efficiently suppressed. The implications for these studies on the role of release factors in nonsense suppression context effects are discussed.
Language of Publication
English
Unique Identifier
89127134

Order full text for this document


MeSH Heading (Major)
Codon|*; Escherichia coli|*GE; Genes, Bacterial|*; Peptide Termination Factors|*ME; RNA, Messenger|*; Suppression, Genetic|*
MeSH Heading
Plasmids; RNA, Transfer|GE; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0026-8925
Country of Publication
GERMANY, WEST


Record 72 from database: MEDLINE
Order full text for this document

Title
Use of tRNA suppressors to probe regulation of Escherichia coli release factor 2.
Author
Curran JF; Yarus M
Address
Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder 80309.
Source
J Mol Biol, 1988 Sep, 203:1, 75-83
Abstract
It has been suggested that Escherichia coli release factor 2 (RF-2) translation is autoregulated. Mature RF-2 protein can terminate its own nascent synthesis at an intragenic, in-phase UGA codon, or alternatively, a +1 frameshift can occur that leads to completion of the RF-2 polypeptide. Translational termination presumably increases with RF-2 concentration, providing negative regulatory feedback. We now show, in lacZ/RF-2 fusions, that translation of a UAG codon at the position of the UGA competes with frameshifting, which proves one postulate of the translational autoregulatory model. We also identify a nearby sequence that is required for high-frequency frameshifting and suggest a constraint for the codon preceding the shift point. Both these sequences are incorporated into a model for frameshifting. Our measurements allow us to compute the relative rates in vivo of these reactions: release factor action, frameshifting and tRNA selection at an amber codon.
Language of Publication
English
Unique Identifier
89037196

Order full text for this document


MeSH Heading (Major)
Gene Expression Regulation|*; Peptide Termination Factors|*GE; RNA, Transfer|*GE
MeSH Heading
Codon; Escherichia coli; Lac Operon; Mutation; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.; Suppression, Genetic

Publication Type
JOURNAL ARTICLE
ISSN
0022-2836
Country of Publication
ENGLAND


Record 73 from database: MEDLINE
Order full text for this document

Title
Differential subcellular distribution of guanine nucleotide exchange factor in suckling and adult rat brain.
Author
Calés C; Fando JL; Alcazar A; Salinas M
Address
Departamento de InvestigaciÆon, Hospital RamÆon y Cajal, Madrid, Spain.
Source
Neurosci Lett, 1988 May, 87:3, 271-6
Abstract
Guanine nucleotide exchange factor (GEF) activity in ribosomal high salt wash and cytosolic fractions from suckling (4-10-day-old) and adult (60-day-old) rats was assayed by two different methods, by measuring: (i) its ability to promote binding of [3H]Met-tRNAi to eukaryotic initiation factor-2 (eIF-2) preparations that are partially or wholly in the form of eIF-2-GDP complexes (at Mg2+ concentrations near the optimum for protein synthesis), and (ii) under similar conditions, its ability to catalyze the displacement of [3H]GDP, previously bound to eIF-2, by unlabelled GDP. A purified eIF-2 (GEF-free) from brain was used as the source of eIF-2 activity. GEF activity in ribosomal fractions is higher in the brain of suckling than adults rats, and a direct correlation therefore exists between ribosomal GEF activity and the previously observed age-related decrease in eIF-2 activity in ribosomal high salt wash protein fractions. On the other hand GEF activity in the postmicrosomal supernatant is lower in the brain of suckling than adult rats. These findings further support the hypothesis that the progressive decrease in protein synthesis during brain development is controlled through regulation of the initiation step, by modulation of eIF-2/GEF activities.
Language of Publication
English
Unique Identifier
88246934

Order full text for this document


MeSH Heading (Major)
Aging|*ME; Brain|*ME/PH; Proteins|*ME
MeSH Heading
Animal; Guanosine Diphosphate|ME; Peptide Initiation Factors|ME; Rats; Ribosomes|ME; RNA, Transfer, Amino Acyl|ME; Subcellular Fractions|AN; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0304-3940
Country of Publication
NETHERLANDS


Record 74 from database: MEDLINE
Order full text for this document

Title
In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosis.
Author
Oehninger S; Acosta AA; Kreiner D; Muasher SJ; Jones HW Jr; Rosenwaks Z
Address
Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk 23507.
Source
J In Vitro Fert Embryo Transf, 1988 Oct, 5:5, 249-56
Abstract
The purpose of this report is to present a 6-year experience in the management of endometriosis with in vitro fertilization and embryo transfer (IVF/ET). We divided 136 patients who underwent 280 cycles into three groups: (1) previous history of endometriosis but normal pelvis at the time of oocyte retrieval, (2) stages I-II endometriosis (revised AFS classification), and (3) stages III-IV endometriosis. The stimulation protocols, estradiol (E2) responses, and distribution of terminal E2 patterns were similar in all groups. Group 3 had significantly fewer preovulatory and immature oocytes retrieved and fewer embryos transferred. The fertilization rate and the per cycle/per transfer pregnancy rates were similar in all groups. The miscarriage rate was higher in group 3, and the ongoing pregnancy rate per cycle was lower. Luteal phase E2 and progesterone levels were comparable in all groups. No differences were found when groups 2 and 3 were analyzed for the presence of one or two ovaries or the presence/absence of ovarian endometriosis. The overall fertilization rate, the per cycle/per transfer pregnancy rates, and the miscarriage rate were similar to those of tubal factor patients. We underscore the excellent outcome of patients with minimal or mild endometriosis in IVF/ET. We conclude that patients with moderate or severe endometriosis have a compromised reproductive potential, probably because of a reduced oocyte recovery rate and poor embryo quality.
Language of Publication
English
Unique Identifier
89156623

Order full text for this document


MeSH Heading (Major)
Embryo Transfer|*; Endometriosis|*/*TH; Fertilization in Vitro|*; Ovarian Neoplasms|*TH; Pregnancy Complications, Neoplastic|*TH
MeSH Heading
Abortion, Spontaneous|ET; Adult; Estradiol|BL; Female; FSH|PD; Gonadotropins, Chorionic|PD; Human; Infertility, Female|TH; Luteal Phase; Oocytes; Ovulation Induction; Pregnancy; Pregnancy Outcome; Progesterone|BL

Publication Type
JOURNAL ARTICLE
ISSN
0740-7769
Country of Publication
UNITED STATES


Record 75 from database: MEDLINE
Order full text for this document

Title
Method to determine effect of antibiotics at residue levels on R-factor transfer.
Author
Brady MS; Katz SE
Address
Rutgers University, Cook College, Department of Biochemistry and Microbiology, New Brunswick, NJ 08903.
Source
J Assoc Off Anal Chem, 1988 Mar, 71:2, 299-301
Abstract
An analytical system was developed which can assess the ability of antibiotic/antimicrobial residues (0.01-1.00 ppm) to affect the conjugal transfer of resistance among the Enterobacteriaceae. The donor strain, Escherichia coli RP-4 (Amr Tcr Nmr Kmr Lac+), and recipient strain, E. coli Sc-8632 (Smr Lac-), were incubated together in a 1:9 donor:recipient ratio for 18 h with gentle shaking (50 rpm) in brain heart infusion broth in the presence of residue levels of antibiotics. The mating cultures were serially diluted and spread-plated onto MacConkey agar containing 25 micrograms streptomycin/mL to select the total recipient population of sensitive E. coli Sc-8632 and transconjugants. After an 18 h incubation at 37 degrees C, the plates were replicated onto MacConkey agar containing 25 micrograms ampicillin/mL to select the ampicillin-resistant transconjugant population. Repeatability was good; the average transfer was 51.8%, with a coefficient of variation of 9.3%. Residue levels of tylosin (0.10 and 1.00 ppm) increased the transfer of the ampicillin marker beyond the 95% confidence limits. Oxytetracycline, bacitracin, streptomycin, penicillin, and virginiamycin did not increase the percent transfer. Oxytetracycline at 0.01 ppm decreased the percent transfer. In general, residue levels of antibiotics (0.01-1.00 ppm) did not affect the conjugal transfer of antibiotic resistance.
Language of Publication
English
Unique Identifier
88256967

Order full text for this document


MeSH Heading (Major)
Antibiotics|*PD; Enterobacteriaceae|*DE/GE; R Factors|*DE
MeSH Heading
Drug Residues|AN; Escherichia coli|DE; Microbial Sensitivity Tests; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0004-5756
Country of Publication
UNITED STATES


Record 76 from database: MEDLINE
Order full text for this document

Title
Biochemical and physical characterization of an unmodified yeast phenylalanine transfer RNA transcribed in vitro.
Author
Sampson JR; Uhlenbeck OC
Address
Department of Chemistry and Biochemistry, University of Colorado, Boulder 80309.
Source
Proc Natl Acad Sci U S A, 1988 Feb, 85:4, 1033-7
Abstract
A recombinant plasmid was constructed with six synthetic DNA oligomers such that the DNA sequence corresponding to yeast tRNA(Phe) is flanked by a T7 promoter and a BstNI restriction site. Runoff transcription of the BstNI-digested plasmid with T7 RNA polymerase gives an unmodified tRNA of the expected sequence having correct 5' and 3' termini. This tRNA(Phe) transcript can be specifically aminoacylated by yeast phenylalanyl-tRNA synthetase and has a Km only 4-fold higher than that of the native yeast tRNA(Phe). The Km is independent of Mg2+ concentration, whereas the Vmax is very dependent on Mg2+ concentration. Comparison of the melting profiles of the native and the unmodified tRNA(Phe) at different Mg2+ concentrations suggests that the unmodified tRNA(Phe) has a less stable tertiary structure. Using one additional DNA oligomer, a mutant plasmid was constructed having a guanosine to thymidine change at position 20 in the tRNA gene. A decrease in Vmax/Km by a factor of 14 for aminoacylation of the mutant tRNA(Phe) transcript is observed.
Language of Publication
English
Unique Identifier
88124969

Order full text for this document


MeSH Heading (Major)
RNA, Fungal|*GE/ME; RNA, Transfer, Amino Acid-Specific|*GE; RNA, Transfer, Phe|*GE/ME; Saccharomyces cerevisiae|*GE
MeSH Heading
Base Sequence; DNA, Fungal|GE; DNA, Recombinant; Molecular Sequence Data; Nucleic Acid Conformation; Nucleic Acid Denaturation; Phenylalanine|ME; Phenylalanine-tRNA Ligase|ME; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0027-8424
Country of Publication
UNITED STATES


Record 77 from database: MEDLINE
Order full text for this document

Title
Hydration of CO2 by carbonic anhydrase: intramolecular proton transfer between Zn2+-bound H2O and histidine 64 in human carbonic anhydrase II.
Author
Liang JY; Lipscomb WN
Address
Gibbs Chemical Laboratories, Department of Chemistry, Harvard University, Cambridge, Massachusetts 02138.
Source
Biochemistry, 1988 Nov, 27:23, 8676-82
Abstract
The energy barrier for the intramolecular proton transfer between zinc-bound water and His 64 in the active site of human carbonic anhydrase II (HCA II) has been studied at the partial retention of diatomic differential overlap (PRDDO) level. The most important stabilizing factor for the intramolecular proton transfer is the zinc ion, which lowers the pKa of zinc-bound water and electrostatically repels the proton. The energy barrier of 127.5 kcal/mol for proton transfer between a water dimer is completely removed in the presence of the zinc ion. The zinc ligands, which donate electrons to the zinc ion, raise the barrier slightly to 34 kcal/mol for a 4-coordinated zinc complex including three imidazole ligands from His 94, His 96, and His 119 and to 54 kcal/mol for the 5-coordinated zinc complex including the fifth water ligand. A few model calculations indicate that these energy barriers are expected to be reduced to within experimental range (approximately 10 kcal/mol) when large basis set, correlation energies, and molecular dynamics are considered. The proton-transfer group, which functions as proton receiver in the intramolecular proton transfer, helps to attract the proton; and the partially ordered active site water molecules are important for proton relay function.
Language of Publication
English
Unique Identifier
89118287

Order full text for this document


MeSH Heading (Major)
Carbon Dioxide|*ME; Carbonate Dehydratase|*ME; Histidine|*; Zinc|*ME
MeSH Heading
Binding Sites; Human; Kinetics; Protein Binding; Protons; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.; Water

Publication Type
JOURNAL ARTICLE
ISSN
0006-2960
Country of Publication
UNITED STATES


Record 78 from database: MEDLINE
Order full text for this document

Title
The allosteric three-site model for the ribosomal elongation cycle. New insights into the inhibition mechanisms of aminoglycosides, thiostrepton, and viomycin.
Author
Hausner TP; Geigenmüller U; Nierhaus KH
Address
Max-Planck-Institut fÂur Molekulare Genetik, Abteilung Wittmann, Berlin-Dahlem, West Germany.
Source
J Biol Chem, 1988 Sep, 263:26, 13103-11
Abstract
According to the allosteric three-site model for the ribosomal elongation cycle (Rheinberger, H.J. and Nierhaus, K.H. (1986) J. Biol. Chem. 261, 9133-9139), two types of A site (aminoacyl-tRNA site) occupation exist. First is the A site occupation after initiation (i-type), with only one site, the P site (peptidyl-tRNA site), being prefilled with a tRNA (initiator tRNA). Second is the A site occupation after an elongation cycle (e-type), with two prefilled sites, namely the P and E sites containing peptidyl-tRNA and deacylated tRNA, respectively. The individual reactions of the elongation cycle were tested, including both types of A site occupation in the presence of various antibiotics. A test system was used allowing the functional studies to be made with quantitative tRNA binding at 6 mM Mg2+. The following results were obtained: 1) thiostrepton (5 x 10(-6) M) induced a complete block of both EF-(elongation factor) G dependent and EF-G independent translocation, in agreement with older observations. The A-site occupation of the e-type was severely inhibited in contrast to that of the i-type. Thus, thiostrepton blocks the allosteric transitions in both directions, i.e. the transition from pre- to post-translocational state (translocation) and that from the post- to the pre-translocational state (A site occupation of the e-type). In addition the ribosomal binding of EF-G.[3H] GMPPNP was inhibited by about 60%. 2) Similarly, viomycin (5 x 10(-5) M) appears to be an inhibitor of both allosteric transitions, since it strongly inhibited the e-type (but not the i-type) A site occupation in addition to translocation. 3) The aminoglycosides streptomycin, hygromycin B, neomycin, kanamycin, and gentamicin prevented A site occupation of the e-type (residual activity below 15%). Neomycin and hygromycin, in addition, blocked the translocation reaction. Only marginal effects were observed with A site occupation of the i-type. It appears that the inhibition of the A site binding of the e-type (allosteric transition from the post- to the pretranslocational state) is the predominant effect of the misreading-inducing aminoglycosides.
Language of Publication
English
Unique Identifier
88330807

Order full text for this document


MeSH Heading (Major)
Aminoglycosides|*PD; Antibiotics|*PD; Galactosyltransferases|*ME; Ribosomes|*DE; RNA, Transfer, Amino Acid-Specific|*ME; RNA, Transfer, Phe|*ME; Thiostrepton|*PD; Viomycin|*PD
MeSH Heading
Escherichia coli|GE; Guanylyl Imidodiphosphate|ME; Lincomycin|PD; Magnesium|ME; Models, Genetic; Peptide Elongation Factors|ME

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 79 from database: MEDLINE
Order full text for this document

Title
Sequences between the internal control regions of tRNAArg of Drosophila melanogaster influence stimulation of transcription of the 5' flanking DNA.
Author
Horvath D; Spiegelman GB
Address
Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
Source
Nucleic Acids Res, 1988 Mar, 16:6, 2585-99
Abstract
Recombinants between 5' deletion mutants of a tRNA(3bVal) gene which is inactive as an in vitro transcription template and a tRNAArg gene, which is an active in vitro template were made. The 5' flanking region of tRNA(Arg) including 36 nucleotides of the coding sequence of the gene stimulated transcription of the tRNA(3bVal), deleted to the +17 position, gene by over 50 fold. When the 5' flanking region of the tRNA(Arg) gene included 22 nucleotides of the coding sequence stimulation was reduced by a factor of 3. Thus the sequences between +22 and +36 of tRNA(Arg) are required to permit maximum stimulation of tRNA(3bVal) in vitro template activity.
Language of Publication
English
Unique Identifier
88203201

Order full text for this document


MeSH Heading (Major)
Drosophila melanogaster|*GE; Regulatory Sequences, Nucleic Acid|*; RNA, Transfer, Amino Acid-Specific|*GE; RNA, Transfer, Arg|*GE; Transcription, Genetic|*
MeSH Heading
Animal; Base Sequence; DNA Mutational Analysis; DNA, Recombinant; Endonucleases|PD; Genes, Structural; In Vitro; RNA, Transfer, Val|GE; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0305-1048
Country of Publication
ENGLAND


Record 80 from database: MEDLINE
Order full text for this document

Title
Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli O157:H7 at the level of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes.
Author
Ogasawara T; Ito K; Igarashi K; Yutsudo T; Nakabayashi N; Takeda Y
Address
Faculty of Pharmaceutical Sciences, Chiba University, Japan.
Source
Microb Pathog, 1988 Feb, 4:2, 127-35
Abstract
A Vero toxin (VT2 or Shiga-like toxin II) from Escherichia coli O157:H7 was shown to inhibit protein synthesis in a rabbit reticulocyte lysate, but not in wheat germ or Ercherichia coli lysates. The toxin, VT2, inactivated 60S ribosomal subunits of rabbit reticulocytes. The site of inhibition of protein synthesis by VT2 was shown to be elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes. VT2 did not affect Met-tRNAf binding to ribosomes, non-enzymatic binding of aminoacyl-tRNA to ribosomes, peptide bond formation or translocation.
Language of Publication
English
Unique Identifier
89070296

Order full text for this document


MeSH Heading (Major)
Bacterial Toxins|*PD; Escherichia coli|*PY; Peptide Elongation Factors|*AI; Protein Synthesis Inhibitors|*; Ribonucleoproteins|*AI; Ribosomes|*DE/ME; RNA, Transfer, Amino Acid-Specific|*ME
MeSH Heading
Animal; Cell-Free System; Centrifugation, Density Gradient; Globin|BI; GTP Phosphohydrolase|ME; Peptides|BI; Protein Binding; Rabbits; Rats; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0882-4010
Country of Publication
ENGLAND


Record 81 from database: MEDLINE
Order full text for this document

Title
Identification of a protein factor binding to the 5'-flanking region of a tRNA gene and being involved in modulation of tRNA gene transcription in vivo in Saccharomyces cerevisiae.
Author
Marschalek R; Dingermann T
Address
Institut fÂur Biochemie der Medizinischen FakultÂat, UniversitÂat Erlangen-NÂurnberg, FRG.
Source
Nucleic Acids Res, 1988 Jul, 16:14B, 6737-52
Abstract
Control mechanisms of tRNA gene transcription were studied in vivo in Saccharomyces cerevisiae. In order to be able to monitor in vivo transcription products of an individual tRNA gene, a 'tester gene' was used which is readily transcribed in vivo in yeast but does not cross-hybridize with any cellular yeast tRNA. A series of insertion mutants were constructed, modifying thereby the immediate and further distant 5'-flanking region of the 'tester tRNA gene'. Small linker molecules of different length and different sequence were inserted at positions -3 and -56 on the non-coding strand. Resulting tRNA gene variants were transformed into yeast cells and in vivo synthesized products were monitored by primer extension analysis. From the experimental data we suggest that a few essential nucleotides within the flanking region are able to determine the in vivo transcription activity of the 'tester tRNA gene'. Our results are rationalized on a biochemical level by protein binding assays: At least one protein binds to the 5'-flanking region of the 'tester tRNA gene' and different protein complexes are sequestered on active or less active tRNA gene variants.
Language of Publication
English
Unique Identifier
88303307

Order full text for this document


MeSH Heading (Major)
DNA, Fungal|*GE; Nuclear Proteins|*PH; RNA, Fungal|*GE; RNA, Transfer, Amino Acid-Specific|*GE; RNA, Transfer, Val|*GE; Saccharomyces cerevisiae|*GE; Transcription Factors|*PH; Transcription, Genetic|*
MeSH Heading
Base Sequence; Gene Expression Regulation; Molecular Sequence Data; Regulatory Sequences, Nucleic Acid; RNA Processing, Post-Transcriptional; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0305-1048
Country of Publication
ENGLAND


Record 82 from database: MEDLINE
Order full text for this document

Title
Effect of uridine dethiolation in the anticodon triplet of tRNA(Glu) on its association with tRNA(Phe).
Author
Houssier C; Degée P; Nicoghosian K; Grosjean H
Address
Laboratoire de Chimie MacromolÆeculaire et Chimie Physique, UniversitÆe de LiÄege, Belgium.
Source
J Biomol Struct Dyn, 1988 Jun, 5:6, 1259-66
Abstract
The effect of U(34) dethiolation on the anticodon-anticodon association between E. coli tRNA(Glu) and yeast tRNA(Phe) has been studied by the temperature jump relaxation technique. An important destabilization upon replacement of the thioketo group of s2U(34) by a keto group, was revealed by a lowering of melting temperature of about 20 degrees C. The measured kinetic parameters indicated that this destabilization effect was originated in an increase of dissociation and a decrease of association rate constants by a factor of 4 to 5. Modifications in both stacking interactions and flexibility in the anticodon loop would be responsible for this effect.
Language of Publication
English
Unique Identifier
90148456

Order full text for this document


MeSH Heading (Major)
Anticodon|*ME/UL; RNA, Transfer|*ME; RNA, Transfer, Amino Acid-Specific|*ME; RNA, Transfer, Glu|*ME; RNA, Transfer, Phe|*ME; Thiouridine|*
MeSH Heading
Circular Dichroism; Nucleic Acid Denaturation; RNA, Bacterial|ME; RNA, Fungal|ME; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0739-1102
Country of Publication
UNITED STATES


Record 83 from database: MEDLINE
Order full text for this document

Title
Separation of formyl-methionyl transfer RNA, methionyl transfer RNA, and transfer RNAfmet using mixed-mode high-performance liquid chromatography on C6-modified aminopropylsilyl-hypersil.
Author
Ricker RD; Kaji A
Address
University of Pennsylvania, School of Medicine, Department of Microbiology, Philadelphia 19104-6076.
Source
Anal Biochem, 1988 Nov, 175:1, 327-33
Abstract
Preparative amounts of formyl-methionyl-tRNAfmet, methionyl-tRNAfmet, and tRNAfmet were separated from each other with baseline resolution in 30 min using mixed-mode HPLC on hexanoic anhydride-modified aminopropylsilyl-Hypersil 2. Pure tRNAfmet was aminoacylated with [35S]methionine in the presence or absence of a formyl donor and was immediately fractionated on the column. Two isoacceptors, tRNA1fmet and tRNA2fmet, as well as aminoacyl-tRNA synthetases were clearly separated from each other. The purified f[35S]-methionyl-tRNA was biologically active in that as much as 98% could be bound to ribosomes in response to AUGUAA in vitro. Formyl-methionine was released from this complex by the action of termination factor and greater than 92% of bound formyl-methionine was released by puromycin.
Language of Publication
English
Unique Identifier
89226327

Order full text for this document


MeSH Heading (Major)
Chromatography, High Pressure Liquid|*MT; RNA, Transfer, Amino Acid-Specific|*IP; RNA, Transfer, Amino Acyl|*IP; RNA, Transfer, Met|*IP
MeSH Heading
Escherichia coli|AN; Hexanoic Acids; RNA, Bacterial|IP; Silicones

Publication Type
JOURNAL ARTICLE
ISSN
0003-2697
Country of Publication
UNITED STATES


Record 84 from database: MEDLINE
Order full text for this document

Title
Restrained refinement of two crystalline forms of yeast aspartic acid and phenylalanine transfer RNA crystals.
Author
Westhof E; Dumas P; Moras D
Address
Institut de Biologie MolÆeculaire et Cellulaire, Centre National de la Recherche Scientifique, Strasbourg, France.
Source
Acta Crystallogr A, 1988 Mar, 44 ( Pt 2):, 112-23
Abstract
Four transfer RNA crystals, the monoclinic and orthorhombic forms of yeast tRNA(Phe) as well as forms A and B of yeast tRNA(Asp), have been submitted to the same restrained least-squares refinement program and refined to an R factor well below 20% for about 4500 reflections between 10 and 3 A. In yeast tRNA(Asp) crystals the molecules exist as dimers with base pairings of the anticodon (AC) triplets and labilization of the tertiary interaction between one invariant guanine of the dihydrouridine (D) loop and the invariant cytosine of the thymine (T) loop (G19-C56). In yeast tRNA(Phe) crystals, the molecules exist as monomers with only weak intermolecular packing contacts between symmetry-related molecules. Despite this, the tertiary folds of the L-shaped tRNA structures are identical when allowance is made for base sequence changes between tRNA(Phe) and tRNA(Asp). However, the relative mobilities of two regions are inverse in the two structures with the AC loop more mobile than the D loop in tRNA(Phe) and the D loop more mobile than the AC loop in tRNA(Asp). In addition, the T loop becomes mobile in tRNA(Asp). The present refinements were performed to exclude packing effects or refinement bias as possible sources of such differential dynamic behavior. It is concluded that the transfer of flexibility from the anticodon to the D- and T-loop region in tRNA(Asp) is not a crystal-line artefact. Further, analysis of the four structures supports a mechanism for the flexibility transfer through base stacking in the AC loop and concomitant variations in twist angles between base pairs of the anticodon helix which propagate up to the D- and T-loop region.
Language of Publication
English
Unique Identifier
90166328

Order full text for this document


MeSH Heading (Major)
RNA, Transfer, Amino Acid-Specific|*; RNA, Transfer, Asp|*; RNA, Transfer, Phe|*; Yeasts|*GE
MeSH Heading
Anticodon; Base Composition; Chemistry, Physical; Crystallography; Nucleic Acid Conformation; Temperature

Publication Type
JOURNAL ARTICLE
ISSN
0108-7673
Country of Publication
DENMARK


Record 85 from database: MEDLINE
Order full text for this document

Title
Functional analysis of the interaction of a tissue-specific factor with an upstream enhancer element of the rat prolactin gene.
Author
Kim KE; Day RN; Maurer RA
Address
Department of Physiology and Biophysics, University of Iowa, Iowa City 52242.
Source
Mol Endocrinol, 1988 Dec, 2:12, 1374-81
Abstract
A nuclear factor which binds to an upstream element of the rat PRL gene has been identified and the functional properties of the factor-DNA interaction have been assessed by mutagenesis of the factor binding sites. Gel mobility shift assays have been used to identify a factor which binds to a fragment from the -1712 to -1494 region of the rat PRL gene. The DNA binding factor is present in nuclear extracts from PRL-producing GH3 cells, but not in nuclear extracts from several other cell lines. Although previous studies have shown that the estrogen receptor binds to this region of DNA, chromatography on heparin-agarose demonstrated that the factor detected by mobility shift assay is probably not the estrogen receptor. Nuclease protection experiments demonstrate that the factor binds to a discrete region at positions -1666 to -1652. The protected region includes half of a palindrome, TCATTAT ... ATAATGA. Mutagenesis by T to G transversions of either both halves of this symmetrical sequence, or only the upstream portion shown to interact with the factor substantially reduced factor binding as assessed by gel mobility shift assay. Transfer of fusion genes containing this region of DNA into GH3 cells demonstrated that the -1712 to -1494 region has a basal enhancer activity which is reduced severalfold by T to G mutagenesis of the complete dyad symmetry at positions -1665 to -1644. The results suggest that the -1712 to -1494 region of the rat PRL gene contains two relatively independent elements. One element, located at positions -1582 to -1569, interacts with the estrogen receptor and mediates estrogenic stimulation of transcription.(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
89112219

Order full text for this document


MeSH Heading (Major)
Enhancer Elements (Genetics)|*; Prolactin|*GE/ME
MeSH Heading
Animal; Base Sequence; Cells, Cultured; DNA|AN/ME; Estrogens|PD; Molecular Sequence Data; Rats; Receptors, Estrogen|DE/ME; Support, U.S. Gov't, P.H.S.; Transcription, Genetic|DE

Publication Type
JOURNAL ARTICLE
ISSN
0888-8809
Country of Publication
UNITED STATES


Record 86 from database: MEDLINE
Order full text for this document

Title
Brownian dynamics simulations of intramolecular energy transfer.
Author
Berger JW; Vanderkooi JM
Address
Department of Biochemistry and Biophysics, School of Medicine, University of Pennsylvania, Philadelphia 19104.
Source
Biophys Chem, 1988 Jul, 30:3, 257-69
Abstract
A novel technique for modelling intramolecular energy transfer is presented. Brownian dynamics calculations are used to compute the trajectories of donor and acceptor species, and the instantaneous orientation factor is calculated during each temporal iteration. In this work, several model systems are considered. Trajectories were computed for energy transfer between a flexible donor and a rigidly fixed acceptor. We have considered configurations where the donor is, (1) tethered to a fixed point in space, but free to diffuse rotationally, and (2) constrained to wobble in a cone. The luminescence decay of the donor is 'measured', and a non-single-exponential decay is observed for configurations of efficient energy transfer. Luminescence anisotropy measurements of constrained and unconstrained donors reflect the contribution of both energy transfer and rotational diffusion to the shape of the anisotropy decay curve.
Language of Publication
English
Unique Identifier
89088430

Order full text for this document


MeSH Heading (Major)
Energy Transfer|*; Models, Chemical|*
MeSH Heading
Chemistry; Kinetics; Luminescence; Support, U.S. Gov't, P.H.S.; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0301-4622
Country of Publication
NETHERLANDS


Record 87 from database: MEDLINE
Order full text for this document

Title
Tissue distribution, purification and characterization of rat phosphatidylinositol transfer protein.
Author
Venuti SE; Helmkamp GM Jr
Address
Department of Biochemistry, University of Kansas Medical Center, Kansas City 66103.
Source
Biochim Biophys Acta, 1988 Dec, 946:1, 119-28
Abstract
Phosphatidylinositol transfer activity is measured in cytosol fractions prepared from 13 rat tissues; specific activity is highest in brain and lowest in adipose and skeletal muscle. Based upon electrophoretic analysis phosphatidylinositol transfer protein is purified to homogeneity from whole rat brain. The protein has a molecular weight of 36,000 and exists as a mixture of species having isoelectric points of 4.9 and 5.3. In a vesicle-vesicle assay system, the intermembrane transfer rate is greatest for phosphatidylinositol and less by a factor of 2 for phosphatidylcholine; transfer of phosphatidylethanolamine, phosphatidylserine or sphingomyelin is not observed. Using a polyclonal rabbit antibody against bovine phosphatidylinositol transfer protein, immunologic cross-reactivity is noted between the rat protein and other mammalian phosphatidylinositol transfer proteins. A strong correlation is established between a tissue's capacity for phosphatidylinositol transfer and the amount of immunoreactive transfer protein seen in that tissue. Purified phosphatidylinositol transfer protein is capable of transporting newly synthesized phosphatidylinositol molecules from rat brain microsomes to small unilamellar phospholipid vesicles. The results are discussed within the context of cellular phosphoinositide metabolism and the maintenance of the metabolically responsive pool of phosphatidylinositol in the plasma membrane.
Language of Publication
English
Unique Identifier
89088183

Order full text for this document


MeSH Heading (Major)
Carrier Proteins|IP/*PK
MeSH Heading
Adipose Tissue|AN; Animal; Brain Chemistry; Isoelectric Point; Male; Molecular Weight; Muscles|AN; Rats; Rats, Inbred Strains; Support, U.S. Gov't, P.H.S.; Tissue Distribution

Publication Type
JOURNAL ARTICLE
ISSN
0006-3002
Country of Publication
NETHERLANDS


Record 88 from database: MEDLINE
Order full text for this document

Title
A tridecamer DNA sequence supports human mitochondrial RNA 3'-end formation in vitro.
Author
Christianson TW; Clayton DA
Address
Department of Pathology, Stanford University School of Medicine, California 94305-5324.
Source
Mol Cell Biol, 1988 Oct, 8:10, 4502-9
Abstract
Vertebrate mitochondrial genomes contain a putative transcription termination site at the boundary between the genes for 16S rRNA and leucyl-tRNA. We have described previously an in vitro transcription system from human cells with the capacity to generate RNA 3' ends with the same map positions as those synthesized in vivo. By assaying the ability of variously truncated templates to support 3'-end formation, we demonstrated that the tridecamer sequence 5'-TGGCAGAGCCCCGG-3', contained entirely within the gene for leucyl-tRNA, is necessary to direct accurate termination. When two tridecamer sequences and their immediate flanking regions were placed in tandem, termination occurred at both promoter-proximal and promoter-distal sites. Furthermore, termination was competitively inhibited, in a concentration-dependent manner, by DNA containing the tridecamer sequence. These results suggest a modest sequence requirement for transcription termination that is contingent on a factor capable of recognizing the presence of the tridecamer DNA sequence.
Language of Publication
English
Unique Identifier
89039880

Order full text for this document


MeSH Heading (Major)
DNA, Mitochondrial|*GE; Genes, Regulator|*; Regulatory Sequences, Nucleic Acid|*; RNA, Ribosomal|*GE; RNA, Ribosomal, 16S|*GE; RNA, Transfer, Amino Acid-Specific|*GE; RNA, Transfer, Leu|*GE; Terminator Regions (Genetics)|*
MeSH Heading
Base Sequence; Chromosome Deletion; DNA Mutational Analysis; Human; In Vitro; RNA Processing, Post-Transcriptional; Structure-Activity Relationship; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0270-7306
Country of Publication
UNITED STATES


Record 89 from database: MEDLINE
Order full text for this document

Title
Regulation of polypeptide-chain initiation in rat skeletal muscle. Starvation does not alter the activity or phosphorylation state of initiation factor eIF-2.
Author
Cox S; Redpath NT; Proud CG
Address
Biological Laboratory, University, Canterbury, England.
Source
FEBS Lett, 1988 Nov, 239:2, 333-8
Abstract
In rats, 48-h starvation causes a decrease in the rate of protein synthesis in skeletal (e.g. gastrocnemius) muscle, due largely to impairment of peptide-chain initiation. In other cell types inhibition of initiation is associated with decreased activity and recycling of initiation factor eIF-2, and increased phosphorylation of its alpha-subunit. However, 48-h starvation has no effect on the activity or recycling of eIF-2 measured in extracts of gastrocnemius muscle, or on the level of alpha-subunit phosphorylation. The effects of starvation on peptide-chain initiation in skeletal muscle must therefore involve alterations in other components of the translational machinery.
Language of Publication
English
Unique Identifier
89031258

Order full text for this document


MeSH Heading (Major)
Muscles|*ME; Peptide Initiation Factors|*ME; Proteins|*ME
MeSH Heading
Animal; Guanosine Diphosphate|ME; Guanosine Triphosphate|ME; Kinetics; Male; Phosphorylation; Polyribosomes|ME/UL; Rats; Rats, Inbred Strains; Reference Values; Ribosomes|ME; RNA, Transfer, Met|ME; Starvation; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0014-5793
Country of Publication
NETHERLANDS


Record 90 from database: MEDLINE
Order full text for this document

Title
Is the carbon monoxide transfer factor diminished in the presence of diabetic retinopathy in patients with insulin-dependent diabetes mellitus?
Author
Britton J
Address
Respiratory Medicine Unit, City Hospital, Nottingham, England.
Source
Eur Respir J, 1988 May, 1:5, 403-6
Abstract
Impaired carbon monoxide gas transfer has been demonstrated in patients with insulin-dependent diabetes mellitus (IDDM), but no relationship has been documented between impairment of gas transfer and the presence of other clinical evidence of diabetic microangiopathy. This study set out to determine whether carbon monoxide gas transfer was related to the presence of microangiopathy by measuring the carbon monoxide transfer coefficient (KCO) in twenty patients with IDDM complicated by retinopathy, and in twenty patients without retinopathy. The patients were reasonably matched for age (mean 47 yrs in the retinopathy group, 41 yrs in the non-retinopathy group) but those with retinopathy had a longer mean duration of diabetes (23 yrs vs 13 yrs). Carbon monoxide transfer coefficient was normal in both groups, with no significant difference between them. Values for forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) were lower than predicted in the retinopathy group (92 (SEM 3.6%) and 91 (SEM 4.0%) respectively, p less than 0.05) but were not significantly different from those in the non-retinopathy group. This study demonstrates normal lung function in IDDM, with no relationship between impairment of gas transfer and the presence of microangiopathy elsewhere.
Language of Publication
English
Unique Identifier
89005552

Order full text for this document


MeSH Heading (Major)
Carbon Monoxide|PD/*PH; Diabetes Mellitus, Insulin-Dependent|*PP; Diabetic Retinopathy|*PP
MeSH Heading
Adult; Forced Expiratory Volume; Human; Male; Middle Age; Pulmonary Gas Exchange|DE; Smoking|PP; Spirometry; Vital Capacity|DE

Publication Type
JOURNAL ARTICLE
ISSN
0903-1936
Country of Publication
DENMARK


Record 91 from database: MEDLINE
Order full text for this document

Title
Evidence that the two amino termini of plasma fibronectin are in close proximity: a fluorescence energy transfer study.
Author
Wolff C; Lai CS
Address
Department of Radiology, Medical College of Wisconsin, Milwaukee 53226.
Source
Biochemistry, 1988 May, 27:9, 3483-7
Abstract
A fluorescence energy transfer technique has been used to study the intramolecular distance between the two amino termini of human plasma fibronectin. The glutamine-3 residue near the amino terminus of each chain was labeled enzymatically with either monodansylcadaverine or monofluoresceinylcadaverine by use of coagulation factor XIIIa. The nonradiative fluorescence energy transfer between the dansyl (donor) and fluorescein (acceptor) pair in the same protein molecule was determined from steady-state fluorescence measurements. On the basis of the transfer efficiency of 78%, the intramolecular distance between two glutamine-3 residues of fibronectin was estimated to be approximately 23 A, suggesting that the two amino termini of plasma fibronectin are in close proximity. High salt, which affects the hydrodynamic properties of the protein, has no effect on the measured distance. The results support the contention that both compact (in low salt) and expanded (in high salt) conformers of fibronectin are relatively spherical in shape.
Language of Publication
English
Unique Identifier
88269545

Order full text for this document


MeSH Heading (Major)
Fibronectins|*BL
MeSH Heading
Energy Transfer; Human; Osmolar Concentration; Protein Conformation; Spectrometry, Fluorescence|MT; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-2960
Country of Publication
UNITED STATES


Record 92 from database: MEDLINE
Order full text for this document

Title
Preliminary results using pentoxifylline in a pronuclear stage tubal transfer (PROST) program for severe male factor infertility.
Author
Yovich JM; Edirisinghe WR; Cummins JM; Yovich JL
Address
PIVET Medical Centre University of Western Australia, Perth.
Source
Fertil Steril, 1988 Jul, 50:1, 179-81
Abstract
In vitro trials with washed spermatozoa incubated in medium containing 1 mg/ml of the methyl xanthine phosphodiesterase inhibitor PF showed improved counts of total motile and total progressively motile spermatozoa in cases of oligospermia/asthenospermia. Application of this agent in a PROST program for a series of nine couples presenting for treatment with histories of failed fertilization in vitro resulted in five pregnancies (four singleton, one triplet) and the subsequent delivery of normal infants. The results warrant further evaluation of this sperm treatment for cases of severe male factor infertility.
Language of Publication
English
Unique Identifier
88255360

Order full text for this document


MeSH Heading (Major)
Embryo Transfer|*; Fertilization in Vitro|*; Infertility, Male|*DT; Pentoxifylline|*TU; Theobromine|*AA
MeSH Heading
Human; Male; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0015-0282
Country of Publication
UNITED STATES


Record 93 from database: MEDLINE
Order full text for this document

Title
Identification of proteins of the 40 S ribosomal subunit involved in interaction with initiation factor eIF-2 in the quaternary initiation complex by means of monospecific antibodies.
Author
Bommer UA; Stahl J; Henske A; Lutsch G; Bielka H
Address
Academy of Sciences of the GDR, Department of Cell Physiology, Berlin-Buch.
Source
FEBS Lett, 1988 Jun, 233:1, 114-8
Abstract
Monospecific polyclonal antibodies against seven proteins of the 40 S subunit of rat liver ribosomes were used to identify ribosomal proteins involved in interaction with initiation factor eIF-2 in the quaternary initiation complex [eIF-2 X GMPPCP X [3H]Met-tRNAf X 40 S ribosomal subunit]. Dimeric immune complexes of 40 S subunits mediated by antibodies against ribosomal proteins S3a, S13/16, S19 and S24 were found to be unable to bind the ternary initiation complex [eIF-2 X GMPPCP X [3H]Met-tRNAf]. In contrast, 40 S dimers mediated by antibodies against proteins S2, S3 and S17 were found to bind the ternary complex. Therefore, from the ribosomal proteins tested, only proteins S3a, S13/16, S19 and S24 are concluded to be involved in eIF-2 binding to the 40 S subunit.
Language of Publication
English
Unique Identifier
88255275

Order full text for this document


MeSH Heading (Major)
Immunoassay|*; Liver|*UL; Peptide Initiation Factors|*ME; Proteins|*ME; Ribosomal Proteins|*ME; Ribosomes|*ME
MeSH Heading
Animal; Centrifugation, Density Gradient; Cross-Linking Reagents; Guanosine Triphosphate|AA/ME; Macromolecular Systems; Rats; RNA, Transfer, Met|ME

Publication Type
JOURNAL ARTICLE
ISSN
0014-5793
Country of Publication
NETHERLANDS


Record 94 from database: MEDLINE
Order full text for this document

Title
Affinity labeling by a photoreactive GTP analogue of the alpha-subunit of eukaryotic initiation factor eIF-2 in different initiation complexes.
Author
Bommer UA; Salimans MM; Kurzchalia TV; Voorma HO; Karpova GG
Address
Department of Cell Physiology, Academy of Sciences of the GDR, Berlin-Buch.
Source
Biochem Int, 1988 Mar, 16:3, 549-57
Abstract
The interaction of GTP with initiation factor eIF-2 in different complexes was studied by affinity labeling using a derivative of [3H]GTP carrying a photoreactive group in the alpha-phosphate moiety. In the binary complex [eIF-2.GTP analogue], in the ternary complex [eIF-2.GTP analogue.Met-tRNAf] as well as in the eIF-2. eIF-2B complex the alpha-subunit of eIF-2 was found to be specifically labeled. GTP is concluded to interact during polypeptide chain initiation with the alpha-subunit of eIF-2 at least by its alpha-phosphate group.
Language of Publication
English
Unique Identifier
88251451

Order full text for this document


MeSH Heading (Major)
Affinity Labels|*ME; Azides|*ME; Guanosine Triphosphate|*AA/ME; Liver|*ME; Peptide Chain Initiation|*; Peptide Initiation Factors|*ME; Proteins|*ME
MeSH Heading
Animal; Molecular Weight; Rats; Reticulocytes|ME; RNA, Transfer, Amino Acyl|ME

Publication Type
JOURNAL ARTICLE
ISSN
0158-5231
Country of Publication
AUSTRALIA


Record 95 from database: MEDLINE
Order full text for this document

Title
Dependence of O2 transfer conductance of red blood cells on cellular dimensions.
Author
Yamaguchi K; Jürgens KD; Bartels H; Scheid P; Piiper J
Address
Department of Medicine, School of Medicine, Keio University, Tokyo, Japan.
Source
Adv Exp Med Biol, 1988, 222:, 571-8
Abstract
To estimate the significance of the dimensions of RBC on O2 transfer, the kinetics of O2 release from RBC into medium containing dithionite (40 mmol/l) was measured, by a stopped-flow technique, for nine different species with varying RBC size (man, llama, vicuna, alpaca, dromedary camel, pygmy goat, domestic hen, muscovy duck and turtle). The observed O2 transfer kinetics were found to be size-dependent, i.e. the O2 transfer conductance of the single RBC, gst, was lower, whereas the specific O2 transfer conductance of packed RBC, Gst, or of whole blood, theta st, was higher for smaller RBC. The ratio of surface area to effective diffusion path length which was found to be about one fourth of the mean cell thickness irrespective of cell size and cell shape, may be considered as the essential morphological factor determining O2 transfer efficiency of the single RBC.
Language of Publication
English
Unique Identifier
88206948

Order full text for this document


MeSH Heading (Major)
Erythrocytes|CY/*ME; Oxygen|*BL; Oxyhemoglobins|*ME
MeSH Heading
Animal; Blood Flow Velocity; Comparative Study; Human; Species Specificity

Publication Type
JOURNAL ARTICLE
ISSN
0065-2598
Country of Publication
UNITED STATES


Record 96 from database: MEDLINE
Order full text for this document

Title
Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation.
Author
Forman R; Fries N; Testart J; Belaisch Allart J; Hazout A; Frydman R
Address
Institut National de la SantÆe et de la Recherche MÆedicale, Unite 187, Department of Obstetrics and Gynaecology, HÈopital Antoine BÆeclÄere, Clamart France.
Source
Fertil Steril, 1988 Jan, 49:1, 118-22
Abstract
Multiple follicular stimulation for IVF may be associated with greatly elevated serum E2 concentrations that are presumed to be antinidatory. This factor was analyzed in 825 consecutive embryo transfer cycles. The pregnancy rate decreased significantly after the transfer of one and two embryos in association with preovulatory E2 levels greater than the 90th percentile for the group (2320 pg/ml). The pregnancy rate did not vary with preovulatory E2 concentration following the transfer of three embryos. Highly significant correlations were noted between preovulatory E2 and early luteal phase concentrations of E2 and P. In a subgroup of 245 cycles, there were no significant relationships between implantation and early luteal phase levels of P or the ratio of E2/P. There was a small but nonsignificant tendency for the pregnancy rate to decrease in association with raised luteal E2. It is concluded that excessive E2 levels at the time of ovulation induction with hCG had an adverse effect on implantation when one or two embryos are transferred, but this may be overcome by the transfer of three embryos. The consequences for embryo transfer are discussed.
Language of Publication
English
Unique Identifier
88083714

Order full text for this document


MeSH Heading (Major)
Embryo Transfer|*; Estradiol|*BL; Ovum Implantation|*
MeSH Heading
Female; Fertilization in Vitro; Human; Luteal Phase; Menstrual Cycle; Progesterone|BL

Publication Type
JOURNAL ARTICLE
ISSN
0015-0282
Country of Publication
UNITED STATES


Record 97 from database: MEDLINE
Order full text for this document

Title
Hyperstimulation: the need for cryopreservation of embryos.
Author
Van den Abbeel E; Van der Elst J; Van Waesberghe L; Camus M; Devroey P; Khan I; Smitz J; Staessen C; Wisanto A; Van Steirteghem A
Address
Centre for Reproductive Medicine, Academic Hospital and Medical School, Vrije Universiteit Brussel, Belgium.
Source
Hum Reprod, 1988 Oct, 3 Suppl 2:, 53-7
Abstract
Successful application of in-vitro fertilization (IVF), zygote intra-Fallopian transfer (ZIFT) and gamete intra-Fallopian transfer (GIFT) requires ovarian hyperstimulation for the maturation of multiple follicles. To control the risk of multiple pregnancies, the number of gametes (GIFT) or embryos (IVF, ZIFT) replaced is limited to three. For the supernumerary embryos resulting from IVF, ZIFT or GIFT, the strategy is cryopreservation for a later transfer. Cryopreservation was performed using either dimethylsulphoxide or 1,2-propanediol as a cryoprotective agent. Embryos were frozen either in the pronucleate stage with 1,2-propanediol or in the multicellular stage with dimethylsulphoxide or 1,2-propanediol. Survival after thawing was scored for both cryoprotective agents as a function of the developmental stage of the embryo and the embryonic quality. Evaluation of survival after thawing was performed on the basis of morphological intactness of the 1-cell pronucleate embryo or of the blastomeres of multicellular embryos. For pronucleate stage embryos, the use of 1,2-propanediol resulted in a 60% survival after thawing. For 2-cell stage embryos the survival was similar for dimethylsulphoxide and 1,2-propanediol. Later stage embryos survived better when dimethylsulphoxide was the cryoprotectant. For all stages, embryo quality before freezing was a crucial factor in survival after thawing. The pregnancy rate (12.2%) was similar for the two cryopreservation protocols. In conclusion, the choice of an appropriate cryoprotective agent can increase the survival after thawing when embryos are of good quality before freezing.
Language of Publication
English
Unique Identifier
89155720

Order full text for this document


MeSH Heading (Major)
Cryoprotective Agents|*; Dimethyl Sulfoxide|*; Embryo|*; Embryo Transfer|*; Fertilization in Vitro|*MT; Preservation, Biological|*MT; Propylene Glycols|*
MeSH Heading
Female; Freezing; Human; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0268-1161
Country of Publication
ENGLAND


Record 98 from database: MEDLINE
Order full text for this document

Title
The nutrient factor queuine: biosynthesis, occurrence in transfer RNA and function.
Author
Kersten H
Address
Department of Biochemistry, University of Erlangen-NÂurnberg, Fahrstrasse, FRG.
Source
Biofactors, 1988 Jan, 1:1, 27-9
Abstract
Queuine, 7-(( (4,5-cis-dihydroxy-2-cyclopenten-1-yl)-amino]-methyl)-7-deazagu ani ne is synthesized de novo only in eubacteria and is preseent in place of guanine 34 in specific tRNAs containing anticodones GUN where N is one of the four canonical nucleotides. The biosynthetic pathway starting with GTP shares common steps with that of pteridines and riboflavin, and involves iron ions and a 'vitamin B12' coenzyme. Lower and higher eukaryotes are supplied with queuine by nutrition or the intestinal flora. The modification of tRNA with queuine is tissue specific and depends on the metabolic state of cells and tissues. Starvation for queuine and/or Q-deficiency in tRNA causes a few specific changes in the pattern of protein synthesis involving lactate dehydrogenases and cytochromes.
Language of Publication
English
Unique Identifier
89351483

Order full text for this document


MeSH Heading (Major)
Guanine|*AA/BI/ME; RNA, Transfer|*GE/ME
MeSH Heading
Animal; Anticodon|GE; Base Sequence

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0951-6433
Country of Publication
ENGLAND


Record 99 from database: MEDLINE
Order full text for this document

Title
Codon choice and gene expression: synonymous codons differ in their ability to direct aminoacylated-transfer RNA binding to ribosomes in vitro.
Author
Thomas LK; Dix DB; Thompson RC
Address
Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder 80309.
Source
Proc Natl Acad Sci U S A, 1988 Jun, 85:12, 4242-6
Abstract
Phe-tRNA (anticodon GAA)--polypeptide-chain elongation factor Tu-GTP ternary complexes react faster with ribosomes programmed with UUC codons than with ribosomes programmed with UUU codons. A similar preference is shown by Leu-tRNA2 (anticodon GAG) complexes, which react faster with ribosomes programmed with CUC than with those programmed with CUU. The difference is seen in the rate of ternary-complex binding to the ribosome; no differences are seen in peptide-bond formation. Highly expressed mRNAs in Escherichia coli favor codons terminating in cytosine rather than uracil when both codons are read by a single tRNA with an anticodon beginning with guanine. The results suggest that intrinsic differences between the efficiencies of synonymous codons play an important role in modulating gene expression in E. coli.
Language of Publication
English
Unique Identifier
88247998

Order full text for this document


MeSH Heading (Major)
Codon|*; Escherichia coli|*GE/ME; Ribosomes|*ME; RNA, Messenger|*; RNA, Transfer, Amino Acyl|GE/*ME; Transcription, Genetic|*
MeSH Heading
Base Sequence; Guanosine Triphosphate|ME; Kinetics; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0027-8424
Country of Publication
UNITED STATES


Record 100 from database: MEDLINE
Order full text for this document

Title
Dependence of instantaneous transfer function on regional ischemic myocardial volume.
Author
Hashiguchi R; Koiwa Y; Ohyama T; Takagi T; Kikuchi J; Butler JP; Takishima T
Address
First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Source
Circ Res, 1988 Dec, 63:6, 1003-11
Abstract
To obtain the instantaneous left ventricular transfer function curve (instantaneous TFC) under conditions of regional ischemia, sinusoidal accelerations ranging from 30 to 150 Hz were applied to a small area of the epicardium of cross-circulated isovolumic canine left ventricle, and the contralateral acceleration was measured under control and during regional coronary occlusion (n = 11). The TFC is the ratio of the output to input acceleration amplitudes. The instantaneous TFC was characterized as a single-peaked configuration under control coronary perfusion. However, TFCs progressively changed from a single-peaked to a double-peaked configuration during regional ischemia. To quantify this change in instantaneous TFC, we defined an index D as the mean squared difference of TFC during ischemia from TFC during control. Index D was linearly related to the percent mass of the ischemic region at 40 minutes after onset of ischemia. We conclude that 1) transfer function curves are sensitive measures of myocardial heterogeneity and 2) the fractional ischemic weight of the ventricle is a major factor in determination of the deformation in instantaneous TFC at the later stages of regional ischemia.
Language of Publication
English
Unique Identifier
89063654

Order full text for this document


MeSH Heading (Major)
Coronary Disease|*PP/TH; Heart|*PP
MeSH Heading
Animal; Cardiology|IS; Dogs; Electrophysiology; Energy Transfer; Fourier Analysis; Myocardial Reperfusion; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0009-7330
Country of Publication
UNITED STATES


Record 101 from database: MEDLINE
Order full text for this document

Title
The MgADP-induced decrease of the SH1-SH2 fluorescence resonance energy transfer distance of myosin subfragment 1 occurs in two kinetic steps.
Author
Garland F; Gonsoulin F; Cheung HC
Address
Department of Natural Sciences, University of Michigan-Dearborn 48128.
Source
J Biol Chem, 1988 Aug, 263:24, 11621-3
Abstract
The fluorescence resonance energy transfer distance between 5-[2-[iodoacetyl)amino)ethyl]aminoaphthalene-1-sulfonic acid covalently attached to the SH1 thiol of myosin subfragment 1 as the energy donor and N-(4-dimethylamino-3,5-dinitrophenyl)maleimide attached to SH2 as the energy acceptor has been found to decrease by about 7 A in the presence of MgADP (Dalby, R. E., Weiel, J., and Yount, R. G. (1983) Biochemistry 22, 4696-4706; Cheung, H. C., Gonsoulin, F., and Garland, F. (1985) Biochim. Biophys. Acta 832, 52-62). Fluorescence stopped-flow experiments on the same system have yielded biphasic traces which are resolvable into a fast and slow component, k1 and k2, respectively. Results of experiments in which k1 and k2 were measured as a function of excess ADP concentration showed: 1) a nonlinear dependence of the apparent rate constants on [ADP]; 2) k1 is a factor of 10 faster than k2. These results are consistent with the 3-step mechanism previously proposed for nucleotide binding to myosin S1 (Garland, F., and Cheung, H. C. (1979) Biochemistry 18, 5281-5289). Kinetic experiments in which the anisotropy of the donor was monitored show this quantity to be unchanged over the course of the reaction. The biphasic decrease of donor intensity is assigned to an increase in energy transfer efficiency which, from the above results, is due to a decrease in donor-acceptor distance, occurring in two steps. The fast step is associated with a 4-5-A decrease of the donor-acceptor separation, while the slow step is associated with a further decrease of approximately 2 A.
Language of Publication
English
Unique Identifier
88298826

Order full text for this document


MeSH Heading (Major)
Adenosine Diphosphate|*PD; Magnesium|*PD; Myosin|*; Peptide Fragments|*; Sulfhydryl Compounds|*
MeSH Heading
Animal; Energy Transfer; Kinetics; Maleimides; Naphthalenesulfonates; Rabbits; Spectrometry, Fluorescence; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 102 from database: MEDLINE
Order full text for this document

Title
Retinol-regulated gene expression in human tracheobronchial epithelial cells. Enhanced expression of elongation factor EF-1 alpha.
Author
Ann DK; Wu MM; Huang T; Carlson DM; Wu R
Address
Department of Biochemistry and Biophysics, California Primate Research Center, Davis.
Source
J Biol Chem, 1988 Mar, 263:8, 3546-9
Abstract
Conducting airway epithelial cells requires vitamin A or its synthetic chemicals (retinoids) for their survival and for the expression of normal mucociliary functions. By using molecular cloning, we have shown that one of the effects of retinol on cultured human tracheobronchial epithelial (HTBE) cells is the enhancement (from 2- to 4-fold) of the mRNA encoding the elongation factor EF-1 alpha. Sequence analysis has shown that clone HT7, which was identified by differential hybridization procedures, contained a cDNA insert which encoded a protein closely resembling (81%) elongation factor EF-1 alpha from brine shrimp and completely identical to the published sequence of human elongation factor EF-1 alpha (Brands, H.H.G.M., Maassen, J.A., Van Hemert, F.J., Amons, R., and Moller, W. (1986) Eur. J. Biochem. 155, 167-171). Regions of homology of HT7 to EF-Tu from yeast mitochondria, plant chloroplasts, and Escherichia coli are also evident. A single RNA band at 1700 bases was observed for both untreated and retinol-treated HTBE cells, and for mouse liver and parotid glands when Northern transfer from denaturing agarose gel was probed with a 32P-labeled HT7 insert. An enhanced amino acid incorporation and increased protein content per cell for HTBE cells grown in the presence of retinol were observed. Results presented by these studies indicate that retinol may regulate the transcription of a factor required for translation.
Language of Publication
English
Unique Identifier
88153640

Order full text for this document


MeSH Heading (Major)
Bronchi|*ME; Gene Expression Regulation|*DE; Genes, Structural|*DE; Peptide Elongation Factors|*GE; Trachea|*ME; Transcription, Genetic|*DE; Vitamin A|*PD
MeSH Heading
Amino Acid Sequence; Base Sequence; Cells, Cultured; Cloning, Molecular; Epithelium|ME; Human; Molecular Sequence Data; RNA, Messenger|GE; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 103 from database: MEDLINE
Order full text for this document

Title
A constitutive promoter directs expression of the nerve growth factor receptor gene.
Author
Sehgal A; Patil N; Chao M
Address
Department of Cell Biology and Anatomy, Cornell University Medical College, New York, New York 10021.
Source
Mol Cell Biol, 1988 Aug, 8:8, 3160-7
Abstract
Expression of nerve growth factor receptor is normally restricted to cells derived from the neural crest in a developmentally regulated manner. We analyzed promoter sequences for the human nerve growth factor receptor gene and found that the receptor promoter resembles others which are associated with constitutively expressed genes that have housekeeping and growth-related functions. Unlike these other genes, the initiation of transcription occurred at one major site rather than at multiple sites. The constitutive nature of the nerve growth factor receptor promoter may account for the ability of this gene to be transcribed in a diverse number of heterologous cells after gene transfer. The intron-exon structure of the receptor gene indicated that structural features are precisely divided into discrete domains.
Language of Publication
English
Unique Identifier
89096903

Order full text for this document


MeSH Heading (Major)
Gene Expression Regulation|*; Genes, Structural|*; Nerve Growth Factors|*ME; Promoter Regions (Genetics)|*; Receptors, Cell Surface|*GE
MeSH Heading
Animal; Base Sequence; DNA Restriction Enzymes; Escherichia coli|GE; Human; L Cells (Cell Line)|ME; Mice; Molecular Sequence Data; Nucleotide Mapping; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Transfection

Publication Type
JOURNAL ARTICLE
ISSN
0270-7306
Country of Publication
UNITED STATES


Record 104 from database: MEDLINE
Order full text for this document

Title
Synaptic transfer of rod signals to horizontal and bipolar cells in the retina of the toad (Bufo marinus).
Author
Belgum JH; Copenhagen DR
Address
Department of Ophthalmology, University of California, San Francisco 94143.
Source
J Physiol (Lond), 1988 Feb, 396:, 225-45
Abstract
1. Simultaneous intracellular recordings of responses to light flashes were obtained from rod-horizontal cell and rod-hyperpolarizing bipolar cell pairs in isolated retinae of the toad. The gain and temporal filtering of synaptic transfer were characterized throughout the rods' range of light responses. 2. Paired rod-horizontal cell and rod-bipolar cell responses to dim flashes (less than 0.4 Rh*, where Rh* denotes effective photoisomerizations per rod per flash) exhibited nearly the same time course. Analysis of the onset of the horizontal cell responses revealed a temporal lag equivalent to a single stage of low-pass filtering (tau f = 75-200 ms). No filtering was discerned in the transfer of dim-flash responses from rods to bipolars. On average, horizontal cells were five times as sensitive (mV/Rh*) and hyperpolarizing bipolar cells 10.7 times as sensitive as their paired rods. 3. For brighter flashes, up to 1600 Rh*, the rising and return phases of bipolar responses appeared to be simple scaled versions of the rod responses. The scaling factor was equal to the ratio of flash sensitivities for dim flashes. Rod responses greater than about 2 mV produced a saturation of the bipolar cell response. 4. The return phases of the horizontal cell responses were kinetically similar, scaled versions of the rod responses for rod potentials less than about 5 mV. However, the rising phases lagged significantly behind those of the rod. The effective time constant of the lag increased proportionally with flash intensity. For the brighter flashes, the horizontal cell response peaked as much as a second after the rod response. 5. The linear scaling, minimal temporal filtering and saturation of the bipolar cell responses were satisfactorily reproduced by a model of synaptic transfer that assumed that the rate of transmitter release followed the rod voltage exponentially and that the postsynaptic conductance followed Michaelis-Menten saturation (Falk & Fatt, 1972). 6. The progressively longer lag in the horizontal cell responses to brighter flashes was satisfactorily simulated by a kinetically limited Falk and Fatt model which postulated that the effective electrical time constant of the horizontal cell membrane strongly depended on synaptic or voltage-modulated conductances. 7. Satisfactory model simulations of all postsynaptic responses required that an e-fold change in the release rate of transmitter from the rod be obtained with a 2 mV change in the rod potential.
Language of Publication
English
Unique Identifier
88316697

Order full text for this document


MeSH Heading (Major)
Photoreceptors|*PH; Retina|CY/*PH; Synapses|*PH
MeSH Heading
Action Potentials; Animal; Bufo marinus; Comparative Study; In Vitro; Kinetics; Membrane Potentials; Models, Neurological; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0022-3751
Country of Publication
ENGLAND


Record 105 from database: MEDLINE
Order full text for this document

Title
Bipotential murine hemopoietic cell line (NFS-60) that is responsive to IL-3, GM-CSF, G-CSF, and erythropoietin.
Author
Hara K; Suda T; Suda J; Eguchi M; Ihle JN; Nagata S; Miura Y; Saito M
Address
Division of Hemopoiesis, Jichi Medical School, Tochigi-ken, Japan.
Source
Exp Hematol, 1988 May, 16:4, 256-61
Abstract
NFS-60 cells were previously obtained from leukemia cells that were infected with the Cas-Br-M murine leukemia virus in vivo. We examined the proliferation and differentiation capacity of NFS-60 cells in the presence of native and recombinant (r) interleukin 3 (IL-3), recombinant granulocyte colony-stimulating factor (rG-CSF), recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF), and r-erythropoietin (Ep) using methylcellulose culture methods. This cell line was able to form colonies in response to each hemopoietic factor, but colony formation was rarely seen in their absence. Some populations of NFS-60 cells could differentiate into neutrophils and macrophages in the presence of IL-3 and GM-CSF. Moreover, in the presence of Ep, this cell line formed well-hemoglobinized colonies as well as nonerythroid colonies. In the presence of G-CSF, NFS-60 cells remained in the promyelocytic state. Electron microscopic studies confirmed these morphologies. A single-cell transfer experiment demonstrated that neutrophils, macrophages, and erythroblasts were derived from a single cell. It is concluded that the NFS-60 cell line is a factor-dependent, bipotential hemopoietic cell line.
Language of Publication
English
Unique Identifier
88196253

Order full text for this document


MeSH Heading (Major)
Erythropoietin|*PD; Growth Substances|*PD; Hematopoiesis|*DE; Hematopoietic Stem Cells|PA/*PH
MeSH Heading
Animal; Cell Differentiation|DE; Cell Line; Colony-Forming Units Assay; Colony-Stimulating Factors|PD; Interleukin-3|PD; Leukemia, Experimental|PA; Mice; Micromanipulation; Support, Non-U.S. Gov't; Tumor Cells, Cultured

Publication Type
JOURNAL ARTICLE
ISSN
0301-472X
Country of Publication
UNITED STATES


Record 106 from database: MEDLINE
Order full text for this document

Title
The cell cycle can occur in starfish oocytes and embryos without the production of transferable MPF (maturation-promoting factor).
Author
Picard A; Labbe JC; Doree M
Address
Laboratoire ARAGO, Banyuls sur Mer, France.
Source
Dev Biol, 1988 Jul, 128:1, 129-35
Abstract
All cells undergoing the transition from interphase to metaphase have been postulated to contain a "maturation-promoting factor" (MPF) capable of causing meiotic maturation when injected into immature oocytes. We have shown in an accompanying paper (A. Picard, M. C. Harricane, J. C. Labbe, and M. Doreé, 1988, Dev. Biol. 128, 121-128) that the basic oscillator driving the cell cycle still operates in maturing starfish oocytes and fertilized eggs in the absence of germinal vesicle (GV) material. Under such conditions of enucleation, we now show, however, that MPF activity cannot be detected after hormonal stimulation of prophase-arrested oocytes in Astropecten or after the normal time of second meiotic cleavage in Marthasterias. In contrast, cell cycles occur with the production of transferable MPF activity in embryos from which both pronuclei have been removed after fertilization. Reinjection of the entire contents of a GV after the normal time of second meiotic cleavage restores the ability of cytoplasm to induce meiotic maturation in immature recipient oocytes after transfer. Transduction of the hormonal stimulus at the level of the plasma membrane, stimulation of the phosphorylation of cytoplasmic proteins, and activation of a cycling Ca2+- and cyclic nucleotide-independent histone kinase still occur in the absence of GV material. Since previous studies have demonstrated that the presence of GV material in the recipient oocytes is absolutely required in starfish for the amplification of microinjected MPF (Kishimoto et al., 1981; Picard and Doree, 1984), we propose that some unidentified component of the GV is required, at least after the normal time of second meiotic cleavage in donor oocytes and at any time in recipient oocytes, for the successful transfer of MPF activity in starfish.
Language of Publication
English
Unique Identifier
88255496

Order full text for this document


MeSH Heading (Major)
Cell Cycle|*; Growth Substances|*BI; Oocytes|DE/ME/*UL; Starfish|*CY/EM; Zygote|DE/ME/*UL
MeSH Heading
Adenine|AA/PD; Animal; Cell Nucleus|PH; Cytoplasm|PH; Fertilization; Meiosis|DE; Mitosis; Phosphoproteins|ME; Phosphorylation; Protamine Kinase|ME

Publication Type
JOURNAL ARTICLE
ISSN
0012-1606
Country of Publication
UNITED STATES


Record 107 from database: MEDLINE
Order full text for this document

Title
Retrovirus-mediated gene transfer of beta-nerve growth factor into mouse pituitary line AtT-20.
Author
Wolf D; Richter Landsberg C; Short MP; Cepko C; Breakefield XO
Address
Genetics Department, Harvard Medical School, Boston, MA 02114.
Source
Mol Biol Med, 1988 Feb, 5:1, 43-59
Abstract
Expression of the biologically active beta-subunit of mouse nerve growth factor (beta-NGF) was conferred onto cultured AtT-20 mouse pituitary cells via a replication-defective retroviral vector. The retroviral LTR promoter was used for expression of a cDNA for beta-NGF corresponding to the shorter mRNA species produced by most tissues that receive sympathetic innervation. The vector included the TU5 gene conferring resistance to the neomycin analogue G418 under the control of an SV40 early promoter. AtT-20 cells, which produce essentially no endogenous beta-NGF, were infected and then cloned under G418 selection. Clones were evaluated for release into the medium of biologically active beta-NGF using a bioassay for neurite extension from PC-12 cells. The biological activity was equivalent to 1 to 10 ng of beta-NGF per mg cell protein over 24 hours. Immune precipitation and SDS/polyacrylamide gel electrophoresis of labelled proteins in the medium showed that the major form of immunoreactive beta-NGF secreted from cells comigrated with authentic mature beta-NGF, apparent Mr 13,000. Release of this beta-NGF from cells was stimulated by addition of 1 mM-8-bromocyclic AMP or 10 nM-corticotropin releasing factor, suggesting that at least some of the processed factor is stored in secretory vesicles. These studies, together with those on other cultured cells, which produce beta-NGF and lack secretory granules, e.g. L cells, suggest that the beta-NGF precursor synthesized from the shorter mRNA species can be processed and secreted through either the regulated or constitutive route. This retroviral vector provides a potential means of conferring beta-NGF expression onto a number of different cell types in culture and in vivo.
Language of Publication
English
Unique Identifier
88232271

Order full text for this document


MeSH Heading (Major)
Genes, Structural|*; Nerve Growth Factors|*GE/PD; Retroviridae|*GE; Transfection|*
MeSH Heading
Animal; Cell Line; DNA|GE; DNA Restriction Enzymes; Mice; Pituitary Neoplasms; Promoter Regions (Genetics); Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0735-1313
Country of Publication
ENGLAND


Record 108 from database: MEDLINE
Order full text for this document

Title
T suppressor efferent circuit which affects contact sensitivity to picryl chloride: the late-acting, second nonspecific T suppressor factor bears I-A determinants which are responsible for the I-A genetic restriction in its interaction with its target cell.
Author
Zembala M; Asherson GL; Barlow Y
Address
Division of Clinical Immunology, Copernicus Medical School, Cracow, Poland.
Source
Cell Immunol, 1988 Oct, 116:1, 172-82
Abstract
The T suppressor efferent circuit in the picryl (TNP) system, which inhibits the passive transfer of contact sensitivity, involves at least two antigen-nonspecific factors. The second nonspecific T suppressor factor (ns-2) bears I-A determinants of both the alpha and the beta chain as shown by affinity chromatography on immobilized anti-I-A monoclonal antibodies. Sequential absorption shows that the determinants of the alpha and beta chain occur on the same molecular complex. No absorption was obtained with anti-I-E antibody. There are two genetic restrictions associated with ns-2--the first is in its release from the second T suppressor efferent cell (on exposure to antigen) and the second is in its inhibitory interaction with its target cell. Both are MHC restricted and matching in I-A (but not I-E, or I-J) is sufficient. The question was asked whether the I-A of the ns-2 was directly responsible for the I-A genetic restriction in its action. F1 TsF was made in (H-2k X H-2b)F1 mice by injecting picrylated parental cells intravenously and triggering the release of ns-2 with the corresponding picrylated parental cells. Both I-Ak- and I-Ab-positive ns-2 were produced and were separated by affinity chromatography on immobilized anti-I-A monoclonal antibody. The I-A phenotype of these separated ns-2 of F1 origin determines the genetic restriction in their action; i.e., I-Ak+ ns-2 only inhibits passive transfer by H-2k cells and I-Ab+ ns-2 only acts on H-2b cells. In contrast, the I-A haplotype of the picrylated cell used to induce the Ts cell which makes ns-2 is unimportant. It was concluded that the I-A on the ns-2, and not a possible recognition site for I-A, serves as a restriction element. This finding suggests that ns-2 may act directly on the I-A-restricted T cell which mediates contact sensitivity.
Language of Publication
English
Unique Identifier
89003084

Order full text for this document


MeSH Heading (Major)
Dermatitis, Contact|*IM; Histocompatibility Antigens Class II|*IM; Suppressor Factors, Immunologic|*IM; T-Lymphocytes, Suppressor-Effector|*IM
MeSH Heading
Animal; Cyclophosphamide|PD; Haplotypes; Immune Tolerance|DE; Immunization, Passive; Mice; Picryl Chloride; Spleen|IM; Support, Non-U.S. Gov't; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0008-8749
Country of Publication
UNITED STATES


Record 109 from database: MEDLINE
Order full text for this document

Title
Non-specific regulatory mechanism of contact sensitivity: the requirement of intermediate cells for non-specific suppressor factor (NSF) activity.
Author
Nakano Y
Address
Department of Industrial Health, Osaka Prefectural Institute of Public Health, Japan.
Source
Immunology, 1988 Jun, 64:2, 261-6
Abstract
Non-specific suppressor factor (NSF), which inhibits passive transfer of contact sensitivity (CS), is produced spontaneously from macrophage-like suppressor cells which were induced by intravenous (i.v.) administration of oxazolone (Ox)-conjugated spleen cells. NSF is absorbed with normal spleen cells, and NSF-treated spleen cells acquire the ability to suppress the transfer of the effector cell function of CS non-specifically. In the present study, the events involved in the suppression by NSF were investigated. The involvement of intermediate cells between NSF and effector T cells in the suppression by NSF was suggested by the following observations: (i) NSF was absorbed with plastic-adherent and cyclophosphamide (CY)-sensitive non-T cells present in normal spleen cells; (ii) deletion of plastic adherent and CY-sensitive cells but not of adult thymectomy (ATx)-sensitive cells from the effector cell population, rendered the effector cells resistant to the suppressor activity of NSF; (iii) reconstitution of CY-pretreated effector cell population with Thy-1-negative spleen cells restored the ability of NSF to suppress CY-pretreated effector cells function. On the contrary, reconstitution with Ia-negative spleen cells did not restore the ability of NSF to suppress CY-pretreated effector cells function. Thus, NSF may not suppress directly the effector T-cell function, but intermediate cells, which are possibly macrophage-like cells, may exert a suppressive role after absorbing NSF. Species specificity was observed between the interaction of NSF and intermediate cells. The possible role of the intermediate cells in the suppression circuit of CS by NSF is discussed.
Language of Publication
English
Unique Identifier
88272369

Order full text for this document


MeSH Heading (Major)
Dermatitis, Contact|*IM; Suppressor Factors, Immunologic|*IM
MeSH Heading
Animal; Cell Adhesion; Female; Guinea Pigs; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Plastics; Species Specificity; Spleen|IM; T-Lymphocytes, Suppressor-Effector|IM

Publication Type
JOURNAL ARTICLE
ISSN
0019-2805
Country of Publication
ENGLAND


Record 110 from database: MEDLINE
Order full text for this document

Title
Ovarian stimulation for in-vitro fertilization combining administration of gonadotrophins and blockade of the pituitary with D-Trp6-LHRH microcapsules: pilot studies with two protocols.
Author
Zorn JR; Barata M; Brami C; Epelboin S; Nathan C; Papageorgiou G; Quantin P; Rolet F; Savale M; Boyer P; et al
Address
Centre de FÆecondation in Vitro Baudelocque, St-Vincent-de-Paul et UnitÆe INSERM U 166, Paris, France.
Source
Hum Reprod, 1988 Feb, 3:2, 235-9
Abstract
In women undergoing in-vitro fertilization and embryo transfer (IVF-ET), a total of 408 IVF cycles were stimulated using human menopausal gonadotrophin (HMG) or pure follicle stimulating hormone (FSH) plus HMG in combination with a single injection of D-Trp6-LHRH microcapsules in order to enhance the ovarian response to gonadotrophins and to avoid spontaneous LH surges. Sixty-seven pregnancies were achieved. Two protocols were employed. In protocol 1 ('blocking protocol', n = 268), the pituitary was first inhibited with a full dose (3.75 mg) of D-Trp6-LHRH in microcapsules and ovarian stimulation was started after the hypogonadotrophic hypogonadal state was ascertained (E2 less than 50 pg/ml). In protocol 2 ('flare-up protocol', n = 140), the treatment with D-Trp6-LHRH microcapsules (half-dose = 1.80 mg) and the ovarian stimulation with gonadotrophins were started at the same time. Higher doses of gonadotrophins were needed (39.5 +/- 11.2 ampoules FSH and/or HMG) in protocol 1, in which the pituitary was blocked prior to and during the stimulation, than in protocol 2 (20 +/- 9 ampoules) where the exogenous gonadotrophin stimulation appeared to be augmented by the initial agonistic effect of the injection of D-Trp6-LHRH microcapsules. In patients with purely tubal infertility, under 38 years old and no male factor, the results obtained with protocols 1 and 2 were similar in terms of pregnancy rate per cycle or per embryo transfer: 22.6 versus 20.5% and 28.3 versus 27.4%, respectively. However, considering the cost benefit, 'flare-up' protocols appeared to be a better choice and could be recommended.
Language of Publication
English
Unique Identifier
88187055

Order full text for this document


MeSH Heading (Major)
Fertilization in Vitro|*; Gonadorelin|*AA/AD/PD; Gonadotropins|*TU; Ovulation Induction|*MT; Pituitary Gland|*DE
MeSH Heading
Adult; Capsules; Embryo Transfer; Female; Human; Injections, Intramuscular; Pilot Projects

Publication Type
JOURNAL ARTICLE
ISSN
0268-1161
Country of Publication
ENGLAND


Record 111 from database: MEDLINE
Order full text for this document

Title
Establishment and characterization of factor-dependent macrophage cell lines.
Author
Ohki K; Nagayama A
Address
Department of Microbiology, Saga Medical School, Japan.
Source
J Leukoc Biol, 1988 Dec, 44:6, 465-73
Abstract
Three macrophage cell lines from bone marrow cells of C3H/HeN mice were isolated by successive transfer of the cells in culture with L-cell-conditioned medium (LCM) or WEHI-3 cell-conditioned medium (WEHI-3CM). These cell lines, which express Fc receptors, are involved in Fc-mediated phagocytosis and possess nonspecific esterase activity. Two (BDM-1 and BDM-2) of three cell lines show dependency for growth on either macrophage colony-stimulating factor (M-CSF) (CSF-1) or granulocyte-macrophage colony-stimulating factor (GM-CSF) and do not respond to interleukin 3 (IL-3). The third clone (BDM-3) proliferates in response to IL-3 as well as to GM-CSF and weakly responds to M-CSF and to interleukin 4 (IL-4). GM-CSF, in combination with the suboptimal concentration of M-CSF, acted synergistically on the proliferation of BDM-1 cells. The tumor-promoting phorbol diester, 12-o-tetradecanoyl-phorbol-13-acetate (TPA) also acted synergistically with the three CSFs (IL-3, GM-CSF, and M-CSF) to stimulate the proliferation of BDM-1 cells. The synergistic effect was observed when cells were pretreated with TPA and subsequently stimulated with IL-3. The calcium ionophore A23187 enhanced the proliferation of BDM-1 cells costimulated with TPA and IL-3. These factor-dependent macrophage cell lines should be useful for studying signal transduction mechanisms in the regulation of cell growth.
Language of Publication
English
Unique Identifier
89055022

Order full text for this document


MeSH Heading (Major)
Colony-Stimulating Factors|*PD; Macrophages|*CY/DE
MeSH Heading
Animal; Calcimycin|PD; Cell Division|DE; Cell Line; Culture Media; Drug Synergism; Interleukin-3|PD; Mice; Tetradecanoylphorbol Acetate|PD

Publication Type
JOURNAL ARTICLE
ISSN
0741-5400
Country of Publication
UNITED STATES


Record 112 from database: MEDLINE
Order full text for this document

Title
Cell-free synthesis of deoxyhypusine. Separation of protein substrate and enzyme and identification of 1,3-diaminopropane as a product of spermidine cleavage.
Author
Park MH; Wolff EC
Address
Laboratory of Cellular Development and Oncology, National Institute of Dental Research, Bethesda, Maryland 20892.
Source
J Biol Chem, 1988 Oct, 263:30, 15264-9
Abstract
The post-translational formation of hypusine (N epsilon-(4-amino-2-hydroxybutyl)lysine) occurs in a precursor of eukaryotic initiation factor 4D by way of two major steps: 1) transfer of the 4-aminobutyl moiety from spermidine to the epsilon-amino group of a specific lysine residue to form an intermediate, deoxyhypusine; 2) hydroxylation of the deoxyhypusine residue to form hypusine. The initial step of this modification, deoxyhypusine synthesis, was studied in fractionated lysates of Chinese hamster ovary cells, untreated, or treated with alpha-difluoromethylornithine (DFMO); the enzyme(s) and the protein substrate (eukaryotic initiation factor 4D precursor) were separated. The enzyme activity was found in the 0-45% ammonium sulfate fraction from both untreated and DFMO-treated cells. The protein substrate was detected in the 45-75% ammonium sulfate fraction from cells depleted of spermidine by treatment with DFMO, but not in any fraction from untreated cells. Upon further purification of the protein substrate by ion exchange chromatography, the requirement for a pyridine nucleotide, notably NAD+, became apparent. Free 1,3-diaminopropane was identified as a spermidine cleavage product formed concurrently with the 4-aminobutyl transfer step of deoxyhypusine synthesis. Compounds structurally related to spermidine, e.g. caldine, N4-benzylspermidine, homospermidine, and a spermine homologue, thermine, as well as 1,7-diaminoheptane, 1,8-diaminooctane, and 1,9-diaminononane caused significant inhibition of deoxyhypusine synthesis presumably due to competition with spermidine. 1,3-Diaminopropane exhibited a potent inhibition of deoxyhypusine formation, probably through a different mechanism.
Language of Publication
English
Unique Identifier
89008419

Order full text for this document


MeSH Heading (Major)
Diamines|*AN; Lysine|*AA/BI; Spermidine|*ME
MeSH Heading
Animal; Cell Line; Cell-Free System; Chromatography, Ion Exchange; Eflornithine|ME; Hamsters; NAD|ME; Peptide Initiation Factors|ME

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 113 from database: MEDLINE
Order full text for this document

Title
Determinants of immunity to murine salmonellosis: studies involving immunization with lipopolysaccharide-lipid A-associated protein complexes in C3H/HeJ mice.
Author
Killion JW; Morrison DC
Address
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.
Source
FEMS Microbiol Immunol, 1988 Jan, 1:1, 41-53
Abstract
We have earlier demonstrated that the C3H/HeJ Salmonella hypersusceptible mouse can be protected against infection with this organism by prior immunization with lipopolysaccharide (LPS)-lipid A-associated protein (LAP) complexes, but not with LPS alone. In the current studies, protection has been shown to correlate with the induction of LPS-specific antibody in immunized mice. LPS was demonstrated to be a relevant target antigen for Salmonella immunity since C3H/HeJ mice were afforded higher survival rates when they were challenged with Salmonella that shared the same LPS O-antigen as the vaccine. Although low levels of LPS-specific antibody can be detected 14 days after immunization with LAP-LPS, significant antibody is present only after 21-28 days. In addition, anti-LAP specific antibodies can be detected after 14 days of immunization with LAP-LPS. Adoptive transfer of either day 28 anti-LAP-LPS immune serum or day 28 LAP-LPS immune splenocytes alone to naive recipients affords mice minimal, if any, survival against lethal S. typhimurium LT2 challenge. In contrast, transfer of day 28 anti-LAP-LPS immune serum and day 28 LAP-LPS immune splenocytes together is able to transfer Salmonella immunity to naive C3H/HeJ mice. Further, equivalent transfer of only day 28 anti-LAP-LPS immune serum to C3H/HeJ mice immunized 7 days previously with LAP-LPS provides protection similar to that found in mice adoptively transferred with immune cells and serum. These results suggest that a host cellular factor or factors responsive to LAP-LPS, in addition to day 28 anti-LAP-LPS immune serum, may contribute to the protection afforded C3H/HeJ mice following immunization with LAP-LPS.
Language of Publication
English
Unique Identifier
90180992

Order full text for this document


MeSH Heading (Major)
Lipid A|*IM; Lipopolysaccharides|*IM; Salmonella Infections, Animal|*IM
MeSH Heading
Animal; IgG|AN; IgM|AN; Immunity, Cellular; Immunization; Immunization, Passive; Macrophages|IM; Mice; Mice, Inbred C3H; Spleen|IM; Support, U.S. Gov't, P.H.S.; T-Lymphocytes|IM

Publication Type
JOURNAL ARTICLE
ISSN
0920-8534
Country of Publication
NETHERLANDS


Record 114 from database: MEDLINE
Order full text for this document

Title
Success rate in gamete intrafallopian transfer using low and high concentrations of washed spermatozoa.
Author
Khan I; Camus M; Staessen C; Wisanto A; Devroey P; Van Steirteghem AC
Address
Center for Reproductive Medicine, Vrije Universiteit Brussel, Belgium.
Source
Fertil Steril, 1988 Dec, 50:6, 922-7
Abstract
The effect of a reduced number of spermatozoa on pregnancies and miscarriages was studied retrospectively in 307 consecutive gamete intrafallopian transfer (GIFT) cycles. The number of spermatozoa introduced per GIFT in each group was as follows: 100,000 (group I), 50,000 (group II), 10,000 (group III), 5,000 (group IV), and 2,500 (group V), which gave a pregnancy rate of 20%, 38%, 37%, 30%, and 24%, respectively (differences were not significant). With respect to the pregnancies, no correlation was found between the number of spermatozoa transferred and the cause of infertility. In the male factor group also no significant difference was observed in the pregnancy rate when the sperms were reduced from 100,000 to 2,500. Lowering the number of sperms in GIFT did not reduce the abortion rate, which remained around 33%. It was the patients with unexplained infertility who benefited most from the GIFT procedure. Their pregnancy rate was significantly higher than the pregnancy rate of those who had endometriosis, or andrologic or immunologic disorders.
Language of Publication
English
Unique Identifier
89078646

Order full text for this document


MeSH Heading (Major)
Gamete Intrafallopian Transfer|*; Spermatozoa|*PH
MeSH Heading
Adult; Female; Human; Male; Maternal Age; Pregnancy; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0015-0282
Country of Publication
UNITED STATES


Record 115 from database: MEDLINE
Order full text for this document

Title
Variability of the single-breath carbon monoxide transfer factor as a function of inspired oxygen pressure.
Author
Crapo RO; Kanner RE; Jensen RL; Elliott CG
Address
Division of Respiratory, Critical Care and Occupational Medicine, LDS Hospital, Salt Lake City, Utah 84143.
Source
Eur Respir J, 1988 Jun, 1:6, 573-4
Abstract
We measured single-breath CO transfer factor (TLCO) and alveolar oxygen partial pressure (PAO2) six times at each of three fractions of inspired oxygen (FIO2) (0.17, 0.21, 0.26) in twelve healthy subjects, to determine whether one FIO2 would have the advantage of producing less variable TLCO results than the others. Measured TLCO was adjusted for the increase in carboxyhaemoglobin during the tests. We found no significant differences in intra- or interindividual variance as a function of test FIO2.
Language of Publication
English
Unique Identifier
89005593

Order full text for this document


MeSH Heading (Major)
Carbon Monoxide|*; Pulmonary Diffusing Capacity|*
MeSH Heading
Human; Partial Pressure; Respiratory Function Tests|ST

Publication Type
JOURNAL ARTICLE
ISSN
0903-1936
Country of Publication
DENMARK


Record 116 from database: MEDLINE
Order full text for this document

Title
Tolerance in rats by transplacental transfer of Dipetalonema viteae microfilariae: recognition of putative tolerogen(s) by antibodies that inhibit antigen-specific lymphocyte proliferation.
Author
Haque A; Cuna W; Pestel J; Capron A; Bonnel B
Address
Centre d'Immunologie et de Biologie Parasitaire, Institut Pasteur, Lille, France.
Source
Eur J Immunol, 1988 Aug, 18:8, 1167-72
Abstract
We have previously reported (Nature 1982. 299:361) that the transplacental transfer of Dipetalonema viteae microfilariae (mf) can induce an antigen-specific tolerance in rats. Rats thus tolerized have serum factor(s) which block(s) antigen-specific lymphocyte proliferation. The results of experiments involving fractionation of antisera from tolerant animals indicate that the inhibitory activity for antigen-specific blastogenesis resides in IgG antibodies. Absorption of IgG (eluted from protein A) with specific filarial antigens reduced the inhibition from 58% to 9% whereas a similar immunosorption of IgG size fraction (obtained by applying to AcA 34 Ultrogel) resulted in a decrease from 72% to 35%. This suggests that IgG size fraction might include factor(s) derived from mf and was partially blocking the blastogenic response. Since the tolerant animals harbor only mf, we have used radiolabeled mf surface antigens for immunoprecipitation by antisera from tolerant animals. Antibodies from tolerant animals have a different specificity for filarial antigens compared to those from immunocompetent and mf-resistant rats.
Language of Publication
English
Unique Identifier
88329163

Order full text for this document


MeSH Heading (Major)
Antigens, Helminth|*IM; Dipetalonema|*IM; Dipetalonema Infections|*IM; Filariasis|*IM; Immune Tolerance|*; Lymphocyte Transformation|*
MeSH Heading
Animal; Antibodies, Helminth|IM; Antigens, Surface|IM; IgG|IM; Rats; Rats, Inbred Strains; Support, Non-U.S. Gov't; Suppressor Factors, Immunologic|IM

Publication Type
JOURNAL ARTICLE
ISSN
0014-2980
Country of Publication
GERMANY, WEST


Record 117 from database: MEDLINE
Order full text for this document

Title
Transformation of single myeloid precursor cells by the malignant histiocytosis sarcoma virus (MHSV): generation of growth-factor-independent myeloid colonies and permanent cell lines.
Author
Klingler K; Johnson GR; Nicola NA; Arman G; Kluge N; Ostertag W
Address
Heinrich-Pette-Institut fÂur Experimentelle Virologie und Immunologie, UniversitÂat Hamburg, Federal Republic of Germany.
Source
J Cell Physiol, 1988 Apr, 135:1, 32-8
Abstract
Direct single-cell assays for oncogenic transformation are available for fibroblasts but not for other cell types. Using malignant histiocytosis sarcoma virus (MHSV), a member of the ras family of retroviruses, in vivo-infected granulocyte/macrophage and macrophage precursor cells lost the requirement for externally added hematopoietic growth factors. Factor-independent growth was demonstrated by colony-transfer experiments. More than 25% of the independent colonies were established as permanent macrophage cell lines following a phase of adaptation to tissue culture conditions. Factor-independent colony growth was also obtained by in vitro infection of single cells. As many as 50% of all myeloid precursor cells were target cells for MHSV as measured by this assay. About 2 x 10(-3) of these colony-forming cells acquired growth factor independence and immortality after in vitro infection. Cell lines derived from these colonies did not require adaptation to tissue culture conditions.
Language of Publication
English
Unique Identifier
88213445

Order full text for this document


MeSH Heading (Major)
Cell Transformation, Neoplastic|*; Hematopoietic Stem Cells|*CY/DE; Retroviridae|*GE
MeSH Heading
Animal; Bone Marrow|CY; Cell Line; Cell Line, Transformed; Fluorouracil|PD; Growth Substances|PD; Helper Viruses|GE; Mice; Mice, Inbred Strains; Spleen|CY; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0021-9541
Country of Publication
UNITED STATES


Record 118 from database: MEDLINE
Order full text for this document

Title
Interaction of tRNA transcription factors with satellite I DNA from Xenopus laevis.
Author
Engelke DR
Address
Department of Biological Chemistry, University of Michigan, Ann Arbor 48109.
Source
Gene, 1988, 62:2, 323-30
Abstract
A cloned repeat of Xenopus laevis satellite I DNA was tested for the ability to form stable complexes with tRNA transcription factors in vitro. In template exclusion studies, the satellite I DNA competed efficiently with a tRNA gene for binding of yeast RNA polymerase III transcription factors. DNase I footprinting further showed that transcription factor TF IIIC alone bound to satellite I DNA at both the A block and B block consensus promoter sequences immediately downstream from the transcription start point. The strength and position of these associations indicate that satellite I DNA is a potential site for association of the same DNA-binding proteins that activate tRNA gene transcription.
Language of Publication
English
Unique Identifier
88212187

Order full text for this document


MeSH Heading (Major)
DNA, Satellite|*ME; RNA, Transfer|BI/*GE; Transcription Factors|*ME; Xenopus laevis|*GE
MeSH Heading
Animal; Base Sequence; Binding, Competitive; Molecular Sequence Data; Promoter Regions (Genetics); RNA Polymerase III|ME; RNA Precursors|BI; Support, U.S. Gov't, Non-P.H.S.; Transcription, Genetic

Publication Type
JOURNAL ARTICLE
ISSN
0378-1119
Country of Publication
NETHERLANDS


Record 119 from database: MEDLINE
Order full text for this document

Title
The human growth hormone gene contains both positive and negative control elements.
Author
Peritz LN; Fodor EJ; Silversides DW; Cattini PA; Baxter JD; Eberhardt NL
Address
Metabolic Research Unit, University of California, San Francisco 94143.
Source
J Biol Chem, 1988 Apr, 263:11, 5005-7
Abstract
A subset of DNA sequences in the 5'-flanking DNA of the human growth hormone (hGH) gene was examined by protein-DNA binding and gene transfer-expression experiments. Two adjacent cis-acting elements (I and II) were identified between nucleotides -308/-235 of the hGH gene that modulated the expression of a linked reporter gene in transfected HeLa cells. Elements I and II repressed gene expression whereas element II alone activated it. HeLa whole cell extracts contain two factors that bind hGH DNA carrying elements I and II. Factor I binds to single-stranded DNA, and its binding is correlated with repression of gene expression. Factor II binds between nucleotides -275/-257 of the hGH gene. This region is homologous to the binding site for the adenovirus major late transcription factor, and factor II binding to hGH DNA is competed by adenovirus major late promoter DNA, indicating that the hGH and major late adenovirus promoters share a transcription regulatory element.
Language of Publication
English
Unique Identifier
88186775

Order full text for this document


MeSH Heading (Major)
DNA|*AN; Somatotropin|*GE
MeSH Heading
Animal; Base Sequence; Binding Sites; Deoxyribonuclease I|ME; DNA-Binding Proteins|AN; Gene Expression Regulation; Hela Cells|AN; Human; Pituitary Gland, Anterior|AN; Rats; Support, U.S. Gov't, P.H.S.; Transcription, Genetic; Transfection; Tumor Cells, Cultured|AN

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES


Record 120 from database: MEDLINE
Order full text for this document

Title
The analgesic defect of C57BL/6J-bgJ/bgJ (beige-J: Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermates.
Author
Raffa RB; Kimball ES; Mathiasen JR
Address
Department of Biological Research, Janssen Research Foundation, Spring House, PA 19477-0776.
Source
Life Sci, 1988, 42:12, 1231-6
Abstract
We recently discovered and reported that C57BL/6J-bgJ/bgJ (beige-J) mice have a deficiency in their analgesic response to intracerebroventricularly-administered morphine in the tail-flick test. Postulating a link between these findings and the known immunological defect of beige-J mice (Chediak-Higashi syndrome), we examined the effect of splenectomy on beige-J mice and the adoptive transfer of their mononuclear spleen cells to normal littermate controls (2 x 10(7) cells via tail vein). Eight days after these interventions, the splenectomized beige-J mice responded nearly as well as normal mice to centrally administered morphine in the tail-flick test. The adoptive transfer recipients, in contrast, nearly completely lost their response to the analgesic action of morphine in this test. From the combined results, the spleen appears to be a significant factor in the analgesic defect of beige-J mice and, furthermore, mononuclear splenocytes appear to be the source of a substance that can transfer this defect to otherwise normal animals.
Language of Publication
English
Unique Identifier
88156591

Order full text for this document


MeSH Heading (Major)
Analgesia|*; Chediak-Higashi Syndrome|*GE; Morphine|AD/*PD; Spleen|*TR
MeSH Heading
Animal; Brain|DE/PP; Immunization, Passive; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Species Specificity; Splenectomy

Publication Type
JOURNAL ARTICLE
ISSN
0024-3205
Country of Publication
ENGLAND


Record 121 from database: MEDLINE
Order full text for this document

Title
Glutathione reductase: solvent equilibrium and kinetic isotope effects.
Author
Wong KK; Vanoni MA; Blanchard JS
Address
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461.
Source
Biochemistry, 1988 Sep, 27:18, 7091-6
Abstract
Glutathione reductase catalyzes the NADPH-dependent reduction of oxidized glutathione (GSSG). The kinetic mechanism is ping-pong, and we have investigated the rate-limiting nature of proton-transfer steps in the reactions catalyzed by the spinach, yeast, and human erythrocyte glutathione reductases using a combination of alternate substrate and solvent kinetic isotope effects. With NADPH or GSSG as the variable substrate, at a fixed, saturating concentration of the other substrate, solvent kinetic isotope effects were observed on V but not V/K. Plots of Vm vs mole fraction of D2O (proton inventories) were linear in both cases for the yeast, spinach, and human erythrocyte enzymes. When solvent kinetic isotope effect studies were performed with DTNB instead of GSSG as an alternate substrate, a solvent kinetic isotope effect of 1.0 was observed. Solvent kinetic isotope effect measurements were also performed on the asymmetric disulfides GSSNB and GSSNP by using human erythrocyte glutathione reductase. The Km values for GSSNB and GSSNP were 70 microM and 13 microM, respectively, and V values were 62 and 57% of the one calculated for GSSG, respectively. Both of these substrates yield solvent kinetic isotope effects greater than 1.0 on both V and V/K and linear proton inventories, indicating that a single proton-transfer step is still rate limiting. These data are discussed in relationship to the chemical mechanism of GSSG reduction and the identity of the proton-transfer step whose rate is sensitive to solvent isotopic composition. Finally, the solvent equilibrium isotope effect measured with yeast glutathione reductase is 4.98, which allows us to calculate a fractionation factor for the thiol moiety of GSH of 0.456.
Language of Publication
English
Unique Identifier
89062446

Order full text for this document


MeSH Heading (Major)
Glutathione Reductase|*ME
MeSH Heading
Glutathione|AA; Human; Hydrogen-Ion Concentration; In Vitro; Kinetics; NADP; Protons; Solvents; Substrate Specificity; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-2960
Country of Publication
UNITED STATES


Record 122 from database: MEDLINE
Order full text for this document

Title
Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo.
Author
Tsubura A; Inaba M; Imai S; Murakami A; Oyaizu N; Yasumizu R; Ohnishi Y; Tanaka H; Morii S; Ikehara S
Address
Department of Pathology, Kansai Medical University, Osaka, Japan.
Source
Cancer Res, 1988 Nov, 48:22, 6555-9
Abstract
Using BALB/c nu/nu, BALB/c nu/nufC3H (BALB/c nu/nu mice raised by C3H/HeN foster mother), BALB/c thymus-engrafted BALB/c nu/nufC3H, BALB/c nu/+, and BALB/c nu/+fC3H mice, we examined what kinds of cells are carriers of blood-borne mouse mammary tumor virus (B-MMTV). A radioimmunoassay and an immunoperoxidase assay revealed the presence of MMTV-gp52 antigen in the mammary glands of all BALB/c nu/+fC3H and BALB/c thymus-engrafted BALB/c nu/nufC3H mice (more than 60 days old) but only of some BALB/c nu/nufC3H mice (more than 120 days old): those that possessed a significant number of functional T-cells. BALB/c nu/+ mice did not show the antigen expression at any age. Transfer experiments of cells or plasma from young (less than 12 weeks) BALB/c nu/nufC3H to BALB/c +/+ virgins revealed that cells besides T-cells can also become carriers of B-MMTV. This was confirmed by Southern blotting analyses; exogenous provirus DNA sequences were found in B-cells as well as T-cells of BALB/c nu/+fC3H mice. However, when young BALB/c nu/nu mice were inoculated with BALB/c nu/nufC3H blood, they did not show the MMTV-gp52 antigen expression. Transfer experiments of purified T-cells, B-cells, natural killer cells, and macrophages from BALB/c fC3H mice to BALB/c nu/nu mice revealed that only T-cells have the ability to transfer viral activity to the mammary glands. These results suggest that B-MMTV is carried from the gastrointestinal tract to the mammary glands by lymphoid cells such as T-cells and B-cells, then transferred to the mammary gland cells by the T-cells.
Language of Publication
English
Unique Identifier
89028309

Order full text for this document


MeSH Heading (Major)
Mammae|*MI; Mammary Tumor Viruses, Mouse|*PH; T-Lymphocytes|*PH
MeSH Heading
Age Factors; Animal; Antigens, Viral|AN; Biological Transport; Blotting, Southern; DNA, Viral|AN; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0008-5472
Country of Publication
UNITED STATES


Record 123 from database: MEDLINE
Order full text for this document

Title
Mechanisms of immunologic unresponsiveness induced by ultraviolet-irradiated donor-specific blood transfusions and peritransplant cyclosporine.
Author
Oluwole SF; Chabot J; Pepino P; Reemtsma K; Hardy MA
Address
Department of Surgery, Columbia University College of Physicians & Surgeons, New York, New York 10032.
Source
Transplantation, 1988 Sep, 46:3, 352-8
Abstract
Recipient pretreatment with UV-B irradiated donor-specific blood transfusions (UV-DST) combined with peritransplant cyclosporine on days 0, +1, and +2 leads to permanent cardiac allograft survival in the ACI-to-Lewis rat strain combination. This study investigates the mechanisms of immunologic unresponsiveness induced by UV-DST and CsA by examining several in vitro and in vivo parameters in long-term cardiac allograft recipients. The results of the in vitro studies demonstrate that thoracic duct lymphocytes (TDL) of treated and allografted Lewis rats respond less in a mixed lymphocyte reaction to donor splenic lymphocytes (SpL) by 69%, 75%, and 73% (P less than 0.001) at 30, 50, and 100 days after transplantation, respectively, compared with controls, while the response to a third-party (W/F) SpL is unimpaired. In coculture experiments, the TDL from treated recipients specifically suppressed the response of unmodified Lewis TDL to ACI SpL by 59% and 40% (P less than 0.01) at 30 and 50 days after transplantation, respectively, while responses to W/F SpL were suppressed by only 3-6%. The sera obtained from ungrafted rats transfused with UV-DST suppressed the MLR between unmodified Lewis TDL and ACI SpL by 31% (P less than 0.05) while the sera from UV-DST and CsA-treated and allografted rats specifically suppressed the MLR by 75%, 80% (P less than 0.001) and 37% (P less than 0.01) at 10, 30, and 50 days after transplantation, respectively. In vivo adoptive transfer of 10(4) donor-type dendritic cells (DC) into recipients of beating cardiac allografts at 40 or 60 days after transplantation led to rapid and acute allograft rejection, while the adoptive transfer of 10(8) unseparated SpL obtained at 50 days after transplantation from treated Lewis recipients to syngeneic naive hosts led to a modest but significant prolongation of ACI test cardiac allografts. The transfer of serum from treated and allografted recipients at 10, 30, and 50 days after transplantation led to specific and significant prolongation of test grafts in syngeneic naive hosts. These findings suggest that the mechanisms underlying the in vivo immunologic unresponsiveness induced by pretreatment with UV-DST and peritransplant CsA include inactivation without elimination of class II-antigen presenting cells (APC), generation of specific serum suppressor factor(s) and/or antiidiotypic antibody, and induction of donor-specific suppressor cells.
Language of Publication
English
Unique Identifier
88337354

Order full text for this document


MeSH Heading (Major)
Blood Transfusion|*; Cyclosporins|*TU; Immunosuppression|*MT
MeSH Heading
Animal; Blood|RE; Dendritic Cells|IM; Graft Survival; Heart|TR; Heart Transplantation; Immunization, Passive; Lymphocyte Culture Test, Mixed; Lymphocyte Transformation; Rats; Rats, Inbred Strains; Spleen|IM; Support, U.S. Gov't, P.H.S.; Suppressor Factors, Immunologic|IM; T-Lymphocytes, Suppressor-Effector|IM; Ultraviolet Rays

Publication Type
JOURNAL ARTICLE
ISSN
0041-1337
Country of Publication
UNITED STATES


Record 124 from database: MEDLINE
Order full text for this document

Title
Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
Author
Ng YC; Schifferli JA; Walport MJ
Address
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London.
Source
Clin Exp Immunol, 1988 Mar, 71:3, 481-5
Abstract
We performed experiments to investigate whether immune complexes opsonized with C3b and iC3b transferred from CR1 on one erythrocyte to CR1 on others, and studied the effect of variation in erythrocyte CR1 number on the transfer reaction. We used populations of cells of different blood groups to study this phenomenon which were separated by differential agglutination with monoclonal anti-group antibodies. The rate of transfer of immune complexes between erythrocytes was related to CR1 concentration of both donor and recipient cells; fastest transfer occurred from donor cells of low CR1 numbers to recipient cells of high CR1. These results were not explained by a difference in the binding constant of immune complexes to erythrocytes bearing different numbers of CR1. In the absence of factor I, complexes partitioned between erythrocytes according to their relative concentrations of CR1 with no release of complexes into solution. In serum, the proportion of complexes bound to donor and recipient erythrocytes was similarly related to their respective CR1 numbers with progressive release of complexes into solution. Erythrocyte CR1 may act as a dynamic buffering system which prevents immune complexes that have bound complement from fixing to vascular endothelium.
Language of Publication
English
Unique Identifier
88253859

Order full text for this document


MeSH Heading (Major)
Antigen-Antibody Complex|*ME; Erythrocytes|*IM; Receptors, Complement|*IM
MeSH Heading
Cells, Cultured; Complement 3b|IM; Human; Support, Non-U.S. Gov't; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0009-9104
Country of Publication
ENGLAND


Record 125 from database: MEDLINE
Order full text for this document

Title
Occurrence of platelet basic protein, a precursor of low affinity platelet factor 4 and beta-thromboglobulin, in human platelets and megakaryocytes.
Author
Holt JC; Rabellino EM; Gewirtz AM; Gunkel LM; Rucinski B; Niewiarowski S
Address
Thrombosis Research Center, Temple University, Philadelphia, Pennsylvania 19140.
Source
Exp Hematol, 1988 May, 16:4, 302-6
Abstract
beta-thromboglobulin antigen, a platelet-specific secreted protein, occurs in three forms: platelet basic protein, low affinity platelet factor 4, and beta-thromboglobulin. The combined level of beta-thromboglobulin antigen in megakaryocytes, measured by radioimmunoassay, was 13 +/- 7 micrograms/10(6) cells (SD, n = 6). The relative proportions of the three forms of beta-thromboglobulin antigen present within platelets and megakaryocytes were determined in cells lysed with trichloroacetic acid to minimize artifactual proteolysis. Samples were analyzed by isoelectric focusing in polyacrylamide gel with quantitative immunological detection on a nitrocellulose transfer of the gel. In platelets, the major species found was low affinity platelet factor 4 with precursor platelet basic protein as only 25% +/- 11% (SD, n = 16) of total beta-thromboglobulin antigen. In megakaryocytes partially purified both from normal bone marrow aspirates and from whole marrow specimens obtained after surgery, platelet basic protein was a higher proportion of beta-thromboglobulin antigen (49% +/- 13% SD, n = 11) than was the case in platelets. beta-thromboglobulin itself was never detected under the conditions of cell lysis used. Our results suggest that platelet basic protein is synthesized in megakaryocytes and that its cleavage is associated with an earlier stage of cell development than simply maturation to platelets. Further support for the precursor status of platelet basic protein was found in the expression of predominantly this antigenic form in a human erythroleukemia cell line.
Language of Publication
English
Unique Identifier
88196261

Order full text for this document


MeSH Heading (Major)
beta-Thromboglobulin|*IM; Blood Coagulation Factors|*AN/IP; Blood Platelets|*AN/IM; Isoantigens|*AN/IP; Megakaryocytes|*AN/IM; Protein Precursors|*BL/IP
MeSH Heading
Cell Line; Human; Leukemia, Erythroblastic, Acute|AN/BL/IM; Proteins|IP; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Tumor Cells, Cultured

Publication Type
JOURNAL ARTICLE
ISSN
0301-472X
Country of Publication
UNITED STATES


Record 126 from database: MEDLINE
Order full text for this document

Title
New function of vitamin B12: cobamide-dependent reduction of epoxyqueuosine to queuosine in tRNAs of Escherichia coli and Salmonella typhimurium.
Author
Frey B; McCloskey J; Kersten W; Kersten H
Address
Institut fÂur Biochemie, UniversitÂat Erlangen-NÂurnberg, Federal Republic of Germany.
Source
J Bacteriol, 1988 May, 170:5, 2078-82
Abstract
Queuosine (Q), 7-[(4,5-cis-dihydroxy-2-cyclopentene-1-yl)-amino)methyl)-7- deazaguanosine, and Q derivatives usually replace guanosine in the anticodon of tRNAs(GUN) of eubacteria and of cytoplasmic and mitochondrial tRNAs of lower and higher eucaryotes except yeasts. Q appears to be synthesized de novo exclusively in eubacteria, and the free-base queuine serves as a nutrient factor for eucaryotes. Recently, a Q derivative, oQ, containing a 2,3-epoxy-4,5-dihydroxycyclopentane ring, has been identified in Escherichia coli tRNA(Tyr). Here we show that oQ is formed when E. coli or Salmonella typhimurium is grown in glucose-salt medium. The formation of oQ was independent of molecular oxygen, and oQ-tRNAs were converted to Q-tRNAs by adding cobalamin to the growth medium. Under strictly anaerobic conditions, considerable amounts of Q were present in E. coli and S. typhimurium tRNAs when the bacteria were grown in the presence of cobalt ions with glycerol as the carbon source and fumarate as the electron acceptor. Under these conditions, the biosynthesis of cobalamin was induced. The results suggest that oQ is derived from ribose and that oQ is finally reduced to Q by a cobamide-dependent enzyme.
Language of Publication
English
Unique Identifier
88197994

Order full text for this document


MeSH Heading (Major)
Escherichia coli|GE/*ME; Guanosine|*AA; Nucleoside Q|*AA/*BI/GE/ME; Salmonella typhimurium|GE/*ME; Vitamin B 12|*ME
MeSH Heading
Aerobiosis; Anaerobiosis; Chemistry; Chromatography, High Pressure Liquid; Cobamides|ME; Oxidation-Reduction; RNA, Transfer|AN; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0021-9193
Country of Publication
UNITED STATES


Record 127 from database: MEDLINE
Order full text for this document

Title
Effects of photoperiod and temperature on the binding of follicle-stimulating hormone (FSH) to testicular preparations and plasma FSH concentration in the Djungarian hamster, Phodopus sungorus.
Author
Tsutsui K; Kawashima S; Masuda A; Oishi T
Address
Zoological Institute, Faculty of Science, Hiroshima University, Japan.
Source
Endocrinology, 1988 Mar, 122:3, 1094-102
Abstract
The effects of artificial photoperiod and temperature on testicular FSH binding and plasma FSH levels were studied in adult male Djungarian hamsters. In Exp I, hamsters were transferred to long day (LD) photoperiods (16-h light, 8-h dark) after 8 weeks of adaptation in short day (SD) photoperiods (8-h light, 16-h dark), but the ambient temperature was maintained at 25 C throughout the experiments. A marked increase in the total FSH binding per two testes occurred between 10 and 47 days after transfer to LD, a change that was accompanied by testicular growth. Binding of FSH per testicular weight decreased during the same period. Scatchard plot analyses of the parameters indicated that LD decreased both the concentration of FSH binding sites and the equilibrium dissociation constant (Kd). Plasma FSH levels increased between 10 and 47 days after transfer to LD. In contrast, when hamsters reared under LD for 12 weeks were transferred to SD (Exp II), FSH binding per unit weight basis increased 19 weeks after transfer to SD, but the total binding per two testes decreased markedly. In Exp III, sexually mature male hamsters were subjected to different ambient temperature and photoperiods. There were no significant effects of different ambient temperatures on the testicular weight and testicular FSH binding in animals exposed for 8 weeks to either LD or SD. However, plasma FSH levels of hamsters maintained at 25 C under LD was significantly higher than FSH levels at 7 C under LD. A similar effect of temperature on plasma FSH levels was observed in hamsters under SD. The present study indicates that photoperiod is a more important environmental factor than temperature for the regulation of FSH receptor in the Djungarian hamster.
Language of Publication
English
Unique Identifier
88137119

Order full text for this document


MeSH Heading (Major)
FSH|BL/*ME; Light|*; Periodicity|*; Testis|GD/*ME/RE
MeSH Heading
Animal; Binding, Competitive; Comparative Study; Hamsters; Male; Organ Weight|RE; Receptors, FSH|ME; Support, Non-U.S. Gov't; Temperature

Publication Type
JOURNAL ARTICLE
ISSN
0013-7227
Country of Publication
UNITED STATES


Record 128 from database: MEDLINE
Order full text for this document

Title
The trigeminal system: an advantageous experimental model for studying neuronal development.
Author
Davies AM
Address
Department of Anatomy, St. George's Hospital Medical School, Tooting, London.
Source
Development, 1988, 103 Suppl:, 175-83
Abstract
The trigeminal system is a well-characterized sensory system that has been studied extensively in mammals and birds. The clear definition and easy accessibility of the components of this system throughout development have facilitated investigation of several fundamental aspects of neural development. This has led to important advances in our understanding of the mechanism of axonal guidance, the physiology of neurotrophic factors and the establishment and refinement of neural connections. The first convincing evidence for axonal guidance by chemotropism has been obtained. The site and timing of nerve growth factor (NGF) synthesis and NGF receptor expression have been elucidated, thereby clarifying the role of this neurotrophic factor in development. A novel concept in neurotrophic factor physiology has emerged: the survival of neurones that innervate two separate target fields is regulated by two different neurotrophic factors derived from the respective target fields. The development of somatotopic maps of the periphery in the central nervous system (CNS) is dependent on spatial information provided by the periphery. The transfer of this information from the periphery to the CNS is not simply achieved by the ordered growth and arrangement of the intervening sensory nerve fibres.
Language of Publication
English
Unique Identifier
89276122

Order full text for this document


MeSH Heading (Major)
Models, Biological|*; Nerve Growth Factors|*PH; Trigeminal Ganglion|*EM; Trigeminal Nerve|*EM
MeSH Heading
Animal; Chick Embryo; Mice

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, ACADEMIC
ISSN
0950-1991
Country of Publication
ENGLAND


Record 129 from database: MEDLINE
Order full text for this document

Title
The role of lateral extra-articular procedures for anterolateral rotatory instability.
Author
Carson WG Jr
Address
Department of Orthopaedics, University of South Florida, College of Medicine, Tampa.
Source
Clin Sports Med, 1988 Oct, 7:4, 751-72
Abstract
The goal of any surgical procedure to correct the instability caused by loss of the ACL is to control the abnormal anterior excursion of the tibia on the femur. Because the main problem is loss of the ACL, it would seem most reasonable to approach this problem by performing an intra-articular reconstruction of the ACL, thus approximating as closely as possible the normal anatomy of the ACL. The classic open intra-articular ACL reconstructions are technically demanding surgical procedures that usually require a significant "learning curve" to achieve a level of technical expertise and confidence. In addition, postoperative complications such as adhesions, loss of motion, prolonged muscle atrophy, and a long rehabilitation period are well known. Thus, it would appear that the extra-articular reconstructive procedures for the anterior cruciate-deficient knee would offer some advantage over these more formidable surgical procedures. Whereas the main problem is certainly the loss of the ACL, the extra-articular procedures are directed more toward the most symptomatic anterior excursion of the tibia on the femur, the pivot shift phenomenon, where the anterolateral portion of the tibia moves anterior in relation to the femur. Thus, the goal of the extra-articular reconstructive procedures for anterolateral rotatory instability is to eliminate functional instability. These goals are most readily achieved by positioning some portion of the iliotibial tract posterior to the transverse center of rotation of the knee to provide a reinforcement for the lateral tibial plateau as the knee approaches terminal extension. All of the extra-articular procedures discussed in this article have been used successfully as reported by the various authors. There are many technical details inherent in each of these surgical procedures, and the reader is referred to the original articles for a more explicit description of these surgical procedures. For the individual surgeon to participate in and view the actual surgical procedure that he or she intends to perform would be the ideal situation. Various workshops where surgical procedures of the knee are actually performed and studied are currently available and are of great value to the surgeon. Of equal importance to the technical demands of the various surgical procedures is selection of the appropriate procedure for each patient. The selection must be based on many factors. The most important factor is the identification of the patient with a high level of athletic activity who is unwilling to modify his or her activity level to compensate for a deficient ACL.(ABSTRACT TRUNCATED AT 400 WORDS)
Language of Publication
English
Unique Identifier
89028800

Order full text for this document


MeSH Heading (Major)
Arthroplasty|*MT; Joint Instability|PP/*SU; Knee Injuries|PP/*SU; Tendon Transfer|*MT
MeSH Heading
Athletic Injuries|PP/SU; Human; Ligaments, Articular|IN/PP/SU; Rotation; Rupture

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0278-5919
Country of Publication
UNITED STATES


Record 130 from database: MEDLINE
Order full text for this document

Title
Induced type-B reticulum cell neoplasia in mice III. The importance of T-cell proliferation and cellular relocation in accessory cell transformation.
Author
Brittle MP; Wallis VJ; Chaudhuri M; Goucher RA; Gomer KJ
Address
Chester Beatty Laboratories, London, UK.
Source
Br J Cancer, 1988 Apr, 57:4, 378-84
Abstract
After the transfer of spleen cells from old CBA/T6T6 mice (greater than 75 weeks) into young syngeneic CBA/Ca recipients there usually follows a selective expansion of the donor T-cell population and the emergence of type B reticulum cell neoplasms (RCN-B), also of donor origin though probably derived not from the T-cells but from lymphoid dendritic accessory cells. As few as one million injected cells led to significant donor T-cell hyperplasia and tumour induction. Injection of cells from young donors did not have such consequences. Similar tumours were induced by transferring syngeneic cells in both C57BL and DBA/2 mice, although in the latter strain there was no requirement for the injected cells to derive from old donors. It appeared that T-cell proliferation was independent of donor accessory cells or RCN-B induction, since injection of enriched T-cells led to few tumours, although the T-cell chimaerism was indistinguishable from that in recipients of unseparated spleen cells. Development of tumours, however, seemed to be dependent upon stimulated T-cells. Recipients of spleen cells from old T-cell-deprived mice did not develop tumours; conversely, tumours, mostly of donor origin, were induced in recipients of young syngeneic cells when an extrinsic stimulus to T-cell proliferation was provided by continued allostimulation. The apparent selectivity of tumorigenesis for donor cells has led to the proposal that cellular relocation, as a result of transfer, may be an important predisposing factor in malignant transformation in circumstances of T-cell stimulation provided by antigenic challenge or by transfer of T-cells from old donors.
Language of Publication
English
Unique Identifier
88269399

Order full text for this document


MeSH Heading (Major)
Antigen-Presenting Cells|*IM; Cell Transformation, Neoplastic|*PA; Lymphoma, Large-Cell|*ET; T-Lymphocytes|*IM
MeSH Heading
Age Factors; Animal; Antigens, Surface|AN; Cell Count; Dose-Response Relationship, Immunologic; Female; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mitosis; Neoplasm Transplantation; Spleen|TR; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0007-0920
Country of Publication
ENGLAND


Record 131 from database: MEDLINE
Order full text for this document

Title
Analysis of ultrafiltration and mass transfer in a bioartificial pancreas.
Author
Jaffrin MY; Reach G; Notelet D
Address
DÆepartement de GÆenie Biologique, UniversitÆe de Technologie de CompiÄegne, France.
Source
J Biomech Eng, 1988 Feb, 110:1, 1-10
Abstract
A bioartificial pancreas is an implantable device which contains insulin secreting cells (Langerhans islets), separated from the circulating blood by a semi-permeable membrane to avoid rejection. This paper describes the operation of such a device and evaluates the respective contributions of diffusion and ultrafiltration to the glucose and insulin mass transfer. It is shown that the pressure drop along the blood channel produces across the first half of the channel an ultrafiltration flux toward the islet compartment followed in the second half by an equal flux in reverse direction from islets to blood. The mass transfer analysis is carried out for an optimal geometry in which a U-shaped blood channel surrounds closely a very thin islet compartment formed by a folded flat membrane. A complete model of insulin release by this device is developed and is compared with in vitro data obtained with rats islets. Satisfactory kinetics is achieved with a polyacrylonitrile membrane used in hemodialysis. But the model shows that the membrane hydraulic permeability should be increased by a factor of 10 to significantly improve the performance.
Language of Publication
English
Unique Identifier
88156177

Order full text for this document


MeSH Heading (Major)
Glucose|*PK; Insulin|*PK; Insulin Infusion Systems|*; Membranes, Artificial|*; Models, Biological|*
MeSH Heading
Acrylic Resins; Animal; Biological Transport; Islets of Langerhans|SE; Rats; Support, Non-U.S. Gov't; Ultrafiltration

Publication Type
JOURNAL ARTICLE
ISSN
0148-0731
Country of Publication
UNITED STATES


Record 132 from database: MEDLINE
Order full text for this document

Title
IL-1 inhibits B cell differentiation in long term bone marrow cultures.
Author
Dorshkind K
Address
Division of Biomedical Sciences, University of California, Riverside 92521.
Source
J Immunol, 1988 Jul, 141:2, 531-8
Abstract
There is evidence that stromal cells are responsive to changes in their external milieu and that this can affect their function. IL-1 has been identified as one mediator that can affect stromal cells by increasing their secretion of CSF. The monokine has also been reported to be a B cell differentiation factor. The purpose of this study was to test the effects of IL-1 on the pattern of hemopoietic cell differentiation by adding IL-1 alpha to myeloid long term bone marrow cultures (MBMC) at the time of their transfer to lymphoid bone marrow culture conditions. This usually results in the cessation of myelopoiesis and the induction of B lymphopoiesis. The addition of 50 U/ml of rIL-1 alpha, but not 10 U/ml, to MBMC at the time of their transfer to lymphoid conditions resulted in a complete inhibition of B cell differentiation and sustained myelopoiesis. To determine whether adherent layer cells contributed to this effect, conditioned medium (CM) was collected from adherent layers treated previously with the antibiotic mycophenolic acid. This depletes the hemopoietic cells from the cultures and retains a purified population of stromal cells. CM from mycophenolic acid- treated adherent layers exposed for 24 h to 50 U/ml of IL-1 was added at volume concentrations of 5, 10, and 25% to MBMC at the time of transfer to lymphoid bone marrow culture conditions and at each feeding thereafter. Expression of the B lineage associated 14.8 Ag and IgM was inhibited on a dose dependent basis, and myelopoiesis was sustained in cultures to which 25% CM had been added. Induction of B lymphopoiesis occurred in cultures to which adherent cell CM not exposed to IL-1 had been added. The CM from the IL-1-treated adherent cells contained CSF, because it promoted the growth of myeloid colonies from fresh marrow or MBMC cells and stimulated the granulocyte-macrophage-CSF sensitive FDC-P1 cell line to proliferate. IL-3 was not present in the CM, because stimulation of the IL-3 sensitive 32D cell line was not observed. The CM from the IL-1-treated adherent cells stimulated thymocytes to proliferate in the presence of PHA. This raised the possibility that the induced CSF may have required IL-1 to mediate their effects in the cultures. However, B lymphopoiesis was inhibited and myelopoiesis maintained upon addition of recombinant granulocyte-, macrophage-, and granulocyte-macrophage-CSF to cultures, indicating that IL-1 or other non-CSF molecules induced by it need not be present.(ABSTRACT TRUNCATED AT 400 WORDS)
Language